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 1 Introduction 
 
1.1 Cell growth and ribosome biogenesis 
 
A growing cell needs to synthesize numerous biomolecules to gain size and to divide. 
Especially a large number of proteins must be produced, as they are either directly or 
indirectly involved in almost every cellular function. Prerequisite to this task is the provision 
of a sufficiently large quantity of ribosomes (Rudra and Warner, 2004). The cells in a 
logarithmically growing culture of the budding yeast Saccharomyces cerevisiae contain about 
200.000 ribosomes and accordingly need to produce up to 2000 new ribosomes per minute 
during each round of the cell cycle (Warner, 1999).  
Ribosome biogenesis is a very complex and consumptive process (Figure 1) (Tschochner and 
Hurt, 2003). The mature yeast ribosome consists of four different ribosomal RNAs (rRNA) 
plus 79 ribosomal proteins (RP), arranged in two separate subunits (Wilson and Nierhaus, 
2003; Link et al., 1999; Gerbasi et al., 2004). The production of these components involves a 
considerable portion of the capacities of the cellular transcription, translation and transport 
machineries. For instance the transcription of rRNA by RNA polymerase I (Pol I) accounts 
for 60% of the total transcription of a yeast cell (Warner, 1999). 50 % of all RNA polymerase 
II (Pol II) transcription initiation events give rise to a messenger RNA (mRNA) for one of the 
ribosomal proteins, which in turn need to be translated and the products transferred into the 
nucleus. The successive assembly of the pre-ribosomes, their maturation and intracellular 
transport involves about 150 ribosome biogenesis factors and 100 snoRNPs (Tschochner and 
Hurt, 2003; Kressler et al., 1999).  
 
Thus, while a high rate of ribosome production is required for a fast growth rate, the 
associated consumption of a high percentage of the cells resources necessitates a very tight 
regulation in dependence of the growth conditions, like the availability of nutrients (Warner, 
1999). The status of these determinants for cell growth is forwarded to key regulatory steps of 
the ribosome biogenesis machinery via signal transduction pathways, including the TOR 
(Target Of Rapamycin) and PKA (Protein Kinase A) pathways (Warner, 1999; Rudra and 
Warner, 2004). In the resulting regulatory network different positive or negative signals are 
integrated to precisely adjust the activities of the target proteins. Intracellular signal 
transduction is commonly accomplished via reversible phosphorylation through protein 
kinase cascades. Phosphorylation at specific sites modulates the functions of the enzymes in 
the pathway and finally of the target proteins, e.g. by changing the activities, facilitating 
specific interactions or initiating transports to other cellular compartments (Cohen, 2002; 
Hunter, 2000; Pawson and Scott, 2005). 
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Figure 1. Overview of ribosome biogenesis. The rRNA is transcribed as one large polycistronic precursor by 
RNA polymerase I and subsequently cleaved during several maturation steps. About 150 ribosome biogenesis 
factors associate dynamically to the intermediate complexes and about 100 snoRNPs guide the modifications of 
the rRNA. Furthermore the 79 ribosomal subunits are assembled during the maturation steps to yield the large 
60S and the small 40S ribosomal subunits. [from Tschochner and Hurt, 2003] 
 
 
About 30 years ago, in vivo phosphorylated subunits have been discovered in the yeast Pol I 
complex (Bell et al., 1976; Bell et al., 1977a; Buhler et al., 1976b) (see 1.2.5). As one of the 
first steps of ribosome biogenesis, the transcription of the large rRNA-precursor by Pol I is 
also one of the main targets for regulation, and a number of experiments have shown that 
Pol I activity is linked to its phosphorylation state (Fath et al., 2001; Fath et al., 2004). 
However, little is known about the positions and functions of these post-translational 
modifications. 
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1.2 The RNA Polymerase I transcription system of Saccharomyces cerevisiae 
 
1.2.1 Cellular localization, template and promoter of Pol I  
 
1.2.1.1 The nucleolus 
 
The major site of ribosome biogenesis in eukaryotic cells is the nucleolus, a specialized sub-
compartment of the nucleus. This highly dynamic subnuclear organelle assembles around the 
cluster of tandemly repeated ribosomal DNA (rDNA) genes upon the presence of rRNA 
precursor transcripts (Trumtel et al., 2000; Dousset et al., 2000) and is large enough to be 
visible in conventional light microscopy. Under the electron microscope (EM), three 
morphological different regions of the nucleolus can be distinguished (Léger-Silvestre et al., 
1999) (Figure 2). Early to late steps of ribosome biogenesis have been assigned to these 
structures according to protein localizations, in-situ hybridizations or aberrant morphologies 
in conditional mutants (Léger-Silvestre et al., 1999, Oakes et al., 1998; Trumtel et al., 2000). 
The rDNA is localized in the fibrillar center (FC). Pol I is concentrated at the boundary 
between the FC and the surrounding dense fibrillar component (DFC), and apparently this is 
also the site of rDNA transcription. The nascent pre-rRNA seems to spread into the DFC, 
where the first processing steps occur. Further ribosome maturation occurs in the granular 
component (GC), before the assembled ribosomal subunit precursors leave the nucleolus.  
 
 
 
 
 
Figure 2. The nucleolus of Saccharomyces cerevisiae. The electron micrograph shows the nucleus surrounded 
by the nuclear envelope, including nuclear pores (asterisks). The nucleolus can be seen as a crescent-shaped 
density inside the nucleus. Three morphological different regions can be distinguished in the nucleolus: the 
fibrillar center (FC), the dense fibrillar component (DFC) and the granular component (GC). The bar represents 
200 nm. [from Léger-Silvestre et al., 1999] 
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Interestingly, the nucleolus is not exclusively dedicated to the production of ribosomes 
(Pederson, 1998; Boisvert et al., 2007). Throughout the last years, additional functions of this 
organelle have been reported, linking it to the regulation of mitosis and cell-cycle progression, 
stress-response or the maturation of other ribonucleoprotein particles like snRNPs (Visintin 
and Amon, 2000; Boisvert et al., 2007; Gerbi et al., 2003).  
 
 
1.2.1.2 The ribosomal DNA genes 
 
Multiple copies of the rDNA genes exist in all eukaryotic organisms studied so far. In 
S. cerevisiae a cluster of approximately 150 rDNA repeats is localized on chromosome XII 
(Schweizer et al., 1969; Petes 1979). Each of the head-to-tail arranged 9.1 kb rDNA units 
contains a gene for the 35S pre-rRNA (Bell et al., 1977b; Nath and Bollon, 1977) (Figure 3), 
but only approximately 50 % are actively transcribed by Pol I at a time (Dammann et al., 
1993). The active genes seem to be randomly distributed in the 150 repeats and can be 
distinguished from the inactive genes by their chromatin structure (Dammann et al., 1993; 
Dammann et al., 1995). 
 
 
 
 
 
Figure 3. Scheme of a yeast rDNA unit. The 18S, 5.8S and 25S rRNA are transcribed as a 35S polycistronic 
precursor rRNA by Pol I. The gene for the 5S rRNA transcribed by Pol III is located between two 35S rRNA 
genes and coded on the opposite strand. A number of cis-acting elements were identified in the non-transcribed 
spacers (NTS): Pol I promoter (P); Pol I terminator / enhancer (T/E); autonomous replication sequence (ARS); 
replication fork barrier (RFB); recombination hot-spot 1 (HOT1). [from Nomura et al., 2004 (modified)] 
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The 35S pre-rRNA includes three of the four rRNA species found in mature ribosomes, 
transcribed as one large polycistronic precursor. In 5’→ 3’ direction, the 18S rRNA (the RNA 
component of the small ribosomal subunit) is followed by the 5.8S and the 25S rRNAs (both 
RNA components of the large ribosomal subunit, along with the 5S rRNA) (Udem and 
Warner, 1972; Bell et al., 1977b; Nath and Bollon, 1977). They are separated on the primary 
transcript by the two internal transcribed spacer sequences ITS1 and ITS2 and framed by the 
5’ and 3’ external transcribed spacers (5’- and 3’-ETS, respectively). As an exception to most 
other eukaryotic organisms, in yeast the 5S rRNA gene which is transcribed by RNA 
polymerase III (Pol III) is also included in each rDNA unit (Rubin and Sulston, 1973). It is 
located within the intergenic spacer (IGS) between the 35S rRNA genes, coded on the 
opposite DNA-strand and accordingly transcribed into the other direction (Kramer et al., 
1978; Philippsen et al., 1978). Despite the spatial proximity of the two rDNA genes, there is 
no apparent direct coupling of their transcription, e.g. via cis-acting elements (Paule, 1998; 
Neigeborn and Warner, 1990).  
 
A number of cis-elements were identified in the IGS region and have been extensively studied 
(Figure 3). They include an autonomous replication sequence (ARS) in each rDNA unit and a 
replication fork barrier (RFB), allowing DNA replication only in the same direction as Pol I 
transcription (Brewer and Fangman, 1988; Brewer et al., 1992). The RFB-element was also 
shown to be part of a recombination hot spot termed HOT1 (Voelkel-Meiman et al., 1987; 
Ward et al., 2000) along with an adjacent element originally termed Pol I enhancer (Elion and 
Warner, 1986; Wai et al., 2001) and the Pol I promoter (Musters et al., 1989). Pol I 
transcription terminator elements can be found at the 3’ end of the 35S rDNA gene, but also 
directly upstream of the Pol I promoter (Lang and Reeder, 1993; Lang and Reeder, 1995; 
Reeder et al., 1999; Kulkens et al., 1989; Morrow et al., 1989). The function of the upstream 
terminator does not seem to be related to transcription termination, because unlike described 
for metazoan rDNA repeats, no additional functional Pol I promoters in the IGS (termed 
spacer promoters) were found in yeast (Paule, 1998; Moss and Birnstiel, 1979; Murtif and 
Rae, 1985; Cassidy et al., 1987). Moreover the ‘ribomotor’ model has been proposed 
describing a direct interaction between factors bound to the 5’- and 3’-terminator elements, 
resulting in consecutive loops of the 35S rRNA gene and the IGS including the 5S rRNA gene 
(Kempers-Veenstra et al., 1986; Kulkens et al., 1992; Planta, 1997). As a consequence Pol I 
molecules terminating at the end of the transcript would be in close proximity to the promoter 
for re-initiation, thus facilitating the high processivity of the Pol I transcription system.  
 
 
 5
 Introduction 
1.2.1.3 The rDNA promoter and Pol I transcription factors 
 
The Pol I promoter in the rDNA of S. cerevisiae has been mapped to the region from - 155 to 
+ 24 base pairs (bp) relative to the transcription start site of the 35S rRNA (Musters et al., 
1989). It consists of two DNA elements (Figure 4), namely the core element (- 28 to + 8 bp), 
an essential element spanning the transcription start site, and the upstream element (- 146 to 
- 50 bp), which is dispensable for transcription initiation in vitro, but required to achieve high 
levels of transcription (Musters et al., 1989; Kulkens et al., 1991; Keys et al., 1996; Kenner et 
al., 1998). The correct spacing between the elements was demonstrated to be crucial for 
efficient transcription initiation (Musters et al., 1989; Choe et al., 1992). Most of the 
transcription factors binding to the promoter elements are specific for the Pol I transcription 
system (Nogi et al., 1991b), but also more common proteins like the histones H3 and H4 or 
the TATA-binding protein (TBP) are involved (Keener et al., 1997; Cormack and Struhl, 
1992; Schultz et al., 1992; Hernandez, 1993). 
 
 
 
 
 
Figure 4. Pol I initiation complex at the yeast rDNA promoter. The multiprotein factors UAF (upstream 
activating factor) and CF (core factor) bind to the UE (upstream element) and core element, respectively, 
connected by TBP (TATA binding protein). The initiation-competent Pol I-Rrn3p-complex binds to the Rrn6p-
subunit of the core factor to initiate transcription. Hmo1p can be found throughout the complete rDNA gene; its 
role in transcription initiation at the rDNA promoter is unclear. [from Moss, 2004] 
 
 
The upstream element is recognized by the multiprotein complex ‘upstream activation factor’ 
(UAF) (Keys et al., 1996). It consists of six subunits: Rrn5p, Rrn9p, Rrn10p, Uaf30p and the 
histones H3 and H4 (Keys et al., 1996; Siddiqi et al., 2001; Keener et al., 1997).  Besides its 
stimulatory function, UAF has been shown to be crucial to maintain an epigenetic state, which 
allows only Pol I transcription from this promoter. In yeast strains carrying the deletion of a 
gene for any of the Pol I specific components of UAF, a polymerase switch phenotype can be 
observed, i.e. the rRNA is transcribed from the chromosomal locus by Pol II, albeit with an 
altered transcription start site (Vu et al., 1999; Oakes et al., 1999; Siddiqi et al., 2001).  
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The ‘core factor’ (CF) is another Pol I specific multiprotein transcription factor. It binds to the 
essential core element and is sufficient for a basal transcription level in vitro (Kulkens et al., 
1991; Keener et al., 1998). The three components of the core factor are Rrn6p, Rrn7p and 
Rrn11p (Keys et al., 1994; Lalo et al., 1996; Lin et al., 1996). The TATA-binding protein 
(TBP) was also described to complex with CF, but it is not required for the basal in vitro 
transcription (Keener et al., 1998). Moreover it was shown to interact with components of 
both, UAF and CF, thus helping to recruit CF to the promoter after the initial binding of UAF 
(Steffan et al., 1996; Steffan et al., 1998). 
 
The resulting assembly is capable to recruit an initiation-competent form of Pol I, i.e. Pol I in 
complex with the specific transcription factor Rrn3p (Yamamoto et al., 1996; Milkereit and 
Tschochner, 1998). Rrn3p is required for Pol I transcription initiation (Keener et al., 1998), 
and the template-independent pre-formation of the Pol I-Rrn3p-complex (Yamamoto et al., 
1996; Schneider and Nomura, 2004) seems to be a crucial step in the regulation of Pol I 
transcription (Milkereit and Tschochner, 1998; Peyroche et al., 2000; Claypool et al., 2004; 
Laferté et al., 2006). Rrn3p bridges Pol I to the Rrn6p subunit of CF, thus bringing the 
polymerase into the correct position for transcription initiation (Peyroche et al., 2000). 
 
Additionally, Hmo1 can be found at the rDNA promoter, as well as throughout the complete 
rDNA gene (Hall et al., 2006). It has a stimulating effect on Pol I transcription and is 
synthetic lethal with some non-essential Pol I subunits (see 1.2.3.5 and 1.2.3.6) (Gadal et al., 
2002; Berger et al., 2007), but its function is not known yet. Hmo1 is also present at the 
promoters of many genes coding for ribosomal proteins (RPs) (Hall et al., 2006), and was 
suggested to be involved in the coordination of rDNA transcription and the expression of RPs 
(Berger et al., 2007).  
 
 
1.2.2 Pol I is one of three conserved nuclear multisubunit RNA polymerases 
 
1.2.2.1 The nuclear RNA polymerases and their functions in the cellular transcription 
apparatus 
 
Pol I is one of three nuclear RNA polymerases present in all eukaryotic cells (Roeder and 
Rutter, 1969; Roeder and Rutter, 1970; Ponta et al., 1971; Adman et al., 1972). After the 
initial characterizations of a bona fide single eukaryotic RNA polymerase (Weiss and 
Gladstone, 1959; Weiss, 1960; Furth and Loh, 1963; Frederick et al., 1969), the transcription 
activity in crude nuclear extracts was found to be further separable on DEAE anion exchange 
chromatography columns (Roeder and Rutter, 1969). The order of their elution gave also rise 
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to the nomenclature of RNA polymerase I, II and III (or RNA polymerase A, B and C, 
respectively).  
Recently the ongoing genome sequencing projects of various organisms have revealed a 
fourth subclass of nuclear RNA polymerases in plants, referred to as RNA polymerase IV 
(Pol IV) (Arabidopsis Genome Initiative, 2000; Vaughn and Martienssen, 2005). However, 
the corresponding genes are absent in all fungi, animals and protozoa sequenced so far. 
According to phylogenetic analyses, Pol IV is most likely a variant of Pol II, which evolved 
from the duplication of the genes for the two largest subunits (Luo and Hall, 2007). 
 
Each nuclear RNA polymerase synthesizes specific classes of RNAs. As already mentioned, 
RNA polymerase I transcribes the large polycistronic precursor for three of four ribosomal 
RNAs (Tocchini-Valentini and Crippa, 1970; Zylber and Penman, 1971; Reeder and Roeder, 
1972; Nogi et al., 1991b). Apparently this is the only essential role of Pol I as demonstrated 
by the possibility to rescue deletion strains of essential Pol I subunits. Functional 35S rRNA 
can be produced from cloned rDNA genes under the control of a Pol II promoter to 
complement the loss of Pol I function (Nogi et al., 1991a; Nogi et al., 1991b).  
The primary but not exclusive role of RNA polymerase II is the transcription of mRNAs from 
protein-coding genes (Suzuki and Giza 1976; Detke et al., 1978; Lee and Young, 2000). 
Furthermore Pol II is involved in the production of many non-coding RNAs including 
snRNAs, snoRNAs, siRNAs and microRNAs (Kiss, 2004; Costa, 2005; Mattick and 
Makunin, 2006). 
Pol III has two main functions in the cellular transcription apparatus, namely the production 
of the tRNAs and of the small 5S rRNA (Weinmann and Roeder 1974; Weil and Blatti 1976). 
Additionally the U6 snRNA is synthesized by this RNA polymerase (Kiss, 2004). 
The plant-specific Pol IV appears to be dedicated to the production of siRNAs (Zhang et al., 
2007). 
 
One characteristic feature often used to distinguish the three common nuclear RNA 
polymerases in experiments is their different sensitivity to the inhibitor α-amanitin, a toxic 
cyclic octapeptide from the death cap mushroom Amanita phalloides (Wieland, 1968). While 
Pol II is completely inhibited at low concentrations, Pol III can resist higher inhibitor 
concentrations, and Pol I is insensitive to α-amanitin (Lindell et al., 1970; Kedinger et al., 
1970; Bushnell et al., 2002). In yeast however, Pol I was found to be even more α-amanitin-
sensitive than Pol III (Schultz et al., 1976; Valenzuela et al., 1976b). 
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1.2.2.2 Composition of yeast Pol I  
 
The gene-specificity of the RNA polymerases is accomplished through interactions with other 
proteins of the different transcription machineries, including the corresponding transcription 
factors which recognize specific promoter elements. The enzymatic transcription activity is 
identical for all RNA polymerases. This is reflected by the high level of conservation between 
the cellular RNA polymerases (eukaryotic nuclear RNA polymerases, as well as the RNA 
polymerases of eubacteria and archaea) (Allison et al., 1985; Berghöfer et al., 1988; Langer et 
al., 1995). They are all multiprotein complexes, consisting of two large subunits, which 
harbor the active center, and a number of smaller subunits, required for enzyme assembly, 
regulation and protein interactions (Cramer, 2002).  
 
 
Table 1. The subunits of yeast RNA polymerase I, their counterparts in other RNA polymerases and the 
genes coding for the Pol I subunits. 
 
 
*RPO26 contains an intron (bp 21-96; 911273-911348). 
 
 
Yeast RNA polymerase I consists of 14 subunits (Table 1; Carles et al., 1991; Paule, 1999), as 
revealed by the analyses of Pol I-complexes purified by diverse methods and to different 
extents of completeness and purity (Ponta et al., 1972; Buhler et al., 1974; Van Keulen et al., 
1975; Valenzuela et al., 1976a; Hager et al., 1977; Keener et al., 1998). However, the detailed 
composition of yeast Pol I remained unclear for a long time due to the nearly identical sizes of 
some small subunits (Carles et al., 1991). The high degree of conservation especially between 
the three classes of eukaryotic nuclear RNA polymerases is further underlined by the 
existence of a number of shared subunits. Two subunits are identical in Pol I and Pol III 
(Valenzuela et al., 1976d; Mann et al., 1987; Dequard-Chablat et al., 1991), and another five 
subunits are common to all three RNA polymerases (Buhler et al., 1976a; Valenzuela et al., 
1976b; Valenzuela et al., 1976d; Woychik et al., 1990a; Carles et al., 1991). In the common 
nomenclature for Pol I subunits each protein is named by a combination of the letters A, B 
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and/or C according to its appearance in Pol I, Pol II and/or Pol III, respectively, and the 
molecular weight in kDa as determined by SDS-PAGE  (Table 1). 
All but four of the Pol I subunits are essential proteins (Mémet et al., 1988; Yano and 
Nomura, 1991; Thuriaux et al., 1995; Mann et al., 1987; Woychik et al., 1990a; Dequard-
Chablat et al., 1991; Treich et al., 1992; Woychik and Young, 1990b). Mutant yeast strains 
lacking the gene coding for A49 are viable, but exhibit a slow growth phenotype (Liljelund et 
al., 1992), and strains with a deleted gene coding for A12.2 are unable to grow at elevated 
temperatures (Nogi et al., 1993). The deletion of the gene coding for A14 results in a yeast 
strain which grows slower at high temperatures (Smid et al., 1995), and only the deletion of 
the gene coding for A34.5 does not result in a growth defect phenotype (Gadal et al., 1997). 
Triple mutants lacking A49, A34.5 and A12.2 are viable, but deletion of one of these subunits 
in combination with a deletion of A14 is lethal (Gadal et al., 1997). 
 
 
1.2.2.3 The structure of the yeast Pol I complex resembles the general architecture of 
multisubunit RNA polymerases 
 
The structure of yeast Pol I has been intensively investigated by EM, immuno-EM and cryo-
EM analyses (Schultz et al., 1993; Klinger et al., 1996; Bischler et al., 2002; De Carlo et al., 
2003; Kuhn et al., 2007). As suggested by the high level of conservation between the 
polymerase subunits, it resembles the general architecture of multisubunit RNA polymerases 
(Cramer et al., 2002; Bischler et al., 2002; Kuhn et al., 2007). The overall structure is 
globular, notched by a central cleft, one side of which is formed by a mobile clamp (Figure 5). 
At the front end of the cleft jaws are apparent, while the backside is closed by a wall. A stalk-
like structure protrudes on the clamp side of the polymerase and at the bottom a funnel shaped 
cavity is visible which is connected to the cleft through a pore.  
 
 
 
 
Figure 5. Cryo-EM structure of yeast RNA polymerase I at 12 Å. Front, side and top views are presented 
(from left to right). The positions of the Pol I subunits A43/A14, A49/A34.5, ABC27 (= Rpb5) and ABC14.5 
(= Rpb8), as well as of the downstream rDNA and several domains are indicated. [from Kuhn et al., 2007] 
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Molecular details of multisubunit RNA polymerases have been revealed by the crystal 
structures of the bacterial RNA polymerase from Thermus aquaticus (Zhang et al., 1999; 
Vassylyev et al., 2002) and of the eukaryotic RNA polymerase II from Saccharomyces 
cerevisiae (Fu et al., 1999; Cramer et al., 2000; Cramer et al., 2001; Bushnell and Kornberg, 
2003; Armache et al., 2003; Armache et al., 2005; Kornberg, 2007) (Figure 6). Furthermore 
structures of elongating yeast Pol II (Gnatt et al., 2001; Westover et al., 2004; Kettenberger et 
al., 2004; Wang et al., 2006) and of Pol II molecules in complex with associated factors or 
inhibitors have been obtained, including the transcription factor TFIIB (Bushnell et al., 2004), 
the elongation factor TFIIS (Kettenberger et al., 2003) or the inhibitor α-amanitin (Bushnell et 
al., 2002).  
 
 
 
 
 
Figure 6. X-ray structure of yeast RNA polymerase II at 3.8 Å. Front and top views of the complete 12 
subunit form including the Rpb4/7 heterodimer are shown. The color key for the single subunits is given in the 
scheme representing the top view. [from Armache et al., 2005] 
 
 
Many molecular details of the transcription mechanism were derived from these analyses. The 
downstream DNA enters the RNA polymerase through the jaws and binds to the bottom of 
the cleft, while the clamp closes over the template (Gnatt et al., 2001; Westover et al., 2004; 
Kettenberger et al., 2004). Upon encountering the wall at the backside, the DNA makes a 
sharp bend upwards and exits the polymerase at the top. The active center can be found 
directly at this sharp bend, where the DNA is melted to form the transcription bubble (Cramer 
et al., 2000; Gnatt et al., 2001; Westover et al., 2004; Kettenberger et al., 2004). NTPs 
apparently enter the polymerase through the funnel / pore beneath the active site (Cramer, 
2000). Incorporation of the nucleotides into the nascent RNA chain and translocation involves 
the movement of two important mobile structures named ‘bridge helix’ and ‘trigger loop’ 
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(Gnatt et al., 2001; Wang et al., 2006). The RNA apparently exits the polymerase through an 
opening above the stalk-structure (Cramer et al., 2001; Gnatt et al., 2001; Cramer, 2002). 
 
The Pol II crystal structure could be fitted into the Pol I cryo-EM maps (Bischler et al., 2002; 
Kuhn et al., 2007). The five common subunits occupied the equivalent positions and matched 
perfectly into the map. Most homologous regions also fitted very well, while some strong 
deviations were apparent in other parts (Kuhn et al., 2007). Based on the structural 
similarities, sequence alignments and a new crystal structure of the Pol I subunits A43 and 
A14, it was possible to construct a 12 subunit Pol I homology model (Kuhn et al., 2007). Due 
to the absence of A49 and A34.5 counterparts in Pol II, these subunits are missing in the 
model. However, their position in the complex could be derived from the difference between 
cryo-EM maps of the complete Pol I and of a variant lacking the A34.5/A49 heterodimer 
(Kuhn et al., 2007; Huet et al., 1975; see 1.2.3.6). 
 
Similar cryo-EM analyses have recently been applied to elucidate the structures of yeast 
Pol III (Jasiak et al., 2006; Fernández-Tornero et al., 2007) and of the archael RNA 
polymerase from Pyrococcus furiosus (Kusser et al., 2008).  
 
 
 
 
 
 
 
Figure 7.  Interaction diagram for the Pol I subunits. The scheme was derived from interaction diagrams of 
the 10 subunit Pol II (Cramer et al., 2000; Cramer et al., 2001) and represents the top view. The colors of the 
subunits correspond to the respective Pol II counterparts shown in Figure 6. [from Nomura et al., 2004 
(modified)] 
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1.2.3 Pol I subunits 
 
1.2.3.1 A190 and A135 – the two largest subunits 
 
A190 and A135 are the two largest Pol I subunits; together they make up more than 50 % of 
the 600 kDa holoenzyme. They form the central mass of the polymerase complex and are 
localized on the opposite sites of the cleft (Cramer et al., 2000; Bischler et al., 2002) (Figure 
7) (see 1.2.2.3). According to their homology to the largest subunits of the bacterial RNA 
polymerase (bRNAP), A190 and A135 are also referred to as β’- and β-like subunits, 
respectively (Sweetser et al., 1987; Mémet et al., 1988; Yano and Nomura, 1991; Cramer, 
2002). In the primary sequences of β’- and β-like RNA polymerase subunits, eight and ten 
conserved domains (designated a - h and A - J, respectively) are present (Figure 8) (Jokerst et 
al., 1989; Sweetser et al., 1987; Cramer et al., 2001). Domain d of the largest (β’-like) RNA 
polymerase subunits contains a cluster of three invariant aspartate residues, which coordinate 
the active site metal A, i.e. an Mg2+-ion, required for the enzymatic mechanism (Cramer et al., 
2000; Cramer et al., 2001). The other half of the active center and binding site for the metal B 
is constituted by domain F of the second largest (β-like) subunits (Cramer et al., 2001). 
Consistent with the presence of the catalytic center in these Pol I subunits, A190 and A135 
were found to interact with both DNA and NTPs (Valenzuela et al., 1978).  
 
 
 
Figure 8. Conserved regions a-h of the β’-
like (largest) subunits and regions A-J of the 
β-like (second largest) subunits of the three 
nuclear RNA polymerases from S. cerevisiae. 
Black boxes represent highly conserved 
regions; more divergent regions are depicted in 
gray. Additionally the zinc-binding regions of 
the β-like subunits are shown, as well as the 
CTD of the largest Pol II subunit which has no 
counterpart in the corresponding β’-like 
subunits of Pol I and Pol III. [from Flores et al., 
1999 (modified)] 
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Furthermore A190 and A135 are two of five Pol I subunits with zinc binding domains (Treich 
et al., 1991). The function of the zinc ions in the polymerase activity remains unclear, but 
mutations in the N-terminal zinc binding domain of A190, as well as analogous mutations in 
the largest Pol II subunit, result in temperature-sensitive phenotypes (Wittekind et al., 1988; 
Himmelfarb et al., 1987). The corresponding Zn-binding domain of the E.coli RNA 
polymerase was implicated to function either in downstream DNA binding or intrinsic 
transcription termination (Nudler et al., 1998; King et al., 2004). Replacement of the second 
of four metal-coordinating cysteine residues in the C-terminal zinc binding domain of A135 
by an alanine is lethal for the yeast cell, while the mutation of all four cysteines retains 
viability (Naryshkina et al., 2003).  
Additionally to the post-transcriptional modification by phosphorylation (see 1.2.5; Bell et al., 
1976; Bell et al., 1977a; Buhler et al., 1976b), A190 was shown to be a substrate for 
sumoylation in yeast (Panse et al., 2004).  
 
 
1.2.3.2 AC40 and AC19 – the α-like subunits shared by Pol I and Pol III 
 
AC40 and AC19, the two subunits shared by Pol I and Pol III, are the α-like subunits of these 
complexes. Although AC40 and AC19 are two different proteins, as opposed to the two 
identical α-subunits of the bacterial enzyme (subunit composition α2ββ’ω), ‘α-motifs’ can be 
found in both proteins and in the homologous Pol II subunits Rpb3 and Rpb11 (Martindale, 
1990; Dequard-Chablat et al., 1991; Cramer, 2002). The homodimerization of the bacterial α-
subunits is the first step of the assembly of the RNA polymerase in E. coli, followed by the 
subsequent binding of the β- and β’-subunit (in this order) (Ishihama, 1981). A similar 
mechanism for eukaryotic RNA polymerases was suggested by the isolation of a stable Pol II 
subassembly of subunits Rpb3, Rpb11 and Rpb2 from Schizosaccharomyces pombe, 
resembling the intermediate α2β-complex (Kimura et al., 1997; see also Shpakovski and 
Shematorova, 1999a), and by the analysis of Pol II assembly mutants in S. cerevisiae 
(Kolodziej et al., 1991). Finally the heterodimerization of AC40 and AC19 has been 
demonstrated in vivo (Lalo et al., 1993; Flores et al., 1999), and a subcomplex of the 
homologous Rpb3 and Rpb11 along with Rpb10 (= ABC10β) and Rpb12 (= ABC10α) is 
evident in the yeast Pol II crystal structure (Cramer et al., 2000). 
Besides their role in the assembly of the multiprotein complex, the bacterial α-subunits were 
shown to be involved in promoter DNA binding and in interactions with activator proteins 
(Ebright and Busby, 1995). However, the C-terminal domain required for these interactions is 
absent in the archaeal and eukaryotic α-like polymerase subunits, and similar functions have 
not been observed to date. 
AC19 is phosphorylated in Pol I and in Pol III (Bell et al., 1977a); whether the same site is 
modified in both enzymes remains to be investigated. 
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1.2.3.3 ABC27, ABC23, ABC14.5, ABC10α and ABC10β – the common subunits 
 
The five common subunits ABC27, ABC23, ABC14.5, ABC10α and ABC10β together 
account for approximately 15% of the total mass of the Pol I complex (Carles et al., 1991). 
ABC23 (= Rpb6) is  the eukaryotic counterpart of the bacterial RNAP ω-subunit (Minakhin et 
al., 2001), which is also the only phosphorylated common subunit (Bell et al., 1977; 
Kolodziej et al., 1990). Its function seems to be related to the assembly of the enzyme 
(Nouraini et al., 1996; Minakhin et al., 2001). In the proposed mechanism ABC23 latches the 
C-terminus of the largest polymerase subunit to a more N-terminal region of the protein, thus 
inducing a conformational change, which promotes the binding to the α2β-like intermediate 
complex (Minakhin et al., 2001; see also Lanzendörfer et al., 1997; Ghosh et al., 2001). 
ABC23 features a highly conserved C-terminal half, required for the interactions with the 
largest polymerase subunits, and a variable acidic N-terminal half (McKune et al., 1994). The 
evolutionary conservation is especially evident by the full exchangeability for its mammalian 
counterparts (McKune et al., 1994). Similarly ABC27, ABC14.5, ABC10α and ABC10β can 
be substituted by the corresponding human proteins, but the exchange of ABC27 results in a 
thermosensitive phenotype (Shpakovski et al., 1995; McKune et al., 1995).  
The structure of the five common polymerase subunits has been solved within the crystal 
structure of yeast Pol II lacking two subunits (Cramer et al., 2000; see also Krapp et al., 1998; 
Todone et al., 2000). The structure of the complete twelve subunit Pol II complex (Armache 
et al., 2003) visualized another important feature of ABC23, which was anticipated from 
preceding experiments. It forms the main interaction interphase between the core polymerase 
and two heterodimerized subunits important for interactions with the promoter, i.e. subunits 
Rpb7 and Rpb4 in Pol II or the homologous A43 and A14 in Pol I, respectively (Peyroche et 
al., 2002) (see 1.2.3.4). A connection between ABC23, A43 and A14 was first established by 
their co-dissociation from the polymerase under stringent purification conditions in a ΔA14 
deletion strain (Smid et al., 1995; Lanzendörfer et al., 1997) or upon lowering of the pH to 4 
(Bull et al., 1981). A direct interaction of recombinant ABC23 and A43 was shown by co-
immunoprecipitation from crude extracts of an E. coli culture expressing both subunits 
(Peyroche et al., 2002; see also Woychik et al., 1990a). Finally the docking of the atomic 
model of Pol II lacking Rpb4 and Rpb7 (Cramer et al., 2000) into a 25 Å cryo-EM electron 
density map of Pol I revealed the position of ABC23 near a protruding structure termed 
‘stalk’, which contains A43 and A14 (Bischler et al., 2002, Peyroche et al., 2002; 
Lanzendörfer et al., 1997). 
The dissociation of ABC23 was in each case associated with a complete inactivation of Pol I, 
when tested in an unspecific, promoter-independent transcription assay (Valenzuela et al., 
1976c; Bull et al., 1981; Lanzendörfer et al., 1997). Pol I ΔABC23 was still able to bind DNA 
in a gel-shift retardation assay, but unable to catalyze the formation of phosphodiester bonds 
(Lanzendörfer et al., 1997; see also Valenzuela et al., 1978). Activity could be partially 
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restored by the addition of recombinant ABC23 to the polymerase preparation from the ΔA14 
deletion strain (Lanzendörfer et al., 1997).  
ABC23 is the only common subunit with a homolog in the bacterial RNA polymerase. 
However, there is no evidence that the five eukaryotic proteins resembling the α2ββ’ω 
complex are sufficient to form a functional polymerase. Moreover ABC10α (= Rpb12) and 
ABC10β (= Rpb10), two zinc-binding subunits (Treich et al., 1991; Carles et al., 1991), also 
seem to be crucial for the assembly of the eukaryotic enzyme (Rubbi et al., 1999; Gadal et al., 
1999). As already mentioned, they form a subcomplex with the α-like polymerase subunits, 
and the zinc-binding domains seem to be involved in interactions with the large subunits 
(Cramer et al., 2000). Interestingly mutants of ABC10α and ABC10β were isolated, which are 
specifically defective in the assembly of Pol III (Rubbi et al., 1999) or Pol I (Gadal et al., 
1999), respectively. Mutations in a conserved eukaryote-specific motif (HVDLIEK) in 
ABC10β result in a strong temperature-sensitive phenotype, which can be fully rescued by 
transcribing the 35S rRNA from a Pol II promoter (Gadal et al., 1999). Besides its function in 
enzyme assembly, interactions between ABC10α and the Pol III-specific transcription factor 
TFIIIC have been reported, linking this subunit to the formation of a stable pre-initiation 
complex of RNA polymerase III (Dumay et al., 1999; Lefebvre et al., 1994; Rubbi et al., 
1999). In a similar manner interactions between the common polymerase subunit ABC27 (= 
Rpb5) and the Pol II-specific transcription factor TFIIF were found (Miyao et al., 1998; Wei 
et al., 2001). Its location in the polymerase complex is near the entry site for the downstream 
DNA, in a structure termed ‘jaws’, and a contact between this subunit and the DNA has been 
proposed (Cramer et al., 2000). Furthermore synthetic lethal defects between rpb5 mutants 
and the deletion of A12.2 or its homolog Rpb9, which are located on the opposite ‘jaw’ of the 
respective polymerase complex, have been reported (Zaros et al., 2007). 
Less functional information is available for the common subunit ABC14.5 (= Rpb8). It is the 
only eukaryote specific Pol I subunit, i.e. without any known homologous subunit in the 
archaeal RNA polymerase (Cramer, 2002). The structure of ABC14.5 contains an OB-fold 
(Krapp et al., 1998; Cramer et al., 2000), a protein folding motif capable of binding 
oligonucleotides or oligosaccharides (Murzin, 1993), but its function remains unclear (see 
also Voustina et al., 1999; Briand et al., 2001). 
 
 
1.2.3.4 A43 and A14 – the ‘stalk’ subunits 
 
As described above, the Pol I-specific subunits A43 and A14 form a heterodimer, which 
makes up the protruding ‘stalk’, apparent in EM analyses (Bischler et al., 2002, Peyroche et 
al., 2002; Lanzendörfer et al., 1997) (see 1.2.2.3 and 1.2.3.3). Despite the weak sequence 
homology, which is largely limited to the N-terminal part, A43 was shown to be the Pol I 
counterpart of Rpb7 in Pol II, C25 in Pol III and subunit E in the archaeal RNA polymerase, 
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respectively (Peyroche et al., 2002; Meka et al., 2003; Zaros and Thuriaux, 2005; 
Shpakovskiĭ and Shematorova, 1999b; see also Sadhale and Woychik, 1994). Accordingly the 
A43/A14 heterodimer was considered to belong to the family of Rpb4/Rpb7 (Pol II), C25/C17 
(Pol III) and the archaeal polymerase subunits E/F (termed the ‘RpoE/RpoF-family’ or 
‘Rpb4/7-family’). Although there is no obvious sequence homology between A14 and any of 
the corresponding proteins in this family, a distant relatedness based on structural similarity 
was proposed. Finally the comparison of the recently solved crystal structure of a recombinant 
A43/A14 heterodimer with the structures of the other RpoE/RpoF family members confirmed 
this relationships on a structural level (Kuhn et al., 2007; Armache et al., 2005; Jasiak et al., 
2006; Todone et al., 2001) (Figure 9). The structures of A43, Rpb7, C25 and RpoE can be 
separated into two distinct domains: the N-terminal part, involved in the binding to ABC23 
(called ‘tip domain’), and the C-terminal half, forming the most outer part of the stalk (called 
‘OB-domain’). The latter is named for the OB-fold (Murzin, 1993) found in each of these 
proteins. Due to this protein fold, each of the heterodimers is capable to bind single stranded 
RNA in vitro (Meka et al., 2003; Orlicky et al., 2001; Jasiak et al., 2006), but the significance 
of this feature in vivo remains unclear. A14 consists of a ‘tip-associated domain’, wrapped 
around the ‘tip-domain’of A43, but the more C-terminal ‘HRDC-domain’ present in the other 
members of this protein family seems to be lacking (Kuhn et al., 2007; see also Meka et al., 
2003). 
 
 
 
 
Figure 9. Structural comparison of the yeast A43/A14 heterodimer and its counterparts in the other 
nuclear RNA polymerases and the archaeal RNA polymerase. A43, Rpb7, C25 and RpoE are shown in blue; 
A14, Rpb4, C17 and RpoF in red. The counterparts of A14 possess an additional HRDC domain (light red) 
which is absent in A14. [from Kuhn et al., 2007] 
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The most important common feature of the RpoE/RpoF-like heterodimers is their function in 
transcription initiation through contacts with the respective transcription factors (Peyroche et 
al., 2000; Choder, 2004; Ferri et al., 2000; Zaros and Thuriaux, 2005; Ouhammouch et al., 
2004). A43 was found to be the interaction partner for the Pol I specific transcription factor 
Rrn3p (Peyroche et al., 2000) (see 1.2.1.3). Pol I in complex with Rrn3p forms the initiation-
competent form of Pol I, required for the recruitment of Pol I to the rDNA promoter 
(Milkereit and Tschochner, 1998; Yamamoto et al., 1996). The Pol I-Rrn3p complex 
represents only about 2 % of the total cellular Pol I content, and its formation is apparently the 
key switch in the regulation of rDNA transcription (Milkereit and Tschochner 1998; Claypool 
et al., 2004; Laferté et al., 2006). Both A43 and Rrn3p are phosphoproteins in vivo (Bell et 
al., 1976; Bell et al., 1977a; Buhler et al., 1976b; Fath et al., 2001). 
The exact role of A14 is unclear. It is one of the non-essential Pol I subunits and seems to 
stabilize A43 and ABC23 in the polymerase complex (Smid et al., 1995; Lanzendörfer et al., 
1997). Furthermore the A14 ortholog in S. pombe was described to stabilize the A43-Rrn3p 
interactions (Imazawa et al., 2005). However, recombinant, co-expressed A43 and Rrn3p of 
S. cerevisiae are able to interact in the absence of A14 (Peyroche et al., 2000). 
 
While being absolutely indispensable for promoter-specific transcription initiation, the 
A43/A14 heterodimer is not required for promoter-independent, non-specific in vitro 
transcription (Lanzendörfer et al., 1997; Peyroche et al., 2000), i.e. the basal transcription 
mechanism is independent of these two subunits. The same is true for the other RpoE/RpoF-
like heterodimers (Edwards et al., 1991; Sadhale et al., 1994; Werner and Weinzierl, 2002; 
Naji et al., 2007).  
 
 
1.2.3.5 A12.2 – a TFIIS-like subunit 
 
A12.2 is the smallest Pol I-specific subunit. It is non-essential under normal growth 
conditions, but required for growth at elevated temperatures (Nogi et al., 1993). This is 
consistent with its Pol II homolog Rpb9 (Woychik et al., 1991), while the homologous Pol III 
subunit C11 appears to be an essential protein (Chédin et al., 1998). The members of this 
protein family, which also includes the archaeal TFS (Langer et al., 1995; Hausner et al., 
2000), represent another example for the high degree of conservation between the 
multisubunit RNA polymerase systems. They share a tripartite composition, with the N- and 
C-terminal domains each containing a zinc binding domain (Treich et al., 1991; Van Mullem 
et al., 2002; Woychik et al., 1991; Cramer et al., 2000; Chédin et al., 1998; Hausner et al., 
2000). The short intermediate linker-domain is involved in contacts to the largest polymerase 
subunit, i.e. it adds a β-strand to a sheet in Rpb1 in the Pol II structure (Cramer et al., 2000). 
The C-terminal domain contains a highly conserved motif (Q.RSADE..T.F; only Rpb9 
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contains variations), which is also present in the Pol II elongation factor TFIIS. Thus, A12.2, 
Rpb9, C11 and TFS are sometimes referred to as TFIIS-like RNA polymerase subunits. 
However, this homology is limited to the C-terminal domain of A12.2 and the C-terminal zinc 
binding domain of the much larger TFIIS (Van Mullem et al., 2002; Chédin et al., 1998). 
TFIIS induces the hydrolytic cleavage of the nascent RNA chain from the 3’ end of a 
backtracked Pol II after encountering a transcriptional block (Fish and Kane, 2002). The two 
acidic residues (DE) in the conserved motif were shown to be crucial for the mechanism of 
TFIIS-induced RNA cleavage (Jeon et al., 1994; Kettenberger et al., 2003), and mutation of 
the same residues in C11 is lethal (Chédin et al., 1998). Both Pol I and Pol III exhibit an 
intrinsic RNA cleavage activity, capable of a similar shortening of the RNA from the 3’ end 
in an artificial or stalled ternary complex in vitro (Kuhn et al., 2007; Whitehall et al., 1994). 
This cleavage activity was shown to be dependent on the C-terminal domain of A12.2 or on 
C11, respectively (Kuhn et al., 2007; Chédin et al., 1998). Pol II on the other hand required 
the addition of TFIIS for efficient cleavage under the same conditions (Kuhn et al., 2007), 
possibly due to the altered TFIIS-like motif in Rpb9. A previously described dissociable Pol I 
RNA cleavage factor (Tschochner, 1996; Labhart, 1997) might be required for the 
backtracking of the enzyme, thus facilitating the 3’ trimming of the RNA chain by the 
intrinsic cleavage activity (Kuhn et al., 2007). Finally, similar to TFIIS deletion mutants, 
yeast strains lacking the gene coding for A12.2 are sensitive to the NTP-pool depleting drug 
6-azauracil (6AU), a phenotype often associated with defects in transcription elongation (Van 
Mullem et al., 2002; Exinger and Lacroute, 1992; Archambault et al., 1992; Hampsey, 1997). 
But despite the partial homology, including a conserved motif, and the functional and 
phenotypic similarities, the location of TFIIS and the TFIIS-like proteins in the RNA 
polymerase complex contradicts a common RNA cleavage mechanism. While a loop of TFIIS 
(which includes the conserved residues) enters through the polymerase ‘pore’ underneath the 
active center, A12.2, Rpb9 and C11 are located on top of the ‘jaw’ domain of the largest 
polymerase subunit (Kettenberger et al., 2003; Cramer et al., 2000; Kuhn et al., 2007; 
Fernández-Tornero et al., 2007). 
 
The TFIIS-like polymerase subunits are also involved in the transcription termination 
processes (Prescott et al., 2004; Chédin et al., 1998; Landrieux et al., 2006). Yeast strains 
lacking RPA12 (the gene encoding A12.2) were shown to accumulate Pol I molecules in the 
IGS regions of the rDNA locus, but transcripts of this DNA element were not detectable, 
probably due to degradation (Prescott et al., 2004). In the case of Pol III, C11 was identified 
as a termination factor, but the associated intrinsic RNA cleavage activity does not seem to be 
necessary (Landrieux et al., 2006). The same may be true for Pol I, consistent with the non-
essential character of A12.2. 
Rpb9 and C11 were additionally shown to function in proofreading and transcriptional fidelity 
of the respective RNA polymerases (Nesser et al., 2006; Koyama et al., 2007; Alic et al., 
2007), but this hasn’t been tested for A12.2 yet.  
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However, in spite of all the described processes involving A12.2, its C-terminal domain, 
which includes the highly conserved motif, can be deleted without any effects on cell growth. 
The analysis of deletion mutants lacking either the N-terminal (A12.2 ΔN) or C-terminal half 
of the protein (A12.2 ΔC) revealed, that the ΔN-mutant is not able to bind to the polymerase, 
and thus was phenotypically indistinguishable from a strain with a full Δrpa12 knock-out 
(Van Mullem et al., 2002). In contrast yeast strains expressing the A12.2 ΔC mutant do not 
show the temperature sensitive (ts) phenotype and grow like a wild-type yeast strain. Most 
probably the binding of the N-terminal half of A12.2 is required to assure the correct 
conformation of A190. This is consistent with the observation, that the ts-phenotype of a 
ΔA12.2 strain can be suppressed by overexpression of A190, and that binding of A12.2 
promotes the assembly of the largest subunit and associated to this, increases its stability 
(Nogi et al., 1993). 
This additional consequence of the deletion of A12.2 hampers the interpretation of the results 
obtained with Δrpa12 strains, i.e. to distinguish between effects due to the lacking activity of 
A12.2 or an incorrect folding of A190. For instance the 6AU-sensitivity mentioned above 
could also be suppressed by the overexpression of A190, more arguing for the latter case (Van 
Mullem et al., 2002). The instability of A190 is probably also the cause for an observed 
synthetic lethal defect of ΔA12.2 with ΔA14 (Gadal et al., 1997) or Δhmo1 (Berger et al., 
2007). 
 
 
1.2.3.6 A49 and A34.5 – Pol I specific subunits without counterparts in other RNA 
polymerases 
 
A34.5 and A49 are the only two Pol I-specific subunits without any known counterpart in the 
other RNA polymerases (Gadal et al., 1997; Liljelund et al., 1992). A34.5 is phosphorylated 
in vivo (Bell et al., 1976; Bell et al., 1977a; Buhler et al., 1976b). Both subunits are non-
essential proteins; together they form a heterodimer (Kuhn et al., 2007). Consistent with this, 
Pol I purified from a ΔA34.5 deletion strain also lacks A49 (Gadal et al., 1997), and both 
subunits are susceptible to be lost together from the wild-type complex during purification 
procedures (Valenzuela et al., 1976a) and upon lowering of the pH (Bull et al., 1981). They 
can also be dissociated in a coordinated manner by urea treatment, resulting in an active 12 
subunit Pol I preparation referred to as Pol I* or Pol A* (Huet et al., 1975). This Pol I variant 
lacking A34.5 and A49 can transcribe an artificial d(A-T)n template with a comparable 
efficiency to the wild-type enzyme, but is less active on native calf thymus DNA. Genetic 
analyses of the deletion strains for each of the two subunits revealed synthetic lethal effects 
with deletions of A14. Furthermore synthetic growth defects of ΔA34.5 with the deletion of 
DNA Topoisomerase I (Top1) and Hmo1 (Gadal et al., 1997; Berger et al., 2007) and of 
ΔA49 with deletions of DNA Topoisomerase III (Top3) and Hmo1 were found (Gadal et al., 
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2002; Berger et al., 2007). Together these data indicate a function of the A34.5/A49 
heterodimer in Pol I elongation. This is supported by a recent in vitro RNA extension assay 
(Kuhn et al., 2007). An artificial transcription bubble could only be efficiently elongated to 
the end of the template by Pol I* after adding back the two dissociated subunits. Furthermore 
a ΔA34.5 yeast strain was found to be sensitive to 6AU. Bioinformatic analyses suggested a 
weak homology of A34.5/A49 with two subunits of the Pol II-associated factor TFIIF (Kuhn 
et al., 2007). 
A34.5 and A49 were, along with A190 and A135, found to be polymerase subunits involved 
in contacts with the DNA (Valenzuela et al., 1978). However, this was not confirmed in 
photocross-linking experiments with the mammalian Pol I at the rDNA promoter (Bric et al., 
2004). Possibly these A34.5/A49-DNA-interactions exist only transiently during the 
elongation phase, as they are not strictly required for polymerase activity (Valenzuela et al., 
1978). 
 
 
1.2.4 The life and death of Pol I  
 
1.2.4.1 Expression of the Pol I subunits 
 
DNA Sequence analyses revealed a common element in the promoter regions of the genes for 
all Pol I and Pol III specific and shared subunits, which is absent in the promoters for the 
Pol II subunits, including the five common ones. It was therefore termed the ‘PAC box’ (for 
RNA Polymerase A and C box) (Dequart-Chablat et al., 1991). This promoter element was 
later on found to be often associated with another motif called ‘RRPE’ (for Ribosomal RNA 
Processing Element) (Hughes et al., 2000) in the promoters of about 200 genes, which form 
together the RRB regulon (rRNA Biosynthesis regulon) (Wade et al., 2001; Wade et al., 
2006). The genes included in the RRB regulon code for proteins with various functions in 
ribosome biogenesis, ranging from the Pol I and Pol III subunits to ribosome biogenesis 
factors (e.g. RNA-modifying enzymes), but no ribosomal proteins. Transcription factors, 
which bind to the PAC and RRPE boxes, were not identified yet, but the protein Sfp1 was 
found to be a factor involved in the regulation of these promoters (Jorgensen et al., 2002; 
Fingerman et al., 2003). Although no ribosomal proteins (RPs) are included in the RRB 
regulon, a coordination of their expression with the expression of Pol I subunits might be 
facilitated through a ‘RPG box’ (for Ribosomal Protein Gene) (Leer et al., 1985). This motif 
is present in most RP gene promoters and was also found in the upstream regions of the genes 
for A190, A43 and AC40 (RPA190, RPA43 and RPC40, respectively) (Mémet et al., 1988; 
Mann et al., 1987). Interestingly RPA190 and RPA43 (the genes coding for A190 and A43, 
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respectively) are transcribed divergently from a shared promoter region (Thuriaux et al., 
1995; Goffeau et al., 1996). 
 
The amount of Pol I in a yeast cell was quantified to a number of about 15200 copies per cell, 
averaged for three different Pol I specific subunits (A190, A135 and A43) (Bier et al., 2004). 
Taken into consideration, that Pol I transcription accounts for about 60 % of the total cellular 
transcription (Warner, 1999), it is remarkable, that the copy number of Pol I subunits is only 
half the amount of Pol II molecules (i.e. 30000 copies per cell) (Borggrefe et al., 2001). 
Probably these numbers reflect the fact, that Pol I is highly concentrated in the nucleolus and, 
according to the ribomotor-model (Kempers-Veenstra et al., 1986; Planta, 1997) (see 1.2.1.2), 
uses an efficient re-initiation mechanism. The copy numbers for Pol I and Pol II subunits 
obtained through a systematic large scale quantification of the yeast proteome 
(Ghaemmaghami et al., 2003) do not seem to be very accurate, as the amounts calculated for 
the single components of the stoichiometric polymerase complex vary over a large range. 
 
 
1.2.4.2 Assembly and nuclear import of the complex 
 
The assembly of single subunits into a RNA polymerase complex is best studied for the five 
subunit RNA polymerase of E. coli (RNAP), and assembly of the polymerase core of the 
eukaryotic enzymes seems to follow the same mechanism (see 1.2.3.2). The first step of 
E. coli RNAP assembly is the dimerization of the α-subunits (→ α2), followed by the binding 
of the β-subunit (→ α2β) (Ishihama, 1981). Finally the largest subunit β’ joins this 
intermediate complex, assisted by the ω subunit (→ α2ββ’ω) (Ghosh et al., 2001). The details 
for the α-like (AC40 and AC19; see 1.2.3.2), β- and β’-like (A135 and A190, respectively; see 
1.2.3.1) and ω-like (ABC23; see 1.2.3.3) subunits of Pol I are described above. Furthermore 
the subunits ABC10α, ABC10β were found to be involved in the correct assembly of Pol I 
(see 1.2.3.3). One single copy of each subunit is present in the completed Pol I molecule 
(Hager et al., 1977; Paule, 1998). ABC27 was originally described to be present in a 
stoichiometric ratio of 2 relative to the other subunits (Hager et al., 1977), but this common 
subunit is apparently also present as a single copy (Kuhn et al., 2007), like in the Pol II and 
Pol III complexes (Cramer et al., 2000; Lorenzen et al., 2007; see also Kolodziej et al., 1990). 
 
It is unclear, in which cellular compartment the assembly of Pol I takes place, i.e. the subunits 
could be imported into the nucleus independently or assembled into intermediate 
subcomplexes or in form of the complete polymerase. One study analyzed the nuclear import 
of Pol III subunits in wild-type yeast compared to an N-terminal deletion mutant of the 
second largest Pol III subunit (RPC128ΔN), which shows a mislocalization of this subunit to 
the cytoplasm, but no obvious growth defect (Hardeland and Hurt, 2006). The authors report 
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the coordinated nuclear import of some, but not all Pol III subunits. However, the current 
model of RNA polymerase assembly (α2 → α2β → α2ββ’ω; see above) contradicts the 
formation of a subcomplex from the subunits described to be co-imported. Thus, these results 
point more towards a coordinated import mechanism for the single subunits. 
 
Once assembled, Pol I stays intact without subunit exchange through multiple rounds of the 
transcription cycle (Schneider and Nomura, 2004). This includes the pool of Pol I molecules 
not actively engaged in transcription. These initiation-incompetent complexes were found to 
be able to dimerize under the conditions optimal for in vitro transcription (Milkereit et al., 
1997; Bischler et al., 2002; see also Bull et al., 1981), but no extra peak corresponding to a 
Pol I dimer is obvious after glycerol gradient centrifugation of yeast whole cell extracts 
(Schneider and Nomura, 2004). 
 
 
1.2.4.3 The Pol I transcription cycle 
 
In order to initiate transcription at the rDNA promoter, Pol I needs to be in an initiation-
competent form, i.e. in a complex with transcription factor Rrn3p (Milkereit and Tschochner, 
1998) (see 1.2.1.3). This complex is formed independent from interactions with the promoter 
(Yamamoto et al., 1996; Schneider and Nomura 2004) and involves the Pol I subunits A43 
and possibly A190 (Peyroche et al., 1998; Kuhn et al., 2007) (see 1.2.3.4). At the promoter 
the Pol I-bound Rrn3p interacts with CF (i.e. with the CF-subunit Rrn6p) (Peyroche et al., 
1998), which itself seems to be dependent on UAF and TBP to be recruited to the promoter 
(Aprikian et al., 2001; Bordi et al., 2001) (see 1.2.1.3). Being correctly positioned for 
transcription initiation, Pol I escapes from the promoter and switches to elongation mode, 
including the dissociation of Rrn3p from the complex (Milkereit and Tschochner 1998; 
Aprikian et al., 2001; Bier et al., 2004). During this post-initiation phase CF and TBP 
apparently leave the promoter again, while UAF remains stably associated to the upstream 
element for the next initiation event (Aprikian et al., 2001; Bordi et al., 2001).  
 
Directly after the promoter-escape of one Pol I molecule, the next pre-initiation complex can 
start to form. This results in multiple polymerases transcribing the same rDNA repeat at the 
same time. A spreading technique (‘Miller spreading’) enabled the electron microscopic 
visualization of these active rDNA genes (Miller and Beatty, 1969; Miller, 1981; Rattner et 
al., 1982). The pictures resemble a ‘Christmas tree’, with the DNA forming the ‘trunk’, 
highly packed with Pol I molecules, and each one giving rise to a ‘branch’ of nascent rRNA 
transcripts with growing length along the gene (Figure 10). Using this method, the 
polymerase loading of the active rDNA repeats in the cells of an exponentially growing yeast 
culture was counted to be 51 Pol I molecules per gene in average (French et al., 2003). This 
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equals a density of one polymerase every 132 nucleotides of rDNA, and the initiation interval 
at one promoter was calculated to be about 2.2 seconds. 
 
 
 
 
 
Figure 10. Transcribed rDNA units resemble ‘Christmas trees’. (A) Schematic representation of active (with 
rRNA ‘branches’) and inactive (without rRNA) rDNA units of yeast. (B) One rDNA unit contains the 35S rDNA 
and the intergenic spacer which includes the 5S rDNA. Only the 35S rDNA forms the ‘Christmas tree’. (C) 
Electron micrograph of a transcribed rDNA unit after Miller spreading (aligned with the map in (B)). A Pol I 
molecule can be found at the origin of each nascent rRNA chain. The bar represents 400 nm. [from French et 
al.,2003] 
 
 
During the transcription of the 35S pre-rRNA, ribosome biogenesis factors start to assemble 
on the nascent transcripts, visible as characteristic terminal ‘balls’ in the miller spreads 
(Mougey et al., 1993; Dragon et al., 2002; Tschochner and Hurt, 2003; Osheim et al., 2004). 
Furthermore the correct function of these co-transcriptional processes seem to depend on the 
accurate production of the rRNA precursor, as suggested by the rRNA processing and 
ribosome assembly defects in a Pol I mutant, defective in transcription elongation 
(A135 D784G) (Schneider et al., 2007). Similar effects were also found in a deletion strain 
for the Pol II elongation factor Spt4p which was described to additionally function in the Pol I 
transcription system in a complex with Spt5p (Schneider et al., 2006). No other Pol I 
elongation factors are known so far, but the idea of subunits A34.5 and A49 as ‘built-in’ Pol I 
elongation factors exists (Kuhn et al., 2007) (see 1.2.3.6). Furthermore the function of the 
Pol I subunit A12.2 is linked to transcription elongation (Van Mullem et al., 2002) (see 
1.2.3.5).  
Under optimal growth conditions, Pol I needs approximately two minutes to transcribe the 
35S rRNA precursor from the transcription start site to the terminator, i.e. the calculated 
elongation rate of Pol I is about 60 nucleotides per second at 30° C (French et al., 2003; see 
also Ryals et al.,1982). 
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Termination of the Pol I transcript predominantly appears at a T-rich DNA element 93 bp 
downstream of the 25S rRNA sequence, 17 bp upstream of a binding site for the termination 
factor Reb1p (Lang and Reeder, 1993; Reeder et al., 1999). The Reb1 site causes Pol I to 
pause elongation, thus facilitating transcript release at the T-rich element (Lang and Reeder, 
1995; Jeong et al., 1995; Reeder and Lang, 1997). About 10 % of all transcripts were found to 
be further extended to a second ‘fail safe’ terminator about 250 bp downstream (Reeder et al., 
1999). Two other proteins were identified as Pol I termination factors: Rnt1p, the yeast 
RNase III, which was found to cleave the primary transcript near the 3’ end of the 25S rRNA 
sequence co-transcriptionally (Kufel et al., 1999; Chanfreau et al., 2000; Henras et al., 2004; 
Prescott et al., 2004) and the Pol I subunit A12.2 (Prescott et al., 2004) (see 1.2.3.5).  
 
Following termination, the free Pol I needs to be converted into a form which is competent for 
complex-formation with Rrn3p again (Milkereit and Tschochner, 1998), rendering it capable 
of running another round of the transcription cycle.  
 
 
1.2.4.4 Degradation 
 
The degradation of RNA polymerase subunits is best analyzed for the largest Pol II subunit 
Rpb1, which was found to be a substrate for the E3 ubiquitin-protein ligase Rsp5 (Huibregtse 
et al., 1997; Crews, 2003). Interestingly, Rpb1 of arrested Pol II elongation complexes is the 
preferential substrate for ubiquitination (Somesh et al., 2005). Apparently these polymerases 
are degraded by the 26S proteasome in order to avoid a lethal blockage of essential genes 
(Crews, 2003). The mapped ubiquitination-sites are conserved in A190 (Somesh et al., 2007; 
Kuhn et al., 2007), but as Rpb1 ubiquitination seems to depend on the CTD-domain 
(Huibregtse et al., 1997; Somesh et al., 2005) it is unclear whether a similar mechanism exists 
for Pol I.  
 
 
1.2.5 Pol I phosphorylation 
 
1.2.5.1 Pol I is a phosphoprotein complex 
 
The presence of phosphorylated proteins in the Pol I complex of S. cerevisiae was first 
described about 30 years ago (Bell et al., 1976; Buhler et al., 1976b). Starting with the 
discovery of protein phosphorylation / dephosphorylation as the mechanism modulating the 
activity of glycogen phosphorylase in 1955 (Fischer and Krebs, 1955; Krebs and Fischer, 
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1956; Cohen, 2002), the importance of this reversible posttranslational modification as a 
common regulatory concept was emerging through the early 1970s (Holzer and Duntze, 1971; 
Rubin and Rosen, 1975). In 1976 two independent research groups reported the analysis of 
Pol I preparations from 32P-labeled, exponentially growing yeast cultures, identifying the five 
subunits A190, A43, A34.5, ABC23 and AC19 as in vivo phosphorylated proteins (Bell et al., 
1976; Buhler et al., 1976b; Bell et al., 1977) (Figure 11). Additionally the in vivo 
phosphorylation of Pol II (Buhler et al., 1976b; Bell et al., 1977) and Pol III (Bell et al., 1977) 
was investigated, establishing that all three RNA polymerases are phosphoprotein complexes. 
In these analyses the shared subunits ABC23 and AC19 were found to be phosphorylated in 
each case. Another seven years later the amount of phosphate groups present in the in vivo 
32P-labeled Pol I preparations was quantified to be in the range of 15 ± 3 phosphates per 
enzyme (Bréant et al., 1983). The measurement of the specific radioactivity incorporated into 
the single subunits resulted in the following average distribution of phosphate groups per 
molecule: A190 (6), A43 (4), A34.5 (2), ABC23 (1-2) and AC19 (1-2).  
 
 
 
 
 
Figure 11. In vivo phosphorylated subunits of yeast RNA polymerase I. Pol I was purified from 32P-labeled 
logarithmically growing yeast cells and separated by 2D-gelelectrophoresis. The gel was stained with coomassie 
blue (left) and subjected to autoradiography (right). [from Buhler et al., 1976b] 
 
 
Several experimental data point towards a regulatory role of Pol I phosphorylation. Initiation-
competent Pol I (see 1.2.4.3) differs from total Pol I in its phosphorylation pattern (Fath et al., 
2001) (Figure 12). Dephosphorylation of a fraction enriched in the Pol I-Rrn3p complex 
results in a strong reduction of initiation competence in a reconstituted promoter-specific 
transcription assay and in the destabilization of the otherwise highly salt-resistant complex. 
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Furthermore, in vitro dephosphorylated Pol I fails to form a stable complex with recombinant 
Rrn3p, as opposed to a preparation of native Pol I (Fath et al., 2001). Finally, Pol I becomes 
inactivated in a non-specific transcription assay upon dephosphorylation by alkaline 
phosphatase (Fath et al., 2004). Interestingly the kinetics of this assay indicate that the 
removal of the first (i.e. the most easily accessible) phosphate groups leads to an increased 
activity. This suggests that only part of the modifications is required to activate the enzyme, 
while phosphorylation at other sites has an inhibitory role.  
 
 
 
 
 
Figure 12. The activity of Pol I is linked to its phosphorylation state. (A) Initiation-competent Pol I (i.e. 
complexed with Rrn3p) differs from total Pol I in its phosphorylation pattern. (Fath et al., 2001) (B) 
Dephosphorylated Pol I fails to form a stable complex with recombinant Rrn3p (Fath et al., 2001). (C) 
Dephosphorylated Pol I is inactive in promoter-independent transcription (Fath et al., 2004). 
 
 
The only information about Pol I phosphorylation sites came from large scale phosphorylation 
analyses of the yeast proteome. The approach by Ficarro and colleagues (2002) identified 216 
phosphopeptides, including one peptide of A190 with the three clustered phosphosites S1413, 
S1415 and S1417 (Ficarro et al., 2002). Gruhler et al. investigated in a quantitative analysis 
the changes in protein phosphorylation associated with the yeast pheromone signaling 
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pathway (Gruhler et al., 2005). Among the 585 phosphopeptides without alterations in 
relative abundance (of 729 phosphopeptides in total), one A43 peptide can be found, which 
includes the phosphosite S285. The largest dataset was recently published by Li and co-
workers, who applied large scale phosphorylation analysis to α-factor arrested yeast cells (Li 
et al., 2007). They managed to identify a total of 2288 phosphosites, included in 5985 
redundant phosphopeptides. With this analysis they confirmed the A43 phosphorylation site 
(S285) of the Gruhler dataset. In addition they published a new A190 phosphosite (S1636), a 
cluster of three phosphates in A34.5 (S10, S12 and S14) and one phosphorylated threonine in 
AC19 (T33). However, the A190 site is among the 766 phosphorylation sites with an 
ambiguous localization on the identified phosphopeptide, and accordingly should be assigned 
S1636 or S1638.  
A fourth large scale phosphorylation analysis reported a phosphopeptide of A14 (S121) (Chi 
et al., 2007), but as this subunit is not phosphorylated in vivo (see Figure 11), this result is 
rather questionable.  
 
Up to date, detailed analyses of phosphorylation sites and their function in eukaryotic RNA 
polymerases have been largely limited to the carboxy-terminal domain (CTD) of the largest 
Pol II subunit, which was subject to many investigations due to its importance for Pol II 
transcription (Phatnani and Greenleaf, 2006). The highly conserved CTD consists of 25 to 52 
repeats (depending on the organism) of the heptapeptide sequence YSPTSPS, and the pattern 
of phosphorylation on serines 2 and/or 5 is linked to its regulatory function. However, no 
analogous domain exists in A190.   
 
 
1.2.5.2 Kinases and phosphatases  
 
A number of kinases and phosphatases were described to be involved in the Pol I transcription 
system. However, information about Pol I subunits as their possible targets is missing. 
 
The first potential kinase found to have a function in the Pol I system was TFIIH (Iben et al., 
2002). This multiprotein factor was originally identified as a component of the Pol II basal 
transcription machinery. It contains a cyclin-dependent CTD kinase, an ATP-dependent DNA 
helicase and several subunits involved in nucleotide excision repair (Zurita and Merino, 
2003). A strong decrease of 35S rRNA production was observed in two different TFIIH ts-
mutants (i.e. mutants of the kinase Kin28 and TFB1, a part of the DNA-repair system) with 
similar kinetics to an A43 ts-mutant, but the ability of TFIIH to activate Pol I transcription in 
the presence of a nonhydrolyzable ATP analog in a reconstituted mammalian Pol I 
transcription system contradicts the involvement of the kinase activity of TFIIH (Iben et al., 
2002). 
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CTD kinase I (CTDK-I), i.e. its catalytic subunit Ctk1, is another kinase of the Pol II 
transcription machinery implicated in Pol I transcription (Bouchoux et al., 2004). Its 
described function is the phosphorylation of serine 2 of the CTD, which is associated with the 
elongation phase of Pol II (Komarnitsky et al., 2000; Sims et al., 2004). Ctk1 was found to 
co-immunoprecipitate with Pol I, and the nucleolar fraction PA600 purified from a Δctk1 
deletion strain appeared to be inactive in an in vitro transcription assay (Bouchoux et al., 
2004).  
 
The only phosphatase, described to play a role in Pol I transcription so far, is Fcp1 (Fath et 
al., 2004). In the Pol II machinery, it helps to overcome transcriptional pauses during 
elongation, and due to its ability to dephosphorylate both serines 2 and 5 of the CTD, it is 
involved in the recycling of the polymerase after termination (Sims et al., 2004). The analysis 
of ts-mutants suggested another role of Fcp1 in the production of 35S rRNA. It was also 
found to increase the efficiency of Pol I transcription in unspecific or promoter dependent in 
vitro assays, but it is not required for the formation of the Pol I-Rrn3p-complex and 
transcription initiation. Rather, the Pol I function of Fcp1 was suggested to be associated to 
elongation (Fath et al., 2004). 
 
The kinase Tor1, which is a component of the TORC1-complex (Target Of Rapamycin 
Complex 1) (Loewith et al., 2002; De Virgilio and Loewith, 2006), was recently described to 
be associated with the rDNA promoter under normal growth conditions and excluded from 
the nucleus upon nutrient depletion or rapamycin treatment (Li et al., 2006). One consequence 
of the inhibition of TORC1 by rapamycin is the reduction of Pol I-Rrn3p-complexes and the 
Rrn3 mediated recruitment of Pol I to the promoter (Claypool et al., 2004, Laferté et al., 
2006), which is probably the cause for the previous reported strong decrease of 35S rRNA 
production (Zaragoza et al., 1998; Powers and Walter, 1999). Whether this is a direct effect or 
includes a signaling cascade downstream of TORC1 was not elucidated yet. At the rDNA 
promoter Tor1 might directly phosphorylate Pol I and/or Rrn3p to facilitate the complex 
formation. Although this event is not dependent on a DNA template (Yamamoto et al., 1996; 
Schneider et al., 2004), the ribomotor model (see 1.2.1.2) would suggest complex formation 
in close proximity to the promoter to allow efficient re-initiation of the close-by terminated 
polymerases (see 1.2.4.3). Analysis of a mutant expressing an A43-Rrn3-fusionprotein 
(named CARA for Constitutive Association of Rrn3 and A43) pointed towards Rrn3 as the 
target for modification (Laferté et al., 2006). This would be consistent with the rapamycin 
induced changes in the phosphorylation pattern of the mammalian homolog TIF-IA, which 
has been studied in detail (Grummt, 2003; Mayer and Grummt, 2006). However, the sites of 
modification are not conserved and the analyses of TIF-IA suggest that a more complex 
regulatory mechanism for the mammalian system evolved, certainly associated with the 
requirements to precisely control the growth of different cell types in a multicellular 
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organism. Furthermore, yeast Rrn3p was suggested to interact with Pol I in its 
nonphosphorylated or hypophosphorylated state, based on the ability of recombinant Rrn3 to 
mediate initiation in vitro (even in the presence of an nonhydrolyzable ATP analog) and on 
the comparison of 32P-labeling of Pol I-bound Rrn3p to the total population (Fath et al., 
2001). Thus yeast TORC1 might activate a phosphatase, which in turn renders Rrn3p capable 
of complex formation, or as mentioned above, Tor1 could directly modify Pol I.  
 
 
1.3 Identification of phosphorylation sites using mass spectrometry 
 
To further elucidate the details of the presumed regulation of Pol I via phosphorylation, it is 
crucial to identify the sites of modification. The advances in mass spectrometry (MS) 
facilitated the development of methods which employ this powerful technique to investigate 
posttranslational modifications of proteins. 
 
Mass spectrometry allows to directly detect protein phosphorylation as an additional mass of 
+ 79.9663 Da (Figure 13). First, the peptide-mixtures resulting from proteolytic digestion of 
the proteins (usually digested with Trypsin, due to its high specificity) are analyzed to select 
for putative phosphopeptides showing this specific mass shift compared to the theoretical 
mass of the unmodified version. Further fragmentation of the candidate peptides in a 
subsequent tandem MS (or MS/MS) analysis provides sequence information, allowing to 
verify the identity of the phosphopeptide and to pin down the site of modification to a certain 
amino acid (for detailed information on the mass spectrometric analysis of proteins and 
peptides please refer to Baldwin, 2005; Wells and McLucky, 2005; Medzihradszky, 2005). 
 
Unfortunately straightforward MS analyses of phosphoproteins are hampered by a number of 
unfavorable properties of phosphorylated peptides. Some are associated to the type of mass 
spectrometer used (e.g. MALDI or ESI ion source; TOF, quadrupole or ion trap mass analyzer 
etc.), each of which has its advantages and disadvantages (Smith, 2002), but this introduction 
will focus on the MALDI-TOF/TOF (Matrix Assisted Laser Desorption/Ionization – Time-Of-
Flight/ Time-Of-Flight) mass spectrometer (Karas and Hillenkamp, 1988; Medzihradszky et 
al., 2000; Vestal and Campbell, 2005) used throughout the study. 
For most phosphoproteins, only a minor fraction of the total quantity is actually 
phosphorylated at a time. Accordingly the phosphopeptides are underrepresented in the 
protein digests, which anyway comprise a complex peptide-mixture. In the mass spectrometer 
all peptides need to be ionized in order to obtain information about their masses. Related to 
this ionization process, low abundant peptides are often poorly detected in the presence of a 
large excess of other analytes, a well known phenomenon referred to as ‘suppression effect’ 
(Kratzer et al., 1998; Schlosser et al., 2005). This applies especially for phosphopeptides 
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(Areces et al., 2004) due to their lower ionization efficiency compared to the non-
phosphorylated analogs (Janek et al., 2001).  
Furthermore phosphopeptides are susceptible to decomposition in the mass spectrometer, i.e. 
to the loss of H3PO4 (‘neutral loss’) (Annan and Carr, 1996; Areces et al., 2004). While this 
can be used as a phosphopeptide-marker in some applications (Annan and Carr, 1996; see 
also Lehmann et al., 2007), it also results in a further splitting of the low abundant 
phosphopeptides into fractions with and without the phosphate group (which is still different 
from the non-phosphorylated peptide because the dehydro amino acids resulting from neutral 
loss of H3PO4 lack the OH-group of the original serines or threonines).  
 
 
 
Figure 13. MALDI mass spectra of a phosphopeptide before (top) and 
after dephosphorylation (bottom). In mass spectra the x-axis corresponds to 
the mass to charge (m/z) ratio of the detected ions, while the y-axis shows their 
relative abundance. The highest peak is set to 100 % (referred to as base peak). 
In MALDI-MS the charge is typically +1 (caused by the transfer of one proton 
during the ionization process), thus the m/z ratio equals the molecular mass +1 
Da (MH+). Phosphorylation can be detected as an additional mass of 
+79.9663 Da compared to the non-phosphorylated counterpart. [from Liao et 
al., 1994] 
 
 
There are a number of approaches to deal with these problems, but no ‘standard method’ for 
the mass spectrometric analysis of protein phosphorylation has evolved yet, as reflected by 
the number of reports describing new or improved methods still published every month (e.g. 
about 12 in November 2007).  
Most of these methods rely on an enrichment of the phosphorylated peptides to facilitate their 
detection. This is achieved by binding of negatively charged phosphopeptides to Fe3+- or 
Ga3+-IMAC (Immobilized Metal Affinity Chromatography) columns (Andersson and Porath, 
1986; Posewitz and Tempst; 1999; Lund and Ardö, 2004), pH-dependent adsorption of the 
phosphate groups to TiO2- or ZrO2-beads (Pinkse et al., 2004; Kweon and Håkansson, 2006) 
or the highly specific binding to phosphotyrosine antibodies (Kalo and Pasquale, 1999; 
De Corte et al., 1999) (for an overview please refer to Witze et al., 2007; Reinders and 
Sickmann, 2005; Areces et al., 2004). In some cases additionally a pre-enrichment of 
negatively charged peptides on a strong cation-exchanger (SCX) was used (Nühse et al., 
2003; Gruhler et al., 2005). Furthermore the fractionation of the peptides via C18 reversed 
phase chromatography, to further lower the complexity of the sample and thus minimize 
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suppression effects, was found to be advantageous (Areces et al., 2004). The HPLC is 
coupled directly to the mass spectrometer (referred to as LC-MS); for MALDI-ion sources 
this is facilitated by fraction collection on the MALDI sample plate (LC-MALDI) (Wall et al., 
2002; Zhen et al., 2004). 
 
 
 
 
 
Figure 14. Reaction scheme of the chemical derivatization of phosphopeptides. The derivatization of a 
phosphoserine with ethanethiol (EtSH) is shown as an example. The phosphate group is β-eliminated in the 
presence of Ba(OH)2. The resulting dehydroamino acid is susceptible to Michael-addition of an S- or N-
nucleophile. 
 
 
In this study an alternative approach based on chemical derivatization of the phosphopeptides 
to increase their stability and raise the ionization efficiency was used. The phosphate-group is 
removed in a β-elimination reaction at high pH in the presence of Ba2+-ions and replaced by 
an S- or N-nucleophile (e.g. ethanethiol) in a Michael-addition reaction (Byford et al., 1991; 
Molloy and Andrews, 2001; Klemm et al., 2004) (Figure 14). This technique was originally 
developed to facilitate the detection of phosphoresidues in Edman sequencing (Annan et al., 
1982; Byford et al., 1991; Meyer et al., 1991) and was later on found to be also very useful in 
MALDI-MS applications (Molloy and Andrews, 2001; Jaffe et al., 2001). The derivatization 
results in a unique mass shift which allows the identification of the originally phosphorylated 
residues.  
 
 
1.4 Objective 
 
RNA polymerase I catalyzes the transcription of the 35S rRNA precursor, which is one of the 
first steps of ribosome biogenesis. It is crucial for a cell to control this process in dependence 
of the growth conditions. The regulatory mechanism apparently involves signal transduction 
via reversible phosphorylation through cascades of protein kinases and phosphatases to 
several key regulatory steps of the ribosome biogenesis system.  
About 30 years ago, two independent research groups identified five in vivo phosphorylated 
subunits (A190, A43, A34.5, ABC23 and A34.5) among the fourteen subunits of the Pol I 
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complex from the yeast Saccharomyces cerevisiae by 32P-labeling (Bell et al., 1976; Buhler et 
al., 1976b; Bell et al., 1977). The phosphate content was calculated to be about 15 ± 3 
phosphate groups per enzyme (Bréant et al., 1983) and a connection between the 
phosphorylation state of Pol I and its activity was established in vitro (Fath et al., 2001; Fath 
et al., 2004). However, little information is available about the positions and functions of the 
sites of modification. 
 
The main objective of this thesis was the identification of phosphorylation sites of yeast RNA 
polymerase I. Prerequisite was the development of a rapid procedure to purify Pol I from 
logarithmically growing yeast cells while maintaining its phosphorylation status. An 
additional intended purpose of this purification procedure was to obtain enzyme preparations 
for structural analyses in cooperation with the research group of Patrick Cramer. Thus, 
besides trying to obtain the highest purity possible, it was required to enable easy upscaling of 
the procedure. Another prerequisite for the identification of Pol I phosphorylation sites was 
the establishment of a method to analyze protein phosphorylation using the available MALDI-
TOF/TOF mass spectrometer. Upon successful identification, the phosphorylation sites 
should be characterized by site-directed mutagenesis and growth analyses of the resulting 
mutant yeast strains to gain information about the functions of the reversible phosphorylation 
of Pol I. 
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 2 Results 
 
2.1 Pol I purification 
 
Prerequisite for the identification of Pol I phosphorylation sites was the purification of the 
multisubunit enzyme from yeast whole cell extracts (WCE). Furthermore the purified Pol I 
complex should be used for structure determination in cooperation with the laboratory of 
Patrick Cramer. Thus, besides trying to obtain the highest purity possible, the purification 
procedure would need to be upscaleable afterwards. 
 
The yeast strain used for Pol I purification was GPY2 (Fath et al., 2000), which carries the 
gene coding for an N-terminal His6 / HA-tagged variant of subunit A43 on a low-copy 
plasmid, while the chromosomal locus was knocked out with the LEU2-marker gene. The 
growth behavior of this strain is similar to a wild-type yeast strain, and the binding of the 
His6 / HA-tagged A43 to Ni-NTA resin was already tested before (Fath et al., 2000; Hauger, 
2002).  
Yeast cultures were grown in YPD-media to the logarithmic growth phase (OD600 = 1-2), in 
which the ribosome biogenesis machinery is fully active (Warner, 1999). To ensure the 
integrity of the polymerase in the starting material, the buffer conditions and procedure for 
cell breakage were taken from the protocol for the preparation of the transcriptional active 
nucleolar fractions PA600 and B600 / B2000 (Tschochner, 1996; Milkereit and Tschochner, 
1998). This protocol includes an initial ultracentrifugation step (100.000 g for 90 minutes), 
which separates the crude cell lysate into three phases. The clear middle phase, i.e. the soluble 
fraction of the lysate, was collected while avoiding the turbid insoluble matter in the lower 
phase and the top layer of lipids, and designated WCE. 
 
The first step of the new Pol I purification protocol is the dialysis of the high salt WCE 
(400 mM (NH4)2SO4) against a low salt buffer (50 mM KAc) (Figure 15A). As a 
consequence, a relative small fraction of proteins precipitates from the cell extract, including 
Pol I (Figure 15B). The principle of this low-salt precipitation (Englard and Seifter, 1990) was 
previously used to enrich Pol I from eluates of a DEAE column (a weak anion exchanger) in 
the fractionation scheme mentioned above (Tschochner, 1996; Milkereit and Tschochner, 
1998). Western blot analyses revealed, that Pol I can be quantitatively precipitated from the 
whole cell extract upon complete dialysis (Figure 15B). Pol II and Pol III co-precipitate to 
some extent, but in both cases the major amount remains in the soluble fraction.  
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Figure 15. Yeast RNA polymerase I purification. (A) Pol I purification scheme. (B) Initial low-salt 
precipitation step. Aliquots of the whole cell extract [WCE] and of the dialysate after centrifugation (dialysate 
supernatant [DS]; dialysate pellet [DP]) were analyzed by western blotting. The membrane was stained with 
Ponceau-S for total protein content before immunodetection of Pol I (A49), Pol II (Rpb1) and Pol III (Rpc53) 
subunits. Note that due to the much lower volume and total protein content 0.1 % by volume of the dialysate 
pellet was loaded on the gel instead of the 0.01 % of the other fractions. (C) Coomassie staining of purified Pol I 
[C] and phosphoprotein staining of the same gel [P] using phosphostain ProQ Diamond (Invitrogen). Three 
proteins of an eIF3 subcomplex co-purified with Pol I, namely Rpg1p (1*), Nip1p (2*) and Prt1p (3*). 
 
 
Following centrifugation of the dialysate, the precipitated proteins in the pellet can be 
resolubilized in another buffer. The major advantages of this precipitation at the beginning of 
the purification procedure are the removal of bulk impurities (i.e. they remain in the 
supernatant, which is discarded) and the concentration of the proteins in a small volume, 
facilitating the subsequent column steps. Furthermore sample handling was minimized by 
using the binding buffer of the following nickel-affinity chromatography for resolubilization 
(Figure 15A). The yeast Pol I complex is stable at salt concentrations up to 2 M KAc, as 
demonstrated by the functional polymerase in the B2000 fraction (Tschochner, 1996; 
Milkereit and Tschochner, 1998). Thus, it was possible to apply very stringent conditions 
(1.5 M KAc) with the binding buffer. In the last wash steps and the elution steps of the Ni-
NTA column, the salt concentration was lowered to 300 mM KAc, to adjust the binding 
conditions for the subsequent MonoQ anion exchange chromatography (Figure 15A), from 
which Pol I elutes at approximately 1.1 M KAc. The final polishing step is a gelfiltration 
chromatography using a Superose 6 column to obtain a homogeneous Pol I preparation.  
 
A coomassie stained polyacrylamide gel of the purified Pol I is shown in (Figure 15C). The 
pattern of the stained protein bands resembled the expected pattern for the complete Pol I 
complex (see Paule, 1998) and the identity of the subunits was verified by MALDI-TOF/TOF 
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mass spectrometry. The three co-purified additional protein bands were identified as the 
components of an eIF3-subcomplex, i.e. Rpg1p (= Tif32p), Nip1p and Prt1p (Phan et al., 
2001). However, these are rather contaminating proteins than specific interaction partners. 
 
Starting from 10 l yeast culture (OD600 = 1-2) this purification procedure yielded 
approximately 200 µg Pol I. The upscaling, including some optimizations with respect to the 
crystallization approach (e.g. omitting the detergents from the buffers), was developed by 
Claus Kuhn in the Cramer laboratory. An additional MonoS cation exchange chromatography 
subsequent to the MonoQ column and prior to the gelfiltration removed the last contaminating 
proteins. In this large-scale version the yield was about 5 mg Pol I from 200 l yeast culture.  
The purity of the established Pol I purification method was suitable for structure 
determination by cryo-EM to a resolution of 12 Å (Kuhn et al., 2007) (see 1.2.2.3, Figure 5). 
The purified Pol I was also suitable for crystallization, but the interpretation of the x-ray 
diffraction pattern is still in progress. 
 
The enzyme preparation was tested to be active in a promoter-independent unspecific 
transcription assay, indicating the preservation of the native protein conformation and also of 
the posttranslational modifications throughout the purification procedure, since the 
dephosphorylation of Pol I by alkaline phosphatase results in the loss of transcriptional 
activity (Fath et al., 2004). Interestingly, in early versions of the purification, the activity was 
completely lost during the Ni-NTA affinity chromatography, when using (NH4)2SO4 instead 
of KAc. 
To analyze the phosphorylation status of the purified Pol I, a sample of the preparation was 
separated by SDS-PAGE and the gel stained with the phosphoprotein stain Pro-Q Diamond 
(Invitrogen). The five Pol I subunits, which are phosphorylated in vivo, were also stained in 
the purified Pol I (Figure 15C). The only other band visible in this staining was the co-
purified Nip1p. 
 
 
2.2 Pol I phosphorylation sites 
 
2.2.1 Chemical derivatization of phosphopeptides – establishing the method 
 
Prior to the analysis of the Pol I phosphorylation sites, synthetic phosphopeptides and a model 
phosphoprotein (i.e. α-casein from bovine milk) were used to establish a method facilitating 
the detection of phosphorylated peptides on the available MALDI-TOF/TOF mass 
spectrometer (Applied Biosystems 4700 Proteomics Analyzer). Figure 16A shows an ion- 
spectrum of the phosphopeptide EAIpSAAPFAK (peptide mass MH+ 1083.524 Da) in the 
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normal positive ion reflector mode, using α-cyano-4-hydroxycinnamic acid (CHCA, 2 mg/ml) 
as matrix. Next to the peak of the expected mass to charge ratio (m/z) a second major peak is 
visible (MH+ 988.6377 Da), which corresponds to the same peptide after the neutral loss of 
H3PO4 (see 1.3). 
 
 
 
 
 
Figure 16. MALDI-MS of phosphopeptides and their derivates. Mass spectrum of the synthetic 
phosphopeptide EAIpSAAPFAK before (A) and after (B) β-elimination of the phosphate group and Michael-
addition of ethanethiol (EtSH). Please see text for details. 
 
 
Note that in MALDI-MS normally only singly charged ions are detected (Karas et al., 2000), 
thus the mass to charge ratio (m/z) given in the spectra equals the molecular mass in Da (= M) 
plus one dalton from the proton added during the ionization process (= MH+). However, the 
(MH -H3PO4)+ -ion is not displayed at the exact mass in the spectrum recorded in reflector 
mode (Annan and Carr, 1996; Areces et al., 2004), because the neutral loss of H3PO4 from the 
metastable phosphopeptides occurs in the flight tubes of the mass analyzer. The 
phosphopeptide is accelerated in the ion source with one mass (MH+) but reaches the ion 
mirror with a lower mass [(MH -H3PO4)+] (i.e. with a lower kinetic energy), which finally 
confuses the measurement (see Annan and Carr, 1996 for details). Neutral loss of H3PO4 
results in a mass shift of -97.9769 Da and thus the actual mass of the (MH -H3PO4)+ -ion 
would be 985.5471 Da. The other small peaks apparent in the spectrum result from additional 
fragmentation events (e.g. the loss of H2O (MH+ -18.0106 Da)) or the formation of adducts 
(e.g. Na+-adducts (MH+ +21.9819 Da)), but these are not linked to the presence of a 
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phosphoresidue in the peptide (Ballard and Gaskell, 1993; Paizs and Suhai, 2005; Leite et al., 
2004). 
 
In order to stabilize the phosphopeptides, a chemical derivatization procedure was tested. The 
phosphate group is removed by a β-elimination reaction upon exposure to Ba(OH)2. The 
resulting dehydroamino acids are susceptible to nucleophilic derivatization with alkanethiols 
(Michael-addition) (see 1.3, Figure 14). However, in each study employing this method 
different reaction conditions are described. Thus, a protocol based on the procedure described 
by Molloy and Andrews (2001) was used and several parameters tested according to the 
protocols by Byford (1991), Jaffe et al. (2001) and Klemm et al. (2004). These included the 
concentrations of Ba(OH)2 and of the alkanethiol in the reaction mixture, the solvent used and 
the temperature and length of the incubation. Optimization of the protocol was monitored by 
analyzing the degree of modification of the synthetic phosphopeptide by MALDI-MS.  
Briefly, the final protocol included the following steps: Cysteine residues were first blocked 
with iodoacetic acid to prevent their conversion to dehydroalanine (Byford, 1991) and their 
subsequent modification by the alkanethiol (due to sequence information this could still be 
discriminated from the modified phosphosites, but it would result in additional variables for 
the data evaluation). The β-elimination and Michael-addition were then conducted 
simultaneously in one reaction batch with ethanethiol (EtSH) or pentanethiol (PeSH) as 
nucleophile. Incubation was performed at 37 °C for 90 minutes in the presence of 
approximately 65 mM Ba(OH)2 (taken from a freshly prepared saturated solution) and 30 % 
1-propanol as solvent. Note that in some of the later experiments the incubation temperature 
and solvent were changed to 50 °C and 30 % acetonitrile (ACN), respectively. After the 
incubation, the Ba2+-ions were precipitated as insoluble BaCO3 upon addition of NH4HCO3, 
and residual alkanethiols, solvent and ammonium carbonate were removed by lyophilization. 
The resulting modified, lyophilized peptides could then be further processed by standard 
sample preparation methods (e.g. desalting with ZipTip C18 pipette tips (Millipore)) and 
analyzed by MALDI-TOF/TOF mass spectrometry. 
 
Figure 16B shows the MS spectrum of the phosphopeptide EAIpSAAPFAK after β-
elimination and Michael-addition of ethanethiol. The peak of the original phosphopeptide 
(MH+ 1083.524 Da) is no longer visible. Instead a single major peak at m/z 1047.566 (MH+ 
1047.566 Da) appeared which corresponds to the derivatized phosphopeptide as confirmed by 
MS/MS analysis (Figure 17). In this tandem MS mode a selected peptide is fragmented by 
collision with gas molecules (CID, Collision Induced Dissociation) and a spectrum of the 
resulting fragments is recorded which provides information on the sequence of the peptide. 
Besides confirming the identity of the peptide, the originally phosphorylated serine was thus 
clearly identified as the site of modification. 
 
 
 39
 Results
 
 
 
Figure 17.  MS/MS analyses of phosphopeptides and their derivates. The synthetic phosphopeptide 
EAIpSAAPFAK (A) before (precursor mass 1083.524 Da) and (B) after chemical derivatization with ethanethiol 
(precursor mass 1047.566 Da) (see Figure 16 for the respective MS spectra) were subjected to MS/MS analyses. 
In this mode selected peptides are fragmented along the peptide backbone by Collision Induced Dissociation 
(CID). The analysis of the resulting peptide fragments of different lengths provides sequence information 
facilitating the confirmation of the identity of the peptide and the identification of the site of modification (please 
refer to Medzihradszky, 2005; Wells and McLuckey 2005; Paizs and Suhai, 2005 for detailed information). Due 
to the preferential protonation at the C-terminal lysine or arginine of tryptic peptides in the MALDI ion source 
and the fragmentation conditions in the collision cell, mainly the y-fragment ion series are visible in the spectra. 
The specific mass shifts starting from the y7-ion (i.e. y7-y10) identify the serine at this position as the modified 
amino acid. The -98 Da shifts in the MS/MS spectrum of the underivatized phosphopeptide result from the 
neutral loss of H3PO4. Both spectra were recorded with the ‘optimized precursor’-option of the 4000 Series 
Explorer software (Applied Biosystems).  
 
 
The next strongest peak in the MS-spectrum resulted from the loss of H2O, apparently from 
the glutamate in the N-terminal position of the peptide (MH+ 1029.546 Da). A peak which 
probably corresponds to the loss of ethanethiol in the mass spectrometer (MH+ 988.2 Da) is 
present only at a very low relative intensity, further arguing for the stabilization of the 
modified peptide in MALDI-MS as compared to the non-derivatized phosphopeptide. 
Some other nucleophiles different from alkanethiols were also tested (see Klemm et al., 
2004), but with none of them a complete derivatization comparable to ethanethiol could be 
achieved. 
 
Next, the β-elimination / Michael-addition method was tested with a tryptic digest of the 
model-phosphoprotein α-casein. This protein is quantitatively phosphorylated at eight 
different sites, which are normally distributed to four tryptic peptides (Kjellström and Jensen, 
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2004). In the MALDI-spectrum only two of these were apparent, i.e. the singly 
phosphorylated peptides. After the chemical derivatization with ethanethiol, peaks at the 
expected masses for all four originally phosphorylated peptides could be detected.  
 
Because protein identification by mass spectrometry relies on comparison of experimentally 
determined masses with theoretical masses in a database, any modification must be included 
as variable in the search parameters. Thus, at this stage the masses of serine and threonine 
derivatized with ethanethiol (monoisotopic mass 131.040489 Da (S) and 145.056139 Da (T)) 
or pentanethiol (monoisotopic mass 173.08744 Da (S) and 187.10309 Da (T)) were added to 
the modifications file ( …/mascot/config/mod_file) of the Mascot search engine (Perkins et 
al., 1999) which is implemented in the GPS explorer software (Applied Biosystems) used for 
data evaluation. 
Allowing these variables, the derivatized α-casein phosphopeptides were unambiguously 
identified in the peptide mass fingerprint (PMF). MS/MS analyses confirmed their identity; 
even of the five-time phosphorylated 2.7 kDa peptide, which is normally hard to detect in 
peptide mixtures. No apparent modification of any originally non-phosphorylated peptide 
could be detected after the β-elimination / Michael-addition procedure. 
 
 
2.2.2 Identification of Pol I phosphorylation sites 
 
The established β-elimination / Michael-addition procedure for the detection of 
phosphopeptides in MALDI-MS was applied to yeast RNA polymerase I. 
A scheme of the complete strategy is shown in (Figure 18). Although the polymerase is highly 
purified, the few phosphopeptides would still represent only a minor fraction of the peptide-
mixture derived from the whole 600 kDa complex. Thus, a gel-based strategy was preferred to 
an in-solution digestion strategy, to start from the single purified Pol I subunits. The analyses 
were restricted to the five subunits which were described to be phosphorylated in vivo (see 
1.2.5).  
 
Briefly, Pol I subunits were separated by SDS-PAGE, the gel was stained with coomassie 
blue and the bands of the phosphosubunits were excised. Following standard in-gel digestion 
with trypsin (Shevchenko et al., 2007) the resulting peptides were eluted and modified by the 
β-elimination / Michael-addition procedure described above (2.2.1), using either ethanethiol 
or pentanethiol as nucleophiles replacing the phosphoryl-group. The modified peptides were 
then either desalted with ZipTip C18 reversed phase microtips (Millipore) and spotted 
manually on the MALDI target using the dried-droplet method (Cañas et al., 2007) or 
separated on a nanoHPLC C18 reversed phase column, with the fractions directly collected on 
the MALDI sample plate using a Dionex Probot system (LC-MALDI). The identification of 
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the unknown phosphopeptides in the samples is based on the specific mass shift after 
chemical derivatization compared to the expected mass of the non-phosphorylated form 
(Figure 19 and Figure 20). 
 
 
 
 
 
Figure 18. Identification of phosphorylation sites from purified Pol I. Scheme of the strategy. Either 
ethanethiol (EtSH) or pentanethiol (PeSH) were used for chemical derivatization. Modified peptides were 
alternatively analyzed after ZipTip purification and manual spotting on the target plate or via the LC-MALDI 
approach. 
 
 
Since the objective of these analyses was the identification of post-translational modification 
sites on known proteins and not the identification of unknown proteins in the samples, a small 
‘yeast Pol I sequence database’ was created for the data evaluation. It includes the 14 subunits 
as well as all co-purifying proteins, trypsin and known interaction partners which possibly co-
purify in small amounts (i.e. Rrn3p). The advantage of this customized database is the 
possibility to use more variable modifications in the search parameters without creating false 
positive hits (Johnson et al., 2005). As mentioned above the identification is based on the 
comparison of experimental and theoretical masses. Any possible modification (post-
translational or artificial; e.g. deamidation of asparagines or glutamines caused by the 
β-elimination reaction conditions (Karty and Reilly, 2005)) would change the experimental 
mass, thus prevent a match. Variable modifications in the search parameters can compensate 
for this, but with the number of variables (especially for frequently occurring amino acids) 
and of the number of proteins in the database, the chance for false assignments increases, 
which finally hamper straightforward analyses. 
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Figure 19. Identification of originally phos-
phorylated peptides via specific mass shifts upon 
derivatization. The example shows part of a mass 
spectrum containing the tryptic peptide A43 242-264 
in the non-phosphorylated and in the phosphorylated 
form after β-elimination and Michael-addition of (A) 
ethanethiol or (B) pentanethiol. A large excess of the 
non-phosphorylated form is present in most cases but 
is not required for identification. The actual 
identification of the modified peptides in the spectra is 
performed during the computer-based evaluation by 
defining the respective specific mass shifts as variable 
modification. 
 
 
 
 
 
 
Figure 20. Identification of the modified amino acid in the phosphopeptide. The MS/MS mass spectra of 
peptide A43 207-212 in (A) the non-phosphorylated and (B) the phosphorylated form after chemical 
modification with ethanethiol (EtSH) are shown as example. The precursor mass of (B) corresponds to the 
precursor mass of (A) plus the specific additional mass of + 44.0085 Da resulting from the derivatization of the 
phosphorylated form. The appearance of the additional + 44.0085 Da starting from the y5-ion of the derivatized 
phosphopeptide (i.e. the y5 and y6-ions) identifies this amino acid as the site of modification. Additionally the b2-
ion of the corresponding mass is visible in the spectrum. The -17 Da mass shift of the y-ions starting from y2 
results from the loss of ammonia from the asparagine residue. 
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Table 2. Identified Pol I phosphopeptides and –sites and corresponding amino acids in the Pol I homology 
model. 
 
Phosphopeptide  
Subunit 
Position Sequence1 Phosphosite  
Amino acid  in 
homology model 3  
A190 352-366 ADSFFMDVLVVPPTR S354 Rpb1 W234 
 684-689 DSFFTR S685 Rpb1 T539 
 935-955 GSNVNVSQIMCLLGQQALEGR S936 or S9412 Rpb1 S754 / A759 
A43 207-212 FSFGNR S208 N/D 
 213-228 SLGHWVDSNGEPIDGK S220 A43 S220 
 242-264 VVSVDGTLISDADEEGNGYNSSR S262 or S2632 N/D 
 278-289 IVFDDEVSIENK S285 N/D 
A34.5 7-31 DYVSDSDSDDEVISNEFSIPDGFKK S10 / S12 / S14 N/D 
ABC23 98-119 ALQISMNAPVFVDLEGETDPLR S102 ABC23 S102 
AC19 21-46 HIQEEEEQDVDMTGDEEQEEEPDREK T33 Rpb11 A3 
 49-77 LLTQATSEDGTSASFQIVEEDHTLGNA
LR 
T51 or T54 or S552 Rpb11 I21 / D24 / 
T25 
1 Phosphoserines /-threonines are presented as bold, underlined characters. 
2 Three phosphopeptides could be identified due to the specific mass shift after chemical derivatization and a 
partial MS/MS spectrum, but the phosphorylation site could not be unambiguously assigned. The remaining 
possible serines and threonines are shown in bold, i letters in the peptide sequence. 
3 Some phosphosites could not be localized in the Pol I homology model due to weak homology of the 
respective protein regions to Pol II, missing homologous subunits or deletions in the A43/14 crystal structure. 
 
 
In total 11 Pol I phosphopeptides including 13 phosphorylation sites were identified (Table 
2): three sites on the A190 subunit (S354, S685 and S936/S941), four on A43 (S208, S220, 
S262/S263 and S285), a cluster of three phosphorylation sites on one phosphopeptide of 
A34.5 (S10, S12 S14), one site on the common subunit ABC23 (S102) and two on AC19 
(T33 and T51/T54/S55) which is shared by Pol I and Pol III.  
Three of the sites could not be unambiguously assigned on the corresponding 
phosphopeptides (peptides A190 935-955, A43 242-264 and AC19 49-77). The peptides were 
identified due to the specific mass shift after derivatization with ethanethiol and pentanethiol 
and their identity confirmed by a partial MS/MS spectrum. While some of the serines and 
threonines on these peptides could be excluded as the site of modification, some candidate 
residues were left due to missing peaks in the fragment-ion series. 
The phosphosites A43 S285, A34.5 S10/S12/S14 and AC19 T33 were confirmed by the 
proteome-wide large scale phosphorylation analyses reported by Gruhler et al. (2005) and Li 
et al. (2007) (see 1.2.5.1). Note that the methods applied in these analyses were completely 
different from the chemical derivatization approach used in this study. Both relied on the 
enrichment of phosphopeptides from the whole cell extracts using immobilized metal affinity 
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chromatography (IMAC), one in combination with a pre-fractionation on strong cation 
exchange (SCX) columns, the other after separation by preparative SDS-PAGE.  
Furthermore the additional A190 phosphosites identified in the proteome-wide approaches by 
Ficarro et al. (2002) (three clustered sites S1413, S1415 and S1417) and Li et al. (2007) 
(S1636) should be mentioned.  
 
 
2.2.3 Localization of the phosphorylation sites in the Pol I complex 
 
Figure 21 shows the positions of the identified Pol I phosphorylation sites in the primary 
structures of the five phosphosubunits with respect to the protein’s domain organizations and 
in the context of previously published mutations.  
 
A Pol I homology model facilitated the three-dimensional localization of the identified 
phosphorylation sites in the Pol I complex (Figure 22). The homology model was constructed 
by Claus Kuhn and Patrick Cramer based on the new Pol I cryo-EM structure (see 2.1), the 10 
subunit Pol II crystal structure, sequence-alignments of the Pol I and Pol II subunits and the 
new crystal structure of the A43/A14 heterodimer (Kuhn et al., 2007). The corresponding 
amino acids of the Pol I phosphosites in the homology model are listed in Table 2. Seven of 
the thirteen identified phosphosites could be located in the model. The others could not be 
assigned due to missing homologous subunits in Pol II (A34.5 S10, S12, S14) or deleted 
regions in the A43/14 crystal structure (A43 S208, S262/263, S285). The A190 triple cluster 
(A190 S1413, S1415 and S1417) is in a region of weak homology to Rpb1 and thus also not 
included in the model. Most of the sites can be found at the surface of the enzyme, consistent 
with the accessibility for modifying enzymes (i.e. kinases and the phosphatases) (Pang et al., 
2007) (Figure 22). 
 
The A190 phosphosite S354 can be found on top of the mobile clamp, which encloses the 
DNA template during transcription elongation (Gnatt et al., 2001; Cramer, 2002). It is located 
directly at the Clamp head – Clamp core transition (see Cramer et al., 2001; Kuhn et al., 
2007). Furthermore the phosphorylation site A190 S1636 is positioned in a small region at the 
extreme C-terminus of A190 which additionally contributes to the Clamp core. 
 
 
 45
 Results
 
 
 
 
 
Figure 21. Phosphorylation sites of Pol I. Positions of the identified Pol I phosphorylation sites in the 
primary structure of the five phosphorylated subunits. Phosphorylation sites marked with an asterisk were 
confirmed by proteome wide, large-scale phosphorylation analyses (see text). Sites identified exclusively by 
proteome wide analyses are marked by a triangle. The domain organization of the subunits and the positions of 
amino acid exchanges of known Pol I mutants are shown, as well as a part of the secondary structure of A43. 
References: [1] Ficarro et al., 2002; [2] Li et al., 2007; [3] Kuhn et al., 2007; [4] Wittekind et al., 1988; 
[5] Gruhler et al., 2005; [6] Thuriaux et al., 1995; [7] Peyroche et al., 2000; [8] Cramer et al., 2001; 
[9] Nouraini et al., 1996; [10] Tan et al., 2003; [11] Lalo et al., 1993. 
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Figure 22. Localization of the identified Pol I 
phosphorylation sites in the Pol I homology 
model. The polymerase core and the A43/A14 
heterodimer are shown in grey, blue and red, 
respectively. The fitted Pol I EM-density is 
depicted by the blue mesh. The catalytic Mg2+-
ion was added for better orientation (magenta 
sphere in the middle of the structure). (A) Front 
view. (B) Side view without A43/A14. 
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A190 S685 and S936/941 are located in the Pore 1- and Funnel-region, through which NTPs 
enter the active site during transcription and from which the 3’ end of the RNA is presumed to 
exit upon backtracking of the enzyme (Cramer et al., 2000; Batada et al., 2004). 
 
 
 
 
Figure 23. Localization of A190 S936/941 in the polymerase funnel. (A) Sequence alignment of the largest 
subunits of several eukaryotic RNA polymerases, as well as the homologous subunits from two Archaea species 
and E. coli. Highlighted amino acids are shown in the structure of the pore/funnel-region (B). A section of the 
bottom view of a Pol II elongation complex (PDB 1Y77) is presented with the downstream DNA on the right 
hand side. Rpb1 A759 is not located directly on the surface and thus not shown. 
 
 
The most striking position is that of A190 S936/941 inside the funnel (Figure 23). This 
protein region is highly conserved among the nuclear RNA polymerases as well as among 
different species (Figure 23). Right next to the homologous amino acids in the largest Pol II 
subunit (i.e. Rpb1 S754 / A759) is the conserved K752, which was described to be involved 
in NTP-binding in the A-site (Kettenberger et al., 2004; Westover et al., 2004; Wang et al., 
2006). In the structure of an elongating Pol II (PDB 1Y77; Kettenberger et al., 2004) the 
serine (Rpb1 S754) corresponding to A190 S936 is slightly more outside. Rpb1 A759 on the 
other hand is not located on the protein surface in this structure. 
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In contrast to S936/941, the other phosphorylation site of the pore/funnel region A190 S685 is 
not located inside the pore but on the part of the pore 1-domain which contributes to the 
backside of the polymerase (Figure 24A). There, it is located in the vicinity of ABC14.5, the 
AC40/AC19 heterodimer and a conserved loop of the hybrid binding-domain of A135 (see 
Cramer et al., 2001). Interestingly, the amino acids corresponding to A190 S685 and G728, 
the mutation of which leads to a temperature-sensitive phenotype (G728D, rpa190-3), are in 
close proximity in the Pol I homology model, while the intermediate protein region is looped 
out (Figure 24B). 
 
 
 
 
Figure 24. Localization of A190 S685 on the backside of the polymerase. (A) A magnification of the lower 
part of the homology model is shown. (B) Phosphorylation site A190 685 is in close spatial proximity to A190 
G728 which is mutated to aspartate in the ts-mutant rpa190-3 (Wittekind et al., 1988). 
 
 
The three clustered phosphosites on A190 (A190 S1413 / S1415 / S1417) are placed in the 
Jaw-domain in a region of weak homology and, thus, not included in the homology model.    
 
All A43 phosphosites can be found in the C-terminal OB-domain, with two sites (S262/263 
and S285) being located in a non-essential part of the protein (Peyroche et al., 2000). On the 
other hand, the region including the other two A43 phosphosites (S208 and S220) is 
indispensable for cell viability as demonstrated by a C-terminally truncated mutant [rpa43-1 
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(H216stop)] (Thuriaux et al., 1995). The 18 amino acids longer mutant rpa43-18 (R234stop) 
(Peyroche et al., 2000), which still contains the two sites, is viable but exhibits a ts-
phenotype. Interestingly, the different truncations of these mutants correspond well to 
subsequent truncations N-terminally of the β-strands B4’, B4 and C2 (Figure 21) which were 
recently revealed by the A43/A14 crystal-structure (Kuhn et al., 2007). Furthermore the 
mutations in another ts-mutant called rpa43-4 are within the same protein region as these two 
phosphosites.   
The new A43 crystal structure in the homology model contains only one of the four A43 
phosphorylation sites (S220). The parts with the other three sites (S208, S262/263 and S285) 
needed to be deleted in order to facilitate the crystallization of the recombinant protein (A43 
Δ173-209 Δ252-326). S208 is positioned in an unordered loop between the β-strands C1 and 
C2, and the complete C-terminus seems to be flexible. However, the position of S220 in the 
structure is remarkably on the outermost part of the protruding A43/A14 heterodimer (i.e. of 
the stalk, see 1.2.3.4) (Figure 22). 
 
The A34.5 triple-cluster is positioned at the N-terminal end of the protein. Not much is known 
about the domain organization or structure of this subunit, and due to the lack of a counterpart 
in the Pol II crystal structure, these sites could not be localized in the homology model. The 
position of A34.5, derived from the difference between cryo-EM structures of the complete 
Pol I and a variant lacking the A34.5/A49 heterodimer (Kuhn et al., 2007), is on the lower left 
in the front view of the polymerase (Figure 22). 
 
The single phosphorylation site found on the common subunit ABC23 (S102) falls within the 
conserved C-terminal assembly domain, which is ordered in the Pol II crystal as opposed to 
the N-terminal tail-domain and which is involved in the interactions with Rpb1 and Rpb7 in 
the Pol II complex (Cramer et al., 2001; Armache et al., 2003). One published mutation of the 
close-by Q100 to arginine results in a cold sensitive (cs)- and ts-phentoype accompanied by 
reduced mRNA and tRNA levels along with a destabilization of the association of the Rpb4/7 
heterodimer to the Pol II complex (Tan et al., 2003). A mutant with an exchange of S102 to 
phenylalanine (rpo26-17) was found in a screen for ABC23-mutations which result in a 
synthetic lethal phenotype with a ts-mutant of the largest Pol II subunit [rpo21-4 
(W954(LELE)P)] (Nouraini et al., 1996). However, the yeast strain carrying the mutation 
ABC S102F without the Rpb1-mutation exhibited no growth defect. In the homology model 
the phosphorylation site on this common subunit (ABC23 S102) is located at the C-terminal 
end of α-helix 1 (Cramer et al., 2001), which is positioned between the largest polymerase 
subunit and A43, Rpb7 or C25, respectively. Detailed structural analyses of this region in the 
Pol II complex can be found in several publications (Cramer et al., 2001; Armache et al., 
2003; Tan et al., 2003; Armache et al., 2005). Strikingly, S102 is not directly in one of the 
protein-protein interphases but rather in a narrow free space between the Rpb1-ABC23 and 
ABC23-Rpb7 contacts. 
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Finally, the phosphorylation sites of AC19 (T33 and T51/T54/S55) are located in the tail 
domain and at the transition to the dimerization domain, respectively. 
 
 
2.3 Mutants of the Pol I phosphosites 
 
2.3.1 Creating the mutants 
 
In order to gain insight into the functions of the identified Pol I phosphorylation sites, 
mutations of the single sites to either alanine or aspartate were created to mimic constitutively 
dephosphorylated or phosphorylated states, respectively.  
 
Site-directed mutagenesis was conducted on the cloned Pol I subunit genes (RPA-genes) 
using a variation of the recombination-based mutagenesis method described by Muhlrad and 
co-workers (Muhlrad et al., 1992; Cormack and Castaño, 2002). Briefly, the cloned RPA-
gene was cut near the target site to create a gapped vector. Subsequently this ‘DNA-damage’ 
was repaired with a short PCR-product containing the desired mutation, upon co-
transformation into a wild-type yeast strain (used as a cloning-tool in this case). Clones 
bearing a gap-repaired plasmid could be selected through the marker gene contained on the 
vector and screening for RPA-genes with the mutation was facilitated by additionally 
integrating a new restriction site into the mutagenesis-primers (which results in a silent 
mutation, i.e. no additional alteration of the protein sequence) (Figure 25). This strategy was 
chosen over more common oligonucleotide-directed mutagenesis methods like the 
QuikChange-technique (Stratagene) (Cormack and Castaño, 2002; Sambrook and Russell, 
2001) due to the large size of the used vectors (e.g. pRS314-RPA190 is ~11.4 kb, which is 
difficult to amplify full length in PCR reactions without introducing random mutations).  
 
The final mutant yeast strains were obtained by introducing the mutagenized vector into the 
corresponding plasmid shuffle-strain for the respective Pol I subunit gene using either 
canavanine- or 5-FOA-counterselection (depending on the genotype of the strain) (Sikorski 
and Boeke, 1991). As A34.5 is a non-essential protein, the vectors containing mutant alleles 
of this gene were simply transformed into a Δrpa34 deletion-strain.  
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Figure 25. Strategy for site-directed mutagenesis. 
 
 
The single phosphosites were mutated one at a time to create strains with the exchange of one 
specific phosphosite to alanine or aspartate. Only the two triple-clusters present in A190 
(S1413/S1415/S1417) and A34.5 (S10/S12/S14) were each mutated in combination. In the 
cases with an ambiguous localization of the phosphosite on the corresponding peptide, all 
possible amino acids were exchanged in one mutant. Table 3 lists all phosphosite mutants 
created during this study. Note, that aspartate mutants were not generated for all the 
phosphosites and that the site AC19 T51/T54/S55 due to the ambiguous assignment was not 
included in the analyses yet. 
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Table 3. Pol I phosphorylation site mutations. 
 
Pol I subunit Mutation  Pol I subunit Mutation 
A190 S354A  A43 S208A 
 S354D   S208D 
 S685A   S220A 
 S685D   S208/220A 
 S936/941A   S262A 
 S936D   S262/263/265A 
 S941D   S285A 
 S936E  A34.5 S10/12/14A 
 S941E  ABC23 S102A 
 S1413/1415/1417A   S102D 
   AC19 T33A 
 
 
2.3.2 In vivo analyses of the Pol I phosphorylation site mutants 
 
The consequences of the phosphosite mutations on Pol I function were first studied by in vivo 
growth analyses. Cell growth depends on the efficient production of ribosomes and the rRNA 
production is tightly regulated in response to environmental conditions through signal 
transduction pathways (Warner et al., 1999; Rudra and Warner, 2004) (see 1.1). Thus, severe 
defects in Pol I transcription or the failure to respond to such regulatory signals should be 
detectable through changes in the growth behavior of the mutant strains compared to wild-
type yeast. 
 
The ability of the mutated Pol I subunits to complement the loss of the wild-type protein in 
the plasmid-shuffle strains was checked on full medium (i.e. on YPD agar-plates) at 16, 24, 
30 and 37 °C. Isogenic wild-type strains carrying the same vector without mutations of the 
respective RPA-gene served as a control in each case. In parallel the plasmid-shuffling was 
controlled on different synthetic media lacking one defined amino acid, to check for the 
presence of the mutant copy vector, the loss of the wild-type plasmid and the maintenance of 
the original RPA-gene deletion. One example of these growth complementation experiments 
is shown in Figure 26. All mutated Pol I subunits fully complemented for the loss of their 
wild-type counterparts. The plasmid-shuffling was complete in all cases, while growth of the 
shuffle-strains still depended on the vector, i.e. the chromosomal copy was not restored by 
homologous recombination. These results clearly show, that all single Pol I phosphorylations 
investigated are non-essential post-translational modifications. Unexpectedly, there are even 
no detectable differences in growth for any of the phosphomutant strains compared to their 
corresponding wild-type. 
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Figure 26. Mutation of the single phosphorylated amino acids has no effect on cell growth. Growth of yeast 
strains carrying the A190 S685A or S685D mutations on YPD plates at different temperatures are shown as an 
example. No growth phenotype compared to the corresponding isogenic wild-type strains was detectable for any 
of the tested mutants. Plasmid shuffling and maintenance of the chromosomal deletion was controlled via the 
respective auxotrophic markers. The A190 plasmid-shuffle strain shown in the example uses the canavanine-
shuffle system. All other shuffle strains for the phosphorylated Pol I subunits use the 5-FOA-shuffle system. 
 
 
In the stationary phase, cells down-regulate the production of new ribosomes to a minimal 
level. Upon re-entering the cell cycle from the G0-phase some signal mediates the full 
activation of rRNA transcription by Pol I. A possible involvement of one of the identified 
phosphorylation in this switch was investigated by inoculating liquid cultures of phosphosite-
mutants from stationary phase pre-cultures and observing the growth behavior. In the same 
experiment characteristics like the doubling time of the mutant strains relative to their 
isogenic wild-types could be analyzed by measuring the OD600 of the cultures.  
Neither the lag phase from inoculation to detectable growth of the culture nor the growth rate 
in the logarithmic phase was altered for any of the strains investigated relative to their wild-
type. 
 
Furthermore the growth behavior of the mutant strains in the presence of rapamycin or 
6-azauracil (6AU) was investigated by spotting serial dilutions of the cultures on agar plates 
containing these drugs.  
 54 
 Results
Rapamycin inhibits the TOR-pathway (Target Of Rapamycin), which signals the availability 
of nutrients to the ribosome biogenesis apparatus (De Virgilio and Loewith, 2006) including 
Pol I (see 1.2.5.2). Changes in the rapamycin sensitivity for any of the mutant strains would 
point towards an involvement of the mutated site in these signaling events, but no such 
differences were detectable.  
6AU is commonly used to test for defects in transcription elongation (Hampsey, 1997; Van 
Mullem et al., 2002; Schneider et al., 2007). It lowers the pool of UTP and GTP by 
interfering with their synthesis pathways and is best known from a screen for 6AU sensitive 
mutants which identified the Pol II elongation factor TFIIS (Exinger and Lacroute, 1992; 
Hampsey, 1997).  
 
 
 
 
 
Figure 27. Sensitivity of A190 S685 mutants to 6AU and to extreme temperatures. (A) A yeast strain 
carrying the mutation A190 S685D is less sensitive to the NTP-pool depleting drug 6-azauracil (6AU) than the 
isogenic wild type or a strain with the analogous mutation to alanine. (B) The same mutant (A190 S685D) grows 
better on YPD at elevated temperatures (40° C) than the corresponding wild type strain, while the alanine variant 
is growth inhibited. 
 
 
Remarkably, mutation of A190 S685 to aspartate resulted in a lowered 6AU sensitivity as 
compared to the strain expressing the wild-type subunit (Figure 27A). In contrast the 
analogous mutation to alanine did not alter the growth behavior on 6AU-plates. To rule out 
that some random mutations in the strain carrying the vector with the A190 S685D-allele 
caused this decreased sensitivity (e.g. mutations in the uracil transporter involved in the 
uptake of 6AU), the phenotype was confirmed by repeated plasmid-shuffling and assay on 
6AU.  
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Note that the same mutation A190 S685D, but not S685A, was found to be synthetic lethal 
with a deletion of the non-essential Pol I subunit A12.2 in a SL-screen by Alarich Reiter 
(Reiter, 2007). The RPA-gene phosphomutant vectors created in this study (see 2.3.1) were 
used for the SL-screen, i.e. the mutations were identical. In total 180 combinations of 
phosphorylation site mutants and deletions of non-essential components of the Pol I 
transcription machinery were tested. No other genetic interaction was evident (including all 
combinations of A190 S685D with deletions of the other non-essential Pol I subunits A49, 
A34.5 and A14), showing the specificity of the synthetic lethal effect between A190 S685D 
and Δrpa12 (Reiter, 2007). This indicates an involvement of the reversible phosphorylation at 
A190 S685 in modulating one of the functions of A12.2 which was described to participate in 
elongation, 3’ RNA cleavage and termination (Van Mullem et al., 2002; Kuhn et al., 2007; 
Prescott et al., 2004). 
 
Remarkably, mutants of this phosphorylation site (A190 S685) also showed different 
phenotypes compared to the wild-type at very high temperatures (Figure 27B). Growth on 
YPD plates at 40°C was tested due to reports of rpb1-mutants which grow almost like wild-
type yeast at 36°C but exhibit drastic growth defects at temperatures higher than 38°C 
(Hampsey, 1997). All strains, including the wild-type, grew very slowly at this temperature, 
with the S685D-mutant showing a slightly higher growth rate. In contrast the A190 S685A 
mutant was severely inhibited under these extreme conditions. 
 
 
2.4 The A12.2 paradox – A lethal mutation of a non-essential protein 
 
In the course of the cooperation with the laboratory of Patrick Cramer a mutant of the Pol I 
subunit A12.2 was created to investigate the role of this subunit in the intrinsic Pol I RNA 
cleavage activity (Kuhn et al., 2007). A12.2 and its functions in Pol I transcription are of 
special interest due to its genetic interaction with the phosphosite mutant A190 S685D 
(Reiter, 2007) (see 2.3.2). The full knock-out of this non-essential subunit results in a ts-
phenotype, while deletion mutants lacking only the C-terminal half exhibit no growth defects. 
However, this C-terminal part contains a highly conserved TFIIS-like motif (see 1.2.3.5).  
 
Two acidic residues in the conserved motif which play a crucial role in the TFIIS-mediated 
Pol II RNA cleavage activity (Jeon et al., 1994; Kettenberger et al., 2003) were replaced by 
alanines in A12.2, resulting in the mutant A12.2 D105A E106A (A12.2 DE>AA). 
Mutagenesis was performed on the cloned RPA12 gene, but all attempts to transform the 
vector with the mutant allele into a Δrpa12 deletion strain failed, in contrast to the control 
vectors with the wild-type gene or the empty vector.  
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Figure 28. The mutation A12.2 D105A E106A is lethal. A strain expressing the mutant under the control of a 
galactose-inducible promoter and the corresponding wild-type and vector controls were spotted on plates 
containing either glucose (no expression) or galactose (expression) and grown at different temperatures. On 
glucose all strains grew like a Δrpa12 full deletion strain which is growth inhibited at 37 °C (Nogi et al., 1993). 
The A12.2 DE>AA mutant is unable to form colonies at any temperature on the galactose plates. 
 
 
Thus an A12.2 plasmid-shuffle strain was constructed by transforming the wild-type allele 
encoded on a plasmid carrying the URA3 marker-gene into the Δrpa12 deletion strain. 
However, upon transformation of the mutant, wild-type or empty control vectors into this 
shuffle strain and counterselection on 5-FOA, no viable clones for the A12.2 DE>AA mutant 
could be obtained. These results suggested that paradoxically the mutation of two amino acids 
in a dispensable part of a non-essential protein leads to a lethal phenotype.  
 
To further investigate this possibility, the genes for the wild-type A12.2 and the mutant 
A12.2 DE>AA were cloned under the control of an inducible galactose-dependent promoter, 
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i.e. their expression is repressed on glucose-containing media and induced upon switching to 
galactose as carbon-source. Single clones obtained by transforming these plasmids into the 
Δrpa12 strain and culturing on standard glucose containing YPD-plates, were diluted in sterile 
water and spotted on different glucose and galactose-plates. The results of the incubation of 
these plates at different temperatures are summarized in Figure 28. Under the repressing 
glucose conditions all strains behaved like the Δrpa12 deletion strain. On galactose plates, the 
knock-out was complemented by the wild-type A12.2 as judged by the ability to grow at 
37 °C. In contrast, when inducing the expression of the A12.2 DE>AA mutant, no colonies 
were formed at any incubation temperature, confirming the observation that this mutation 
apparently results in a lethal phenotype. 
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 3 Discussion 
 
3.1 Pol I purification 
 
3.1.1 The new yeast Pol I purification method 
 
A new yeast RNA polymerase I purification procedure was developed which yields an active 
enzyme preparation suitable for the determination of Pol I phosphorylation sites and structure 
determination.  
Six different Pol I purification methods have already been described in the literature (Ponta et 
al., 1972; Buhler et al., 1974; Van Keulen et al., 1975; Valenzuela et al., 1976a; Hager et al., 
1977; Keener et al., 1998). Most of these were published in the years directly following the 
first descriptions of Pol I as one of three distinct nuclear RNA polymerases (Roeder and 
Rutter 1969). However, some of these apparently resulted in incomplete polymerase 
complexes as judged from today’s knowledge about Pol I subunit composition (Ponta et al., 
1972; Van Keulen et al., 1975; Hager et al., 1977). The protocols by Buhler et al. (1974) and 
Valenzuela et al. (1976a) contain basically the same steps (i.e. phosphocellulose batch > 
DEAE-cellulose batch > DEAE-cellulose or -sephadex chromatography > glycerol or sucrose 
gradient) and yielded pure complexes, which were used for most Pol I analyses including the 
identification of the in vivo phosphorylated subunits (Buhler et al., 1976b; Bell et al., 1976; 
Bell et al., 1977). The method by Buhler et al. (1974) was also used for most previous 
structural analyses (Schultz et al., 1990; Schultz et al., 1993; Klinger et al., 1996; De Carlo et 
al., 2003).  
Only one method by Keener et al. (1998) used the efficiency of affinity chromatography 
(Bornhorst and Falke, 2000). In this publication the authors actually describe two procedures: 
the first one used four different chromatography columns with gradient elution 
(phosphocellulose > Q-sepharose > heparin-sepharose > MonoQ). In the second one, the 
initial phosphocellulose and Q-sepharose chromatography steps were replaced by one nickel-
affinity chromatography using an N-terminal His6 / HA3-tagged A135.  
 
The major advantage of the new Pol I purification procedure developed in this study is the 
low-salt precipitation as the first step. It is used to remove bulk proteins and to largely reduce 
the volume of the sample at the same time. This facilitated the upscaling of the procedure 
required to yield the quantities of highly purified protein needed for the crystallographic 
approach. 
 
 Discussion
The subsequent Ni-NTA affinity and MonoQ anion exchange chromatographies are similar to 
two steps of the Keener protocol but other buffer conditions were employed. A Superose 6 
gelfiltration was added as a final purification step. 
 
 
3.1.2 Co-purifying proteins and Pol I interaction partners 
 
In the final preparation three proteins of an eIF3-subcomplex (Rpg1p, Nip1p and Prt1p) (Phan 
et al., 2001) were present. Although co-purification is often a strong argument for protein-
protein interactions, in this case a direct interaction with Pol I in vivo is contradicted by the 
cellular localizations. While Pol I is concentrated in the nucleolus, the translation initiation 
factor eIF3 is found in the cytoplasm (Kumar et al., 2002; Huh et al., 2003). Furthermore no 
indications for such an interaction was found in studies on the eIF3-components, including 
two hybrid screens (Placek et al., 2001; Asano et al., 2000; Uetz et al., 2000) and co-
purification experiments (Asano et al., 2000; Phan et al., 1998; Phan et al., 2001). 
 
The well-known interaction partner Rrn3p was not found in the Pol I preparation. However, 
the Pol I-Rrn3p-complex represents only about 2 % of the total Pol I population (Milkereit 
and Tschochner, 1998), thus no corresponding coomassie band was expected. With the only 
available Rrn3p antibody (Milkereit, 1999) no signals in western blot analyses were visible, 
but the Rrn3p associated with the purified Pol I might be present in amounts below the 
detection limit. On the other hand it might be possible, that the interaction of Rrn3p with the 
His6-tagged A43 subunit prevents binding to the Ni-NTA-column, thus selectively depleting 
the initiation competent Pol I from the preparation. This possibility has not been tested.  
 
 
3.2 Identification of Pol I phosphorylation sites 
 
3.2.1 17 Pol I phosphorylation sites 
 
A total of 13 Pol I phosphorylation sites could be successfully identified in this study. These 
complement four other Pol I phosphorylation sites found exclusively in proteome-wide 
phosphorylation analyses (Ficarro et al., 2002; Li et al., 2007). Phosphorylation at these 17 
sites matches the amount of approximately 15 ± 3 phosphates per enzyme estimated by Bréant 
et al. (1983) for a Pol I preparation from logarithmically growing yeast (see 1.2.5.1). Also at 
the subunit level there is a good correlation between the numbers of calculated phosphate 
groups and of the sites determined so far (Table 4).  
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Table 4. The number of identified phosphosites approximately matches the calculated amount of 
phosphate groups per enzyme. 
 
Subunit  Phosphosites (Ficarro et al., 2002; Gruhler et 
al., 2005; Li et al., 2007; this study) 
 Phosphates per Enzyme or Subunit 
(Bréant et al., 1983) 
Total Pol I  17  15 ± 3 
A190  7  6 
A43  4  4 
A34.5  3  2 
ABC23  1  1 or 2 
AC19  2  1 or 2 
 
 
However, it should be noted that additional phosphorylation sites may exist which were not 
found due to limited amounts of the respective Pol I population (e.g. of the initiation-
competent Pol I) or due to methodological constraints.  
The phosphosubunits were digested with trypsin according to well established in-gel digestion 
protocols (Shevchenko et al., 2007; Cañas et al., 2007). While trypsin digestion is a standard 
procedure in mass spectrometric analyses and yields reliable and reproducible results, the 
sequence coverage is typically within the range of 40 – 60 %, mainly due to unfavorable 
peptide sizes and suppression effects related to differences in ionization efficiencies (Krause 
et al., 1999; Wa et al., 2006). The latter can be largely reduced by the reversed phase 
fractionation applied prior to the analysis, but in order to obtain almost full sequence coverage 
digestions with different specific proteases, producing different peptides, would be necessary 
(Wa et al., 2006). 
The identified phosphosites apparently belong to the major phosphorylated residues in the 
total Pol I preparation. Their detection after chemical derivatization was facilitated by the 
high purity of the single gel-separated subunits and in some cases by the additional peptide 
fractionation (in the LC-MALDI approach), but no specific phosphopeptide-enrichment was 
applied. Thus, some low abundant phosphorylations might have escaped identification due to 
the detection limit.  
 
The validity of the method employed in this study was verified by the five phosphorylation 
sites confirmed through two independent proteome-wide phosphorylation analyses which 
were reported during the course of this study, i.e. A43 S285, the triple-cluster A34.5 S10 / 
S12 / S14 and AC19 T33 (Gruhler et al., 2005; Li et al., 2007). As mentioned before, the 
methods used in these proteome-wide analyses were different from the chemical 
derivatization approach employed in this study. Rather, they relied on combinations of 
peptide fractionation and phosphopeptide enrichment via IMAC-columns. 
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The specificity of the chemical derivatization depends on the reaction conditions (especially 
the choice of the group II metal ions). O-linked carbohydrates can also be susceptible to 
β-elimination, but in the presence of Ba2+-ions their reaction rate is two orders of magnitude 
slower than for the O-linked phosphates (Byford, 1991; Molloy and Andrews, 2001). 
Furthermore the apparent deamidation of asparagines or glutamines caused by the 
β-elimination reaction conditions need to be taken into account for the data evaluation (Karty 
and Reilly, 2005). 
One drawback of the derivatization reactions used to identify the phosphorylation sites is that 
the phosphoryl group of phosphotyrosine is not β-eliminated in the presence of Ba(OH)2 
(Areces et al., 2004). Although tyrosine phosphorylation accounts for only about 0.05 % of 
the total phosphorylation in a mammalian cell, this modification is involved in many 
important cellular processes (Machida et al., 2003; Pawson and Scott, 2005). In yeast, 
however, no members of the protein tyrosine kinase-family were found so far (Zhu et al., 
2000). Rather some tyrosine residues are phosphorylated by protein kinases with dual 
specificity, i.e. kinases which phosphorylate serine/threonine and tyrosine (Hunter and 
Plowman, 1997; Zhu et al., 2000). 
 
 
3.2.2 The total Pol I preparation used for phosphosite identification is a mixture of different 
Pol I populations 
 
Previous experiments indicated that the phosphorylation pattern of Pol I changes through the 
transcription cycle (Fath et al., 2001). The enzyme preparation used in this study to identify 
the phosphosites was a total Pol I preparation from logarithmically growing yeast, i.e. a 
mixture of polymerases from different stages of the transcription cycle plus the pool of free 
Pol I complexes. 
In each wild type yeast cell about 50 % of the approximately 150 rDNA copies are transcribed 
(Dammann et al., 1993) by an average number of 51 polymerases per gene (French et al., 
2003). Accordingly about 3825 polymerases are engaged in elongation or termination which 
account for 25 % of the 15200 Pol I molecules of a yeast cell (Bier et al., 2004). Only about 
2 % of Pol I is present in the initiation active complex with Rrn3p (Milkereit and Tschochner, 
1998). The rest belongs to the large pool of Pol I molecules, which includes the complexes 
that are about to be assembled, imported or degraded.  
Thus, the sites identified in this study are not necessarily phosphorylated at the same time; 
rather each one might be modified in any of these stages. Note that the same considerations 
need to be taken into account for the studies on the in vivo phosphorylated Pol I subunits by 
Bell et al. (1976; 1977) and Buhler et al. (1976b), as well as for the quantification of the 
phosphate groups per enzyme by Bréant and coworkers (1983). 
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The confirmed sites on subunits A43, A34.5 and AC19 were found in the proteome-wide 
analyses from α-factor arrested yeast cells (Gruhler et al., 2005; Li et al., 2007). However, in 
contrast to the effect of other inhibitors of the cell cycle ‘start’ checkpoint, the production of 
rRNA by Pol I is not downregulated upon α-factor treatment (Veinot-Drebot et al., 1989). 
These cells stop division but increase cell size, associated with continued RNA and protein 
synthesis (Throm and Duntze, 1970). Thus, the identified sites in these approaches also arose 
from a mixture of Pol I molecules throughout the transcription cycle and cannot for instance 
be assigned to an inactive state.   
 
 
3.2.3 A similar motif in A190 and A34.5 
 
Two triple clusters of phosphoserines were found among the Pol I phosphorylation sites: 
A190 S1413 / S1415 / S1417 (Ficarro et al., 2002) and A34.5 S10 / S12 / S14. The sequence 
comparison of the corresponding phosphopeptides revealed a striking similarity between the 
two clusters. In both cases the three phosphoserines are separated by aspartates and followed 
by four or three acidic amino acids, respectively (Figure 29). It is likely, that these sites are 
modified by the same kinase and phosphatase. The mutation of all three serines to alanine in 
either motif did not change the growth behavior of the yeast strains. Also a combination of 
alanine mutations in the A190 motif and a full deletion of the non-essential A34.5, which was 
created in the SL-screen by Alarich Reiter, showed no detectable growth phenotype (Reiter, 
2007). 
 
 
 Phosphopeptide Sequence  
 A190  1410-1430 DKESDSDSEDEDVDMNEQINK 
 A34.5  7-31  DYVSDSDSDDEVISNEFSIPDGFKK 
 *  *****:** :. : .* . 
 
 
Figure 29. Alignment of the A190 and A34.5 phosphopeptides containing the similar triple cluster motifs. 
Phosphorylated serines are highlighted. 
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3.3 Possible roles of phosphorylation at the identified sites based on the localization in 
the Pol I homology model and mutant phenotypes 
 
3.3.1 All analyzed Pol I phosphorylations are non-essential post-translational modifications 
- general considerations and possible functions 
 
The identified phosphosites apparently belong to the major phosphorylated sites in the Pol I 
complex. Surprisingly, in vivo analysis of mutants which mimic a constitutive 
unphosphorylated or phosphorylated state of the single sites showed that all Pol I 
phosphorylations analyzed are non-essential post-translational modifications. Furthermore the 
mutations have no apparent effect on cell growth. Thus, none of the single sites plays a crucial 
role in the regulation of Pol I transcription. In view of previous results indicating that Pol I 
activity is linked to its phosphorylation state (Fath et al., 2001; Fath et al., 2004), this was 
quite unexpected. As discussed above some additional sites might have escaped detection, e.g. 
sites which are required for complex formation with the transcription factor Rrn3 and are 
present in only about 2 % of the total Pol I population.  
There are well known examples for non-essential components of the Pol I transcription 
machinery like the four non-essential Pol I subunits (Liljelund et al., 1992; Nogi et al., 1993; 
Smid et al., 1995; Gadal et al., 1997). Still their evolutionary conservation suggests important 
roles in Pol I transcription, which are about to be elucidated. There are also examples for non-
essential phosphorylations like the modification at one of two sites in members of the AGC 
protein kinase family (Roelants et al., 2004). Detailed analyses of such phosphosites are rare 
in the literature but the existence of non-essential protein kinases (Ptacek et al., 2005) 
suggests that there are more. 
 
Most of the Pol I phosphorylations involved in the regulation of the RNA polymerase activity 
apparently do not represent an ‘on-off switch’, but rather contribute to the fine-tuning of the 
enzyme. The kinetics of an assay measuring the in vitro transcription activity after different 
time points of alkaline phosphatase treatment showed that the removal of one or few 
phosphorylations has little effect or even leads to an increased activity (Fath et al., 2004). 
Only longer phosphatase incubation and the further dephosphorylation resulted in complete 
inactivation. 
The consequences of the mutation of single sites involved in this fine-tuning would 
presumably not be detectable by a growth defect phenotype. A change in the Pol I 
transcription activity should result in a changed rate of rRNA production, which would 
influence the growth rate of the cell. However, apparently other regulatory mechanisms can 
compensate for lowered levels of rRNA production. 
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A well studied example for such mechanisms was found in a yeast strain with a reduced 
number of rDNA repeats. A wild-type yeast strain contains about 150 rDNA copies, 
approximately 50 % of which are actively transcribed in the logarithmic growth phase. 
Strikingly in a mutant strain the rDNA copy number was reduced to 42 repeats without 
affecting the cell growth rate or the rRNA synthesis rate (French et al., 2003). In this strain all 
42 rDNA genes were found to be active and to possess a denser polymerase loading, resulting 
in a higher number of Pol I molecules per gene. As a consequence the number of polymerases 
engaged in transcription of the 35S rRNA precursor was almost identical to an isogenic wild-
type strain, thus regulating the rate of rRNA production to wild-type levels. 
 
Another possibility explaining the lack of growth defects in the analyzed mutant strains would 
be a role of the corresponding phosphorylation sites in redundant functions which are not 
necessarily related to the transcription activity. For instance, nuclear import or ubiquitination 
are known to be mediated by phosphorylation in many cases (Hood and Silver, 1999; 
Harreman et al., 2004; Hunter, 2007). The phosphorylation-dependent interaction of a 
polymerase subunit with an importin would be disturbed by the mutation, but it could still be 
co-imported in the assembled Pol I complex. Or there might be multiple ubiquitination 
domains on a subunit while the phosphosite mutation affects only one of them. 
 
In all the cases discussed above the combination of several phosphorylation site mutations 
would be required to cause phenotypic consequences to elucidate the functions associated to 
the modification of these sites. With few exceptions only single phosphorylation site 
mutations have been analyzed in this study and further investigations are required. However, 
some of the phosphosite positions in the Pol I homology model are striking and implicate 
possible roles associated to the function of the corresponding parts of Pol I. These are 
discussed subsequently. 
 
 
3.3.2 A190 S354 and A190 S1636 on the  polymerase clamp 
 
A190 S354 can be found on the top of the mobile clamp at the transition from the clamp head 
domain to the clamp core domain (Cramer et al., 2000; Cramer et al., 2001; Kuhn et al., 
2007). The clamp forms one side of a positively charged cleft through which the DNA 
template enters the polymerase towards the active site (Cramer et al., 2000; Gnatt et al., 
2001). It can adopt two different conformational states: the clamp swings between an open 
and closed form. In the open state the cleft is freely accessible and the RNA polymerase can 
be loaded on the DNA template during transcription initiation (Cramer et al., 2001). Upon 
promoter escape the clamp closes over the template and prevents dissociation of the 
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polymerase, thus facilitating a high transcription processivity (Gnatt et al., 2001; Cramer, 
2002).  
It was proposed, that the binding of nucleic acids (the downstream DNA and the DNA-RNA 
hybrid) causes the closure of the clamp by inducing the folding of five otherwise unordered 
‘switch’ regions which connect the clamp to the polymerase body (Gnatt et al., 2001). During 
transcription termination the re-opening of the clamp needs to be triggered to release the RNA 
polymerase from the DNA template. It is tempting to speculate, that the phosphorylation at 
this particular position on top of the clamp could assist in these conformational changes or in 
the stabilization of one state. However, mutations of A190 S354 resulted in no detectable 
alterations of the yeast cell growth. Thus, this single phosphorylation site cannot be 
exclusively required for the regulation of the clamp closure / opening. The possibility of 
synergetic effects with the phosphorylation of A190 S1636 (Li et al., 2007) still needs to be 
investigated. This site is located more at the bottom of the clamp, in a small C-terminal part of 
A190 which contributes to the clamp core (Kuhn et al., 2007). This site has not been included 
in the mutational analyses yet. 
 
 
3.3.3 A190 S936/941 in the funnel 
 
A190 S936/941 is localized inside the funnel / pore beneath the active site. This cavity allows 
the entry of the nucleotides and apparently forms the exit path for the 3’ end of the nascent 
transcript upon backtracking of the polymerase (Cramer et al., 2000; Gnatt et al., 2001). The 
phosphorylation site is directly adjacent to two overlapping NTP binding sites termed A- and 
E-site (Westover et al., 2004). Binding to the A-site (Addition site) brings matching 
nucleotides into the correct position for phosphodiester bond formation in the active site of 
the enzyme (Gnatt et al., 2001; Westover et al., 2004). The function of the E-site (Entry site) 
seems to be primarily required to overcome the restriction of NTP diffusion towards the 
active site by the narrow funnel / pore opening (Batada et al., 2004). Nucleotides bind to the 
E-site in a base unspecific manner with low affinity, thus largely expanding their lifetime in 
the active center region. Furthermore binding of a NTP to any of the two overlapping sites 
apparently restricts unfavorable backtracking of the polymerase under normal transcription 
conditions (Batada et al., 2004). Negatively charged amino acid side chains in the vicinity of 
the E-site may additionally raise the barrier height for backtracking (Batada et al., 2004). 
The close proximity of A190 S936/941 to a lysine (A190 K934) which is involved in NTP 
binding to both sites and the strikingly high degree of conservation suggests a role of this 
phosphoserine related to the functions described above. The mutant phenotypes however 
contradict this assumption. A190 S936 or S941 were mutated to alanine, aspartate or the 
larger glutamate with no effects on cell growth on either full media or on minimal media 
complemented with the nucleotide pool depleting drug 6-azauracil. Thus, phosphorylation at 
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A190 S936/941 neither interferes with the passage of nucleotides through the funnel nor with 
their binding to the E-site, because this was calculated to be especially important under 
conditions of low NTP concentration (Batada et al., 2004). Furthermore the movement of the 
trigger loop is apparently not restricted by the phosphosite mutations. This highly mobile loop 
closes off the active site beneath a correctly positioned matching NTP in the A-site and forms 
interactions which finally ‘trigger’ the phosphodiester bond formation (Wang et al., 2006).  
 
Interestingly, a number of mutations in the homologous region of the largest Pol II subunit 
result in a sit phenotype (Suppressor of Initiation of Transcription defect), including a 
mutation of the amino acid corresponding to A190 S941 (rpb1-A759P) (Archambault et al., 
1998; Trinh et al., 2006). There are two reasonable explanations for the sit phenotype: either 
the mutant polymerases could be recruited to the promoter more efficiently or the mutations 
could contribute to more efficient transcription elongation (Archambault et al., 1998). 
Consistent with the latter, a mutation in the homologous region of Pol III (rpc160-L750S) was 
found to cause a higher polymerization rate (Rozenfeld and Thuriaux, 2001; Trinh et al., 
2006). A similar effect of the mutations of A190 S936/941 could presumably be easily 
compensated by the cell as discussed above (3.3.1). The rate of rRNA synthesis could be 
adjusted to wild-type level by reducing the number of active rDNA repeats or by lowering the 
polymerase loading per gene, which would result in the observed wild-type growth. This 
possibility could be investigated by in vitro transcription assays. 
 
 
3.3.4 A190 S685 at the backside of the Pore1-domain 
 
The phosphorylation site A190 S685 is localized on the part of the Pore 1-domain which 
contributes to the backside of the polymerase complex, in the vicinity of ABC14.5, the 
AC40/AC19 heterodimer and a conserved loop of the hybrid binding-domain of A135. The 
mutation of S685 to either alanine or aspartate (mimicking constitutively unphosphorylated or 
phosphorylated states, respectively) resulted in no detectable growth defect on full media. In 
contrast the growth behavior changed depending on the mutation on media containing the 
NTP pool-depleting drug 6-azauracil (6AU): while the growth of the alanine mutant (A190 
S685A) was similar to the wild-type yeast strain, the analogous mutation to aspartate (A190 
S685D) resulted in a lowered sensitivity. 6AU-sensitivity is most often associated with 
defects in transcription elongation (Hampsey, 1997; Van Mullem et al., 2002; Schneider et 
al., 2007) like the inability to cleave the 3’ end of the nascent RNA chain from a backtracked 
Pol II upon a lack of the elongation factor TFIIS (Wind and Reines, 2000; Kettenberger et al., 
2003). Strikingly most of the mutations of Rpb1 conferring 6AU sensitivity were found in the 
TFIIS interaction interface, but others were found e.g. on the clamp (Trinh et al. 2006). 
Additional mutations resulting in a 6AU sensitive phenotype were found in Rpb2 (the second 
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largest Pol II subunit), including two mutations in the hybrid binding-domain (Powell and 
Reines, 1996; Trinh et al., 2006). Interestingly the corresponding amino acids in the Pol I 
homology model are near the region of A135 which is in the vicinity of the phosphosite A190 
S685. On the other hand mutations leading to lowered 6AU sensitivity are rare. One example 
is the deletion of the gene coding for the 3’-5’ exoribonuclease Not3 (Riles et al., 2004), 
which was described to be involved in Pol II elongation as part of the CCR4-NOT complex 
(Denis et al., 2001). 
Another striking difference between the alanine and aspartate mutations of A190 S685 is the 
genetic interaction with the non-essential Pol I subunit A12.2: A190 S685D was found to be 
synthetic lethal with the deletion of RPA12 (Reiter, 2007). In contrast the growth behavior of 
the analogous A190 S685A – Δrpa12 strain was similar to a Δrpa12 control strain. 
Furthermore no other synthetic growth defects between an A190 S685 mutation and a gene-
deletion of any other non-essential Pol I subunit was apparent. Synthetic lethality indicates a 
functional linkage between the two genetic interaction partners. Accordingly reversible 
phosphorylation at A190 S685 seems to be linked to one of the functions of the TFIIS-like 
subunit A12.2 which was described to be involved in transcription elongation (Van Mullem et 
al., 2002), termination (Prescott et al., 2004) and 3’ RNA cleavage (Kuhn et al., 2007). 
Moreover interaction of A12.2 with A190 seems to be important for the correct conformation 
of a part of the largest subunit (Nogi et al., 1993; Van Mullem et al., 2002). Interestingly the 
A12.2 binding site is localized in the jaw region of A190, which is on the opposite side of the 
polymerase with respect to the phosphorylation site A190 S685 (Figure 30). Thus a direct 
interaction seems to be rather unlikely. 
 
 
 
 
 
Figure 30. Scheme of Pol I showing the localization of A190 S685 and A12.2. 
 
 
The cleavage of the 3’ end of the nascent rRNA from a backtracked Pol I during the 
elongation phase apparently occurs in the active center (Kuhn et al., 2007). It is unknown how 
the C-terminal part of A12.2 participates in this process (Kuhn et al., 2007). The stimulation 
of the Pol II RNA cleavage activity by TFIIS is facilitated by an acidic hairpin which contains 
the conserved motif present in all TFIIS-like subunits. This hairpin enters the polymerase 
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through the funnel / pore and positions a metal ion required for cleavage in the active site, 
while conformational changes realign the RNA (Kettenberger et al., 2003). The location of 
the TFIIS-like conserved motif of A12.2 is too far from the funnel / pore to stimulate the 
intrinsic Pol I cleavage activity in a similar way. On the other hand, A190 S685 is located on 
the backside of the Pore 1-domain. Phosphorylation at this site might allosterically induce a 
conformational change of the pore and the adjacent active center (Johnson and O’Reilly, 
1996; Johnson and Lewis, 2001), thus possibly stimulating the intrinsic Pol I RNA cleavage 
activity. The same conformational rearrangement by the phosphomimetic mutation to 
aspartate might facilitate more efficient elongation in the presence of 6AU, possibly through 
efficient binding of NTPs to the E-site, easier passage of NTPs through the pore or better 
control of unfavorable backtracking of the polymerase. However, in this conformational state 
the loss of A12.2 might lead Pol I into a dead end situation resulting in the synthetic lethal 
phenotype. 
 
Another possible explanation for the synthetic lethality is the occurrence of two different 
effects of A190 S685D and Δrpa12 on transcription elongation which finally corrupt the 
transcription system. The 6AU sensitivity of a Δrpa12 strain can be rescued by the N-terminal 
domain of A12.2 (Van Mullem et al., 2002), indicating that the full deletion has an impact on 
transcription elongation independent from the RNA cleavage activity. Synthetic lethality of 
A190 S685D with a deletion of the C-terminal domain of A12.2 instead of the full knock-out 
could be tested to address this question.  
 
Finally an involvement of A190 S685 phosphorylation in transcription termination is possible. 
For example an allosteric change could assist in transcript release.  
Further experiments are required to investigate to which of the functions of A12.2 the 
reversible phosphorylation of A190 S685 is linked. Because the alanine and aspartate 
mutations exhibit no growth defect in the presence of A12.2, a conditional mutant could be 
constructed by cloning the gene RPA12 under the control of an inducible galactose-dependent 
promoter. On galactose containing medium these cells would grow like a wild-type strain, but 
upon shifting to glucose the expression of A12.2 would be stopped and thus the synthetic 
effect induced.  
 
 
3.3.5 A43 S220 on the outermost part of the stalk and other sites in the A43 OB-domain 
 
The four phosphorylation sites found in subunit A43 are localized in the C-terminal OB-
domain. It contains an OB-protein fold (Oligonucleotide/oligosaccharide Binding protein 
fold) (Murzin, 1993) which enables the A43/A14 heterodimer to bind RNA in vitro (Meka et 
al., 2003). The in vivo relevance of this feature which can also be found in the homologous 
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subunits of Pol II, Pol III and the archaeal RNA polymerase (Meka et al., 2003; Orlicky et al., 
2001; Jasiak et al., 2006) is unclear. Apparently, phosphorylation of the four sites is not 
required for the oligonucleotide interactions of the OB-domain since the in vitro RNA binding 
studies were performed with recombinant expressed subunits (Meka et al., 2003).  
 
The crucial interactions of A43 include the complex formation with Rrn3p, which renders 
Pol I competent for transcription initiation (Peyroche et al., 2000). This complex formation is 
accompanied by a change in the Pol I phosphorylation pattern in vivo (Fath et al., 2001). 
Furthermore the in vitro interaction seems to depend on the phosphorylation status of Pol I 
but not of Rrn3p (Fath et al., 2001). The interaction interface has not been mapped yet; most 
information on the binding site of Rrn3p came from the ts-mutant rpa43-6 (Peyroche et al., 
2000) which contains three different mutations, resulting in an unstable Pol I-Rrn3p complex. 
The three amino acid exchanges were mapped to a more conserved region of A43 spanning 
from positions 42 to 172 in the primary structure (Peyroche et al., 2000). In the recently 
solved crystal structure of the A43/A14 heterodimer two of the three mutations are located on 
the upstream surface of A43 (Figure 31) (Kuhn et al., 2007).   
 
 
 
 
 
Figure 31. Positions of the phosphosite A43 S220 and of the residues mutated in rpa43-6 in the A43/A14 
crystal structure. A43 S208 is not included in the structure; the position of the next ordered residue (213) is 
shown. Furthermore the conserved P51 is depicted, which was used to dock the crystal structure into the Pol I 
homology model (Kuhn et al., 2007). 
 
 
Only one (S220) of the four A43 phosphosites is included in the structure. The others lie in 
regions which were deleted from the recombinant proteins in order to facilitate crystallization. 
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A43 S220 is located on the outermost part of the protruding A43/A14-stalk and in close 
proximity to one of the mutations of the rpa43-6 mutant. Thus, it is nearby but not within the 
proposed Rrn3p binding site and would be freely accessible to modifying enzymes in the 
initiation-competent complex. 
 
The mutants of the identified phosphosites showed no detectable growth defect, arguing that 
the complex formation between A43 and Rrn3p as a key regulatory step of rDNA 
transcription is not negatively affected. However, an involvement of phosphorylation at these 
sites in the mechanism of Rrn3p-binding / -release can not be excluded. As discussed, only 
about 2 % of the total cellular Pol I is present in the initiation-competent form, the rest 
belongs to the pools of transcribing or free polymerases, and the identified phosphosites most 
probably originated from these latter two (see 3.2.2). Dephosphorylation might render Pol I 
competent for complex formation, while phosphorylation might be involved in the release of 
Rrn3p upon promoter escape. Accordingly the alanine mutations of the phosphorylation sites 
could stabilize the Rrn3-association beyond the transcription initiation step. As shown by the 
CARA-mutant strain which expresses a fusion protein of A43 and Rrn3, even the constitutive 
association of this transcription factor to the polymerase does not alter the growth behavior on 
full media (Laferté et al., 2006; Chédin et al., 2007). In this study only the alanine mutations 
of the single phosphosites have been investigated so far, except for one aspartate mutant (A43 
S208D) and two combined alanine mutations of the neighboring phosphosites S208 and S220 
(A43 S208A S2220A). Rrn3-association has not been tested for any of the mutants. Co-
immunoprecipitation (Co-IP) experiments could be employed to compare the total amounts of 
Pol I-Rrn3p-complexes in wild-type and mutant strains. Furthermore the association of Rrn3 
with the elongating Pol I could be tested by chromatin immunoprecipitation (ChIP) assays.  
 
 
3.3.6 ABC23 S102 in the A190-ABC23-A43 interface 
 
The common ABC23 subunit (= Rpb6) is involved in enzyme assembly (Nouraini et al., 
1996; Minakhin et al., 2001) and forms the main interaction interface of the core polymerases 
to their respective ‘stalk’ heterodimers (Peyroche et al., 2002). ABC23 is phosphorylated in 
the three nuclear RNA polymerase complexes (Bell et al., 1977; Kolodziej et al., 1990) but it 
is unclear whether the same site is modified in all cases. The identified phosphorylation site in 
Pol I (ABC23 S102) can be found in the C-terminal assembly domain. In the Pol I homology 
model it is located in a narrow space between the interaction interfaces A190-ABC23 and 
ABC23-A43. 
Neither the mutation of ABC23 S102 to alanine nor to aspartate resulted in any detectable 
growth defect phenotype in the assays employed in this study. The chromosomal wild-type 
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allele was deleted from the mutant yeast strains and accordingly Pol II and Pol III are not 
impaired by these mutations as well. 
 
A number of experiments indicate that phosphorylation of S102 is not involved in the 
assembly function of ABC23 and not required for basal transcription activity. First, the yeast 
ABC23 can be fully functionally substituted by its mammalian counterpart (McKune and 
Woychik, 1994). Interestingly the C-terminal domains of these two homologous proteins are 
highly conserved but the mammalian subunit contains an alanine in place of the yeast S102 
(McKune and Woychik, 1994). Second, the basal transcription activity of Pol I purified from 
a Δrpa14-strain which additionally lacks the subunits A43 and ABC23, can be restored by the 
recombinantly expressed ABC23 (Lanzendörfer et al., 1997). Third, Pol I immunoprecipitated 
from yeast strains carrying the single phosphosite mutations showed no significant difference 
in subunit composition to the corresponding wild-type, as analyzed by western blots (Reiter, 
2007). 
 
A mutation of the phosphosite S102 to phenylalanine in the ABC23-mutant rpo26-17 is 
synthetic lethal with the insertion mutation W954(LELE)P in the largest Pol II subunit Rpb1 
(Rpb1 ts-mutant rpo21-4) (Nouraini et al., 1996). Strikingly this insertion mutation is 
positioned in a part of the foot domain of Rpb1 which is significantly different between Rpb1 
and A190. The ‘truncated foot’ of A190 is 62 amino acids smaller than the Rpb1 counterpart 
(Kuhn et al., 2007). In contrast there are only minor differences between the foot domains of 
Rpb1 and C160 (the largest Pol III subunit) (Jasiak et al., 2006).  
While all investigated mutations of ABC23 S102 exhibited no detectable growth defect 
phenotype, a mutation of the neighboring Q100 to arginine in the ABC23-mutant rpb6-151 
resulted in a cs- and ts-phenotype, accompanied by reduced mRNA and tRNA levels (Tan et 
al., 2003). Apparently the effects on Pol II transcription are caused by the destabilization of 
the association of the Rpb4/7 heterodimer to the core complex (Tan et al., 2003). ABC23 
Q100 was found be directly involved in this interaction through a hydrogen bond with glycine 
66 of Rpb7 (Armache et al., 2005). The stability of the A43/A14 binding to ABC23 in the 
Pol I complex has not been investigated, but apparently the production of rRNA is not directly 
affected by the ABC23 Q100R mutation (Tan et al., 2003). In a similar manner 
phosphorylation of ABC23 S102 may have different effects on Pol I, Pol II and Pol III, thus 
possibly contributing to the specific binding of the stalk heterodimers A43/A14, Rpb4/Rpb7 
or C25/C17 to their respective core polymerase. The ABC23 phosphosite would be freely 
accessible prior to the binding of A43/A14. However, the phosphomutant phenotypes show 
that it cannot be exclusively the trigger for such a mechanism. 
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3.4 A mutation in the conserved TFIIS-like motif of the non-essential A12.2 is lethal 
 
The C-terminal domain of the TFIIS-like subunit A12.2 is involved in the intrinsic Pol I 
cleavage activity (Kuhn et al., 2007). It contains the highly conserved motif Q.RSADE..T.F 
shared with the other members of the TFIIS-like protein-family (Chédin et al., 1998; Hausner 
et al., 2000). Full deletion of this non-essential Pol I subunit results in a ts-phenotype and 
6AU sensitivity, while truncation of the C-terminal half apparently has no consequences on 
cell growth (Nogi et al., 1993; Van Mullem et al., 2002). Thus it was surprising that mutation 
of the aspartate and glutamate of the conserved C-terminal motif to alanines is lethal (A12.2 
D105A E106A). Apparently the full or partial deletions of A12.2 can be compensated by the 
cell while the DE>AA mutation leads into a dead end situation. Possibly some protein binding 
or conformational change can still occur but the loss of function prevents the release from this 
state. 
In a similar manner the analogous mutation in the homologous, but essential Pol III subunit 
C11 was found to be lethal (Chédin et al., 1998). The DE>AA mutation in the non-essential 
Pol II cleavage factor TFIIS has only been tested in vitro were it resulted in a loss of function 
(Jeon et al., 1994). Structural analysis of TFIIS bound to Pol II revealed that the two acidic 
amino acids of the conserved motif coordinate a metal ion in the active site required for RNA 
cleavage (Kettenberger et al., 2003). However, as discussed above the location of A12.2 in 
the Pol I complex contradicts an RNA cleavage mechanism analogous to the one described 
for TFIIS (see 3.3.4).  
 
But the involvement of an additional free A12.2 in the cleavage mechanism might be 
possible. While one A12.2 is stably associated to the Pol I complex as a polymerase subunit, 
another one could bind through the funnel / pore as a cleavage factor and stimulate RNA 
3’ trimming in a TFIIS-like manner. This would require an additional pool of free A12.2, 
which should be apparent in quantifications of the cellular amount of A12.2, compared to 
other Pol I subunits. This subunit was not included in the quantification of Pol I complexes 
yet (Bier et al., 2004). However, the in vitro assays to test the intrinsic Pol I RNA cleavage 
activity were performed with a highly purified enzyme preparation (Kuhn et al., 2007). As 
described above, this Pol I purification procedure involves an affinity chromatography step 
via a His6-tagged A43 subunit and a size exclusion chromatography step (see 2.1). Thus, a 
potential additional A12.2 would need to be stably associated to the polymerase, but no such 
extra mass was apparent in the cryo-EM analyses. Furthermore the stoichiometric ratio of 
A12.2 to other Pol I subunits in the polymerase complex is 1 (Paule, 1998). The disintegration 
of a part of the polymerase complexes in the in vitro assay reaction batch would be necessary 
to provide the single subunit in a free form. 
Another possible mechanism enabling A12.2 to enter the active center through the funnel / 
pore and stimulate RNA cleavage similar to TFIIS includes its release from the jaw-position 
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when the polymerase becomes stalled. However, Pol I is a very stable complex (Schneider 
and Nomura, 2004) and partial disassembly was not observed so far. 
This leads to a third possibility: a complete free Pol I complex might function as a cleavage 
factor for another DNA bound, backtracked Pol I, i.e. the C-terminal domain of A12.2 bound 
to the jaw-position of one polymerase could access the active center of another polymerase 
and facilitate RNA cleavage. Apparently only the N-terminal part of A12.2 is involved in the 
interaction of this subunit with the polymerase jaws, the C-terminal part seems to be more 
loosely associated (Van Mullem et al., 2002). Such a mechanism could at least partially 
provide a reason for the large pool of free Pol I (about 70 %; see 3.2.2) which is highly 
concentrated in the nucleolus, while the transcription machinery apparently uses an efficient 
re-initiation system. 
 
Further experiments are required to elucidate the exact function of A12.2 in the intrinsic RNA 
cleavage activity of Pol I and whether the C-terminal domain with the conserved motif enters 
the active center similar to TFIIS. The A12.2 DE>AA mutant expressed under the control of a 
galactose-inducible promoter could provide a useful tool for these investigations. Upon 
induction the polymerase molecules apparently become trapped in the ‘dead end situation’ 
which presumably resembles an intermediate state of the A12.2-dependent RNA cleavage 
process. This would enable purification and structural analysis. Furthermore transcription 
assays could be used to investigate whether these ‘dead end situation’ polymerase complexes 
are still active but stalled or completely inactive, thus resulting in the observed lethal 
phenotype. 
 
 
3.5 Outlook 
 
The activity of Pol I was previously found to be linked to its phosphorylation state (Fath et 
al., 2001; Fath et al., 2004). The phosphorylation sites identified in this study and in three 
proteome-wide phosphorylation studies (Ficarro et al., 2002; Gruhler et al., 2005; Li et al., 
2007) form the basis for a detailed analysis of this correlation.  
 
Surprisingly, the mutations of single phosphorylation sites had no apparent impact on the 
growth behavior of the resulting yeast strains in vivo. However, it is possible that other 
regulatory mechanisms of the ribosome biogenesis machinery compensate for slight changes 
in the activity of Pol I. The kinetics of in vitro transcription assays with partially 
dephosphorylated Pol I indicated a more complex regulatory mechanism than an ‘on-off 
switch’ caused by a single phosphorylation (Fath et al., 2004). Combinations of different 
phosphosite mutations will need to be tested to obtain more information about their 
contribution in the regulation of Pol I. Furthermore in vitro assays could be employed to test 
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the effects of the phosphomimetic mutations of single phosphorylation sites on the enzymatic 
activities of Pol I. 
Furthermore additional Pol I phosphorylation sites might have escaped detection. The mass 
spectrometric analyses should be extended with the use of other specific proteases to obtain 
more complete sequence coverage (Wa et al., 2006). Low abundant phosphorylations could 
be analyzed after phosphopeptide enrichment, e.g. via TiO2 chromatography (Pinkse et al., 
2004). 
 
The phosphorylation sites identified in this study were obtained from total Pol I preparations 
similar to the preparations originally used to identify the in vivo phosphorylated subunits by 
32P-labeling (Bell et al., 1976; Buhler et al., 1976b; Bell et al., 1977). A comparison with the 
phosphorylation sites from Pol I preparations enriched in single steps of the transcription 
cycle would be very interesting and could reveal important regulatory sites. Comparison of 
the autoradiographies from 32P-labeled initiation-competent Pol I and total Pol I showed that 
there are apparent differences in the phosphorylation patterns (Fath et al., 2001). Initiation-
competent Pol I could be enriched via two different affinity tags on Rrn3 and on a Pol I 
subunit. Furthermore it might be possible to enrich elongating polymerase via its association 
to the DNA in a chromatin fraction after cross-linking. 
 
The apparent connection of one of the identified phosphoserines (A190 S685) to transcription 
elongation should be further investigated. A mutation of this phosphosite to aspartate resulted 
in a lowered sensitivity to 6AU. The same mutation was found to be synthetic lethal with a 
deletion of the non-essential Pol I subunit A12.2 (Reiter, 2007), which was described to 
function in transcription elongation (Van Mullem et al., 2002), RNA cleavage (Kuhn et al., 
2007) and termination (Prescott et al., 2004). This synthetic lethality with Δrpa12 could be 
used to create a conditional mutant by expressing A12.2 under the control of an inducible 
promoter. Such a conditional mutant would enable to investigate which of the functions of 
A12.2 is apparently connected to the reversible phosphorylation at A190 S685, by e.g. 
analyzing the effects on transcription elongation or on termination upon switching from 
permissive to restrictive conditions, using suitable assays (Schneider et al., 2006; Schneider et 
al., 2007; Kuhn et al., 2007; Prescott et al., 2004; Gadal et al., 2002). 
 
Furthermore a lethal mutation of the non-essential A12.2 (A12.2 D105A E106A) was found 
in this study. Possibly these mutants are trapped in an intermediate state of 3’ RNA cleavage 
from a backtracked polymerase. It would be very interesting to investigate the details of this 
lethal effect. The mutant under the control of the galactose-dependent promoter could also be 
a very useful tool for the studies on the mechanism of the intrinsic Pol I RNA cleavage 
activity. 
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 4 Materials & Methods 
 
4.1 Materials 
 
4.1.1 Saccharomyces cerevisiae strains 
 
Name Genotype Origin 
GPY2 leu2-∆1 ade2-101 trp1-∆63 ura3-52 his3-∆200 lys2-801 
RPA43∆::LEU2 pAS22 (TRP1) 
Fath et al., 2000 
NOY222 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pNOY20 (LEU2 CANs) 
Wittekind et al., 
1988 
ToY605 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-RPA190 (TRP1) 
this study 
ToY778 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S354A (TRP1) 
this study 
ToY781 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S354D (TRP1) 
this study 
ToY779 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S685A (TRP1) 
this study 
ToY780 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S685D (TRP1) 
this study 
ToY677 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S936/941A (TRP1) 
this study 
ToY1030 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S936D (TRP1) 
this study 
ToY1031 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S941D (TRP1) 
this study 
ToY1032 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S936E (TRP1) 
this study 
ToY1033 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S941E (TRP1) 
this study 
ToY245 trp1-∆1 his4-∆401 leu2-3,112 ura3-52 can r rpa190∆::URA3 
pRS314-rpa190-S1413/1415/1417A (TRP1) 
this study 
D101-I2 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 yCPA43 (URA3) 
Thuriaux et al., 
1995 
GPY9 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pGP5 (TRP1) 
Peyroche et al., 
2000 
ToY523 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S208A (TRP1) 
this study 
ToY612 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S208D (TRP1) 
this study 
ToY678 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S220A (TRP1) 
this study 
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ToY679 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S208/220A (TRP1) 
this study 
ToY561 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S262A (TRP1) 
this study 
ToY611 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S262/263/265A (TRP1) 
this study 
ToY562 rpa43::LEU2 ade2-101ura3-52 lys2-801 trp1-∆63 his3-∆200 leu2-
∆1 pRS314-rpa43-S285A (TRP1) 
this study 
T4-1C ura3-52 ade2-1 lys2-801 his3-∆200 trp1-∆1 rpa34-∆::HIS3 Gadal et al., 1997 
ToY1034 ura3-52 ade2-1 lys2-801 his3-∆200 trp1-∆1 rpa34-∆::HIS3 pRS314-
RPA34 
this study 
ToY1035 ura3-52 ade2-1 lys2-801 his3-∆200 trp1-∆1 rpa34-∆::HIS3 pRS314-
rpa34-S10/12/14A (TRP1) 
this study 
JAY444 CAN1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1 rpo26::LEU2 
pRPO26 (URA3) 
Archambault et 
al., 1990 
ToY607 CAN1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1 rpo26::LEU2 
pRS314-RPO26 (TRP1) 
this study 
ToY568 CAN1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1 rpo26::LEU2 
pRS314-rpo26-S102A (TRP1) 
this study 
ToY1036 CAN1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1 rpo26::LEU2 
pRS314-rpo26-S102D (TRP1) 
this study 
DLY200 ura3-52 his3-∆200 trp1∆ lys2-801 ade2-101 rpc19::HIS3 pLS135 
(URA3) 
Lalo et al., 1993 
ToY608 ura3-52 his3-∆200 trp1∆ lys2-801 ade2-101 rpc19::HIS3 pRS314-
RPC19 (TRP1) 
this study 
ToY609 ura3-52 his3-∆200 trp1∆ lys2-801 ade2-101 rpc19::HIS3 pRS314-
rpc19-T33A (TRP1) 
this study 
BSY420 (1n) 1 ade2-1 can1-100 his3∆200 leu2-3,112 trp1-1 ura3-1 Milkereit et al., 
2001 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Brachmann et al., 
1998 
Y06861 BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YJR063w::kanMX4 Winzeler et al., 
1999 
ToY1264 BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YJR063w::kanMX4 
YCplac33-RPA12 (URA3) 
this study 
ToY1265 BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YJR063w::kanMX4 
YCplac111Gal (LEU2) 
this study 
ToY1266 BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YJR063w::kanMX4 
YCplac111Gal-RPA12 (LEU2) 
this study 
ToY1267 BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YJR063w::kanMX4 
YCplac111Gal-rpa12 DE>AA (LEU2) 
this study 
1 Wildtype yeast strain BSY420 was used as a cloning tool in site-directed mutagenesis 
 
 
 
 
 78 
 Materials & Methods
4.1.2 Escherichia coli strains 
 
Name Genotype Origin 
XL1-Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ 
lacIq Δ(lacZ)M15] hsdR17(rK- mK+) 
Stratagene 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
Grant et al., 1990 
 
 
4.1.3 Plasmids 
 
Plasmid Gene Description Derived from Origin 
pRS314 – TRP1, Ampr, CEN6, ARSH4 pBluescript Sikorski and 
Hieter, 1989 
pRS413 – HIS3, Ampr, CEN6, ARSH4 pBluescript II Sikorski and 
Hieter, 1989 
YCplac33 – URA3, Ampr, CEN4, ARS1 pUC19 Gietz and 
Sugino, 1988 
YCplac111Gal – LEU2 , Ampr, CEN4, ARS1 YCplac111 Ferreira-Cerca 
et al., 2005 
pNOY16 RPA190 TRP1, CEN1, ARS3 pTC3 Wittekind et 
al., 1988 
pRS314-RPA190 RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S354A RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S354D RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S685A RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S685D RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-
S936/941A 
RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S936D RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S941D RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S936E RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-S941E RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa190-
S1413/1415/1417A 
RPA190 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pGP5 RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 Peyroche et 
al., 2000 
pRS314-rpa43-S208A RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa43-S208D RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa43-S220A RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa43-S208/220A RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa43-S262A RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
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pRS314-rpa43-
S262/263/265A 
RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa43-S285A RPA43 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-RPA34 RPA34 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpa34-S10/12/14A RPA34 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-RPO26 RPO26 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpo26-S102A RPO26 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpo26-S102D RPO26 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-RPC19 RPC19 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS314-rpc19-T33A RPC19 TRP1, Ampr, CEN6, ARSH4 pRS314 this study 
pRS413-RPA12 RPA12 HIS3, Ampr, CEN6, ARSH4 pRS413 this study 
pRS413-rpa12 DE>AA RPA12 HIS3, Ampr, CEN6, ARSH4 YCplac33 this study 
YCplac33-RPA12 RPA12 URA3, Ampr, CEN4, ARS1 YCplac33 this study 
YCplac111Gal-RPA12 RPA12 LEU2, , Ampr, CEN4, ARS1 YCplac111Gal this study 
YCplac111Gal-rpa12 
DE>AA 
RPA12 LEU2, , Ampr, CEN4, ARS1 YCplac111Gal this study 
 
 
4.1.4 Oligonucleotides 
 
Oligonucleotide Sequence Length Gene Position  
(rel. to ATG) 
A190 -801for +XhoI 5’- GCG CAC TCG AGC CAC GTT 
TGT CTC TTA TC –3’ 
29 nt RPA190 -801– -784 
A190 +69rev 5’- CTC TTT AGC TGT TAG GAT 
C –3’ 
19 nt RPA190 69 – 88 
RPA34 -424for +XhoI 5’- GCG CTC TCG AGT GAA TGT 
ATC AAA TGG GAA GGA G -3’ 
34 nt RPA34 -424 – -402 
RPA34 1067rev +BamHI 5’- GCG CTG GAT CCA CAG GTC 
AAC CTT GGA AGT G -3’ 
31 nt RPA34 1067 – 1048 
RPO26 -234for +XhoI 5’- GCG CTC TCG AGT TGA CAG 
CGA TTT CAA CAG TTA C -3’ 
34 nt RPO26 -234 – -211 
RPO26 806rev +BamHI 5’- GCG CTG GAT CCT TTA CTA 
CAA ATC AGC AAG CGA C -3’ 
34 nt RPO26 806 – 784 
RPC19 -717for +XhoI 5’- GCG CTC TCG AGG ATC TGT 
TCG CTC TGA TGC -3’ 
30 nt RPC19 -717 – -698 
RPC19 844rev +BamHI 5’- GCG CTG GAT CCG TGC TTA 
ATT CTG TTA CAG GTT G -3’ 
34 nt RPC19 844 – 822 
A190 S354A MluI for 5’- GGT CAA GGC TGA CGC GTT 
TTT TAT GGA TGT TCT TG -3’ 
35 nt RPA190 1046 – 1080 
A190 S354D XhoI for 5’- GAG ACC CAA TCT CTC GAG 
AAA ATT GGT CAA GGC TGA CGA 
TTT TTT TAT GGA TG – 3’ 
53 nt RPA190 1022 – 1074 
A190 S354A EcoRI rev 5’- GGA TGT AAC AGC GTC AAG 
AAT TCC TGA C -3’ 
28 nt RPA190 2690 – 2663 
 80 
 Materials & Methods
A190 S685A MluI for 5’- GGC TAA CAA GTA AGG ACG 
CTT TTT TCA CGC GTG AAC AAT 
ACC AG– 3’ 
44 nt RPA190 2035 – 2078 
A190 S685D MluI for 5’- GGC TAA CAA GTA AGG ACG 
ATT TTT TCA CGC GTG AAC AAT 
ACC AG– 3’ 
44 nt RPA190 2035 – 2078 
A190 S936/941A KasI 
for 
5’- CTG GCG CCA AAG GTG CTA 
ACG TTA ATG TTG CTC AAA TTA 
TG -3’ 
41 nt RPA190 2791 – 2831 
A190 S936/941A BglII 
rev 
5’- GCA AAT AAC CAG ATC TAG 
ATG TTT TAA CGG -3’ 
30 nt RPA190 3057 – 3028 
A190 S936D KasI for 5’- CTG GCG CCA AAG GTG ATA 
ACG TTA ATG TTT CTC AAA TTA 
TGT G -3’ 
43 nt RPA190 2791 – 2833 
A190 S941D KasI for 5’- CTG GCG CCA AAG GTT CTA 
ACG TTA ATG TTG ATC AAA TTA 
TGT G -3’ 
43 nt RPA190 2791 – 2833 
A190 S936E KasI for 5’- CTT TCT GGC GCC AAA GGT 
GAG AAC GTT AAT GTT TCT CAA 
ATT ATG TG -3’ 
47 nt RPA190 2787 – 2833 
A190 S941E KasI for 5’- CTT TCT GGC GCC AAA GGT 
TCT AAC GTT AAT GTT GAG CAA 
ATT ATG TG -3’ 
47 nt RPA190 2787 – 2833 
A190 mut4237-49 SalI 
rev 
5’- CTC TTA TTA ATT TGT TCA 
TTC ATG TCG ACG TCT TCG TCC 
TCA GCG TCA GCA TCA GCT TCT 
TTA TCG -3’ 
66 nt RPA190 4292 – 4226 
A190 3038 BglII for 5’- CAT CTA GAT CTG GTT ATT 
TGC AAC GTT GTC TAA C -3’ 
34 nt RPA190 3038 – 3071 
A43 S208A NsiI for 5’- CAT TGG TCT TTT GAT TCA 
TGA TGC ATT TAA TGC TAG -3’ 
36 nt RPA43 432 – 467 
A43 S208A AvrII rev 5’- CCC AGT GGC CTA GGG ATC 
TGT TTC CAA AGG CAA ATT TGC 
C -3’ 
40 nt RPA43 652 – 613 
A43 S208D AvrII rev 5’- CCC AGT GGC CTA GGG ATC 
TGT TTC CAA AGT CAA ATT TGC 
C -3’ 
40 nt RPA43 652 – 613 
A43 S220A BsiWI rev 5’- GAA CAT TTC GTA CGG TGA 
ACC TCA ATT TAC CGT CAA TGG 
GTT CAC CAT TAG CAT CTA CCC 
AGT -3’ 
63 nt RPA43 709 – 647 
A43 S262A AatII for 5’- GAA GAT GCT GAC GTC ATA 
AAC ACA GAT G -3’ 
28 nt RPA43 523 – 550 
A43 S262A MluI rev 5’- CTT TCA GCT TGG GAA CGA 
GAC GCG TTA TAG CC -3’ 
32 nt RPA43 806 – 775 
A43 S262/263/265A 
XmaI rev 
5’- CTT TCA GCT TGG GCC CGG 
GCG GCG TTA TAG CCA TTG C -
3’ 
37 nt RPA43 806 – 769 
A43 S285A MscI for 5’- GTA TTT GAT GAC GAA GTG 
GCC ATC GAA AAC AAA GAG AGC 
C -3’ 
40 nt RPA43 835 – 874 
A43 S285A NcoI rev 5’- GTT GAT ATA TTG TCG AAT 
TTG CCA TGG TTT AGC TAC G -
37 nt RPA43 1128 – 1092 
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3’ 
A34 S10-14A for 5’- ATG TCG AGA TTA TTA TAA 
CCT TAC AG -3’ 
26  nt RPA34 -305 – -280 
A34 S10-14A PflFI rev 5’- GTT TGA TAT GAC TTC GTC 
ATC AGC GTC TGC ATC TGC TAC 
GTA ATC -3’ 
45 nt RPA34 63 – 19 
ABC23 S102A BsiWI 
for 
5’- CTG ATG AGG AGA CGT ACG 
AGG AAA AAC C -3’ 
28  nt RPO26 147 – 174 
ABC23 S102A AgeI rev 5’- CTA CAA AAA CCG GTG CAT 
TCA TGG CAA TTT GTA GG -3’ 
35 nt RPO26 404 – 370 
ABC23 S102D AgeI rev 5’- CTA AAT CTA CAA AAA CCG 
GTG CAT TCA TGT CAA TTT GTA 
GG– 3’ 
41 nt RPO26 410 – 370 
AC19 T33A AatII for 5’- AGA AGA ACA GGA CGT CGA 
TAT GGC TGG CGA TG -3’ 
32  nt RPC19 75 – 106 
AC19 T33A MluI rev 5’- GCC CTT TTT GTA ACG CGT 
CCA CCG CGG TCG -3’ 
30 nt RPC19 361 – 332 
RPA12 -336for +EcoRI 5’- GCG CTG AAT TCG TCA CGA 
TAG AGT TAT CGC TG – 3’ 
32 nt RPA12 -336 – -316 
RPA12 697rev +BamHI 5’- GCG CTG GAT CCG GAT GAT 
AGC TGT TAT TAC TTT GAG – 3’ 
36 nt RPA12 697 – 673 
RPA12 +1for +BamHI 5’- GCG CTG GAT CCA TGT CTG 
TTG TAG GAT CGT T – 3’ 
31 nt RPA12 1 – 20 
RPA12 697rev +SphI 5’- GCG CTG CAT GCG GAT GAT 
AGC TGT TAT TAC TTT G – 3’ 
34 nt RPA12 697 – 675 
A12 D105A-E106A NotI 
for 
5’- CAG TTA AGA TCT GCG GCC 
GCA GGT GCT ACT GTC TTC – 3’ 
36 nt RPA12 298 – 333 
 
All oligonucleotides were purchased from MWG Biotech AG, Ebersberg, Germany. 
 
 
4.1.5 Peptides 
 
Peptide MH+ Comment Origin 
EAIpSAAPFAK -NH2 1083.524 Da Synthetic Phosphopeptide  
(see Klemm et al., 2004) 
Bachem 
TVMENFVAFVDK 1399.6931 Da BSA-sequence 569-580 Bachem 
 
 
4.1.6 Model proteins 
 
Protein Molecular Weight Origin 
BSA (Fraction V) 66 kDa Sigma 
α-Casein 24,5 kDa Sigma 
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4.1.7 Enzymes 
 
Enzyme Origin 
Antarctic Phosphatase New England Biolabs 
Calf Intestinal Phosphatase New England Biolabs 
iProof high-fidelity DNA polymerase Bio-Rad 
Restriction Endonucleases New England Biolabs 
T4 DNA ligase New England Biolabs 
Taq DNA polymerase  
Trypsin, modified, sequencing grade, from bovine pancreas Roche 
 
 
4.1.8 Antibodies 
 
Antibody Species Dilution Origin 
α-A135 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 1980) 
α-A49 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 1980) 
α-A43 rabbit 1:50000 A. Sentenac, Paris (Buhler et al., 1980) 
Pol I antiserum rabbit 1:10000 A. Sentenac, Paris (Buhler et al., 1980) 
α-Rpb1 (8WG16) mouse 1:1000 BAbCO 
α-Rpc53 rabbit 1:100000  
α-Rrn3-NT rabbit 1:400 Milkereit, 1999 
goat-α-rabbit IgG (H+L)-POD goat 1:3000 Dianova 
goat-α-mouse IgG (H+L)-POD goat 1:10000 Dianova 
 
 
4.1.9 Chemicals 
 
Chemicals were purchased at the highest available purity from Sigma-Aldrich, Merck, Fluka, 
Roth or J.T.Baker, except 5-FOA (Toronto Research Chemicals), agarose, electrophoresis 
grade (Invitrogen), bromine phenol blue (Serva), G418/Geneticin (Gibco), milk powder 
(Sukofin), Nonidet P-40 substitute (NP40) (USB Corporation), Tris ultrapure (USB 
Corporation) and Tween 20 (Serva). 
.Ingredients for growth media were purchased from BD Becton, Dickinson and Co. (Bacto 
Agar, Bacto Peptone, Bacto Tryptone and Bacto Yeast Extract), Q-Biogene, Bio101,Inc. or 
Sunrise Science Products (Complete supplement mixtures (CSM), Yeast nitrogen base 
(YNB), amino acids and adenine) and Sigma-Aldrich (D(+)-glucose, D(+)-galactose, amino 
acids and uracil). 
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The matrix for MALDI-MS was α-cyano-4-hydroxycinnamic acid (>98%, TLC) (Sigma-
Aldrich). 
 
 
4.1.10 Other Materials 
 
Material Origin 
Broad Range Protein Markers New England Biolabs 
DNA ladders New England Biolabs 
Yeast genomic DNA (strain S288C) Invitrogen 
Salmon sperm DNA (10 mg/ml) Invitrogen 
PVDF membrane Immobilion P 0.45µm  Millipore 
3MM filter-papers Millipore 
BM Chemiluminescence Blotting Substrate (POD) Roche 
SimplyBlue SafeStain Invitrogen 
Pro-Q Diamond Phosphoprotein stain Invitrogen 
Spectra/Por 2 dialysis tubing (MWCO 12-14 kDa) Spectrum Laboratories 
Ni-NTA Agarose Qiagen 
 
 
4.1.11 Media 
 
Medium Composition 
YPD  1 % (w/v) Bacto Yeast Extract 
(Yeast extract, Peptone, Dextrose) 2 % (w/v) Bacto Peptone 
 2 % (w/v) Glucose 
  
YPD + Geneticin YPD +200 µg/ml geneticin (G418) 
  
YPAD YPD +100 mg/l adenine 
  
SDC-His, -Leu or -Trp 0,67 % (w/v) YNB + Nitrogen 
(Synthetic Dextrose Complete 0,063 % (w/v) CSM -His -Leu -Trp w/ 20 mg/ml Ade 
minus His, Leu or Trp) 2 % (w/v) Glucose 
 supplemented with 20 mg/l L-histidine, 100 mg/l 
L-leucine and/or 50 mg/l L-tryptophane 
  
SDC-Ura 0,67 % (w/v) YNB + Nitrogen 
(Synthetic Dextrose Complete 0,065 % (w/v) CSM -His -Leu -Ura 
minus Ura) 2 % (w/v) Glucose 
 supplemented with 20 mg/l L-histidine, 100 mg/l 
L-leucine 
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SDC -Trp +5FOA SDC -Trp +0,1 % (w/v) 5-FOA 
  
SDC -Arg -Trp 0,67 % (w/v) YNB + Nitrogen 
 0,06 % (w/v) CSM -Arg -His -Lys -Trp -Ura 
 2 % (w/v) Glucose 
 supplemented with 20 mg/l L-histidine, 50 mg/l 
L-lysine, 20 mg/l L-uracil 
  
SDC -Arg -Trp +Can SDC -Arg -Trp +6 mg/l L-canavanine 
  
LB 1 % (w/v) Bacto Tryptone 
(Luria Broth) 0,5 % (w/v) Bacto Yeast Extract 
 0,5 % (w/v) NaCl 
  
LBAmp LB + 100 µg/ml ampicilin 
 
Media for agar plates were supplemented with 2 % (w/v) Bacto Agar. All growth media were 
autoclaved for 20 min at 120 °C. If required antibiotics, fungicides, counterselection drugs or 
other chemicals (e.g. 6AU) were added after cooling to about 60 °C.  
 
 
4.1.12 Equipment 
 
Device Manufacturer 
4700 Proteomics Analyzer MALDI-TOF/TOF Applied Biosystems 
Alpha 2-4 lyophilizer Christ 
Biofuge Fresco refrigerated tabletop centrifuge Hereaus 
Biofuge Pico tabletop centrifuge Hereaus 
C412 centrifuge Jouan 
Centrikon T-1170 ultracentrifuge Kontron Instruments 
Centrikon T-324 centrifuge Kontron Instruments 
CT422 refrigerated centrifuge Jouan 
Electrophoresis system model 45-2010-i Peqlab Biotechnologie GmBH 
FPLC-System (Pumps P-500; Controller LCC-501+; 
Fraction collector FRAC-100) 
Pharmacia Biotech 
Gel Max UV transilluminator Intas 
IKA-Vibrax VXR IKA 
Incubators Memmert 
LAS-3000 chemiluminescence imager Fujifilm 
MicroPulser electroporation apparatus Bio-Rad 
Mini-PROTEAN 3 electrophoresis system Bio-Rad 
NanoDrop ND-1000 spectrophotometer Peqlab Biotechnologie GmBH 
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Optima L-80 X ultracentrifuge Beckman Coulter 
PCR Sprint thermocycler Hybaid 
Power Pac 3000 power supplies Bio-Rad 
Pulverisette 6 planetary mono mill Fritsch 
Roto-Shake Genie  Scientific Industries 
Shake incubators Multitron / Minitron Infors 
Speed Vac Concentrator Savant 
Thermomixer compact Eppendorf 
Trans-Blot SD Semi-dry transfer cell Bio-Rad 
UltiMate 3000 NanoHPLC Dionex 
Ultrospec 3100pro spectrophotometer Amersham 
XCell SureLock Mini-Cell electrophoresis system Invitrogen 
 
 
4.1.13 Software 
 
Software Producer 
4000 Series Explorer v.3.6 Applied Biosystems 
Acrobat 7.0 Professional v.7.0.9 Adobe 
Chromeleon v.6.70 Dionex 
Data Explorer v.4.5 C Applied Biosystems 
GPS Explorer v.3.5 Applied Biosystems 
Illustrator CS v.11.0.0 Adobe 
Image Reader LAS-3000 v.1.12 Fujifilm 
Mascot Matrix Science 
Microsoft Office 2003 Microsoft 
ND-1000 v.3.5.2 Peqlab Biotechnologie GmBH 
Photoshop CS v.8.0.1 Adobe 
PyMOL v.0.99 DeLano Scientific 
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4.2 Methods 
 
4.2.1 Cultivation of S. cerevisiae strains 
 
Strains of the budding yeast Saccharomyces cerevisiae (4.1.1) were cultured using standard 
microbiological methods (Sherman, 2002).  
Liquid cultures were grown in YPD- or SDC-media in shake flasks at 30 °C, except for 
Δrpa12 deletion strains which were grown at 24 °C. Culture volumes were chosen to be 40 % 
of the flask volumes and cell growth was monitored by measuring the optical density at 
600 nm (= OD600).  
For cultivation on solid agar plates containing either YPD- or SDC-media, single colonies or 
small aliquots of glycerol stocks were spread out with sterile disposable inoculation loops 
(Sarstedt) in order to obtain colonies derived from single yeast cells. Plates were incubated 
upside down at the respective temperatures. 
Yeast strains were stored for short periods on agar-plates at 4 °C. Long-term preservation was 
accomplished by storing small aliquots of liquid cultures mixed with glycerol to a final 
concentration of 15 % (v/v) at -80 °C (= glycerol stock). 
 
 
4.2.2 Preparation of yeast whole cell extracts (WCE) 
 
4.2.2.1 Protein extraction on a small scale 
 
For protein extraction on a small scale, cells from 20-50 ml liquid cultures were harvested by 
centrifugation in 50 ml tubes (Sarstedt) for 3 min at 2000 g (Jouan). The cells were washed 
with 1 ml cold H2O transferred into 1.5 ml tubes and resuspended in an equal volume of high-
salt extraction buffer [400 mM (NH4)2SO4, 150 mM HEPES pH 7.6, 10 mM MgCl2, 20 % 
(w/v) glycerol, 5 mM β-mercaptoethanol, 1 mM PMSF, 2 mM benzamidine]. Cold glass 
beads (Ø 0.75–1 mm, Roth) were added to a level with the liquid and the tubes vigorously 
shaken on an IKA Vibrax at 14000 rpm and 4 °C. Afterwards the protein extracts were mixed 
with additional 150 µl ice-cold high-salt extraction buffer and the glass beads and cell debris 
pelleted in a tabletop centrifuge (15 min, 13000 rpm, 4 °C). The cleared yeast WCEs were 
transferred to new tubes and if required frozen in liquid nitrogen before storage at -20 °C. 
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4.2.2.2 Preparation of WCE for Pol I purification 
 
Strain GPY2, carrying the gene for an N-terminal His6/HA-tagged A43 on a plasmid (Fath et 
al., 2000), was cultivated to OD600 = 1-2 at 30 °C in 12 x 800 ml YPD media (= ~10 l) in 2 l 
shake flasks. The cells were harvested by centrifugation (4000rpm, 5 min, 4 °C; Herolab 
A6.9) and combined during a final wash step with cold H2O. The cell pellet was resuspended 
in 0.5 ml ice-cold lysis buffer (150 mM HEPES pH 7.8, 60 mM MgCl2, 60 % glycerol, 3 mM 
DTT, 1 mM PMSF, 2 mM benzamidine) per gram yeast cells and frozen in liquid nitrogen for 
storage at -80 °C if required. 
Frozen cells were thawed on ice and (NH4)2SO4 added to a final concentration of 400 mM 
(from a 2.5 M stock solution) and mixed with an equal volume of ice-cold dilution buffer 
(400 mM (NH4)2SO4, 100 mM HEPES pH 7.8, 20 mM MgCl2, 1 mM DTT, 1 mM PMSF, 
2 mM benzamidine). 120 ml of this cell suspension were added to 120 ml pre-cooled glass 
beads (Ø 0.75–1 mm, Roth) and the cells were lysed using a Pulverisette 6 planetary mono 
mill (Fritsch) (3 cycles of 4 min 500 rpm and 1 min cooling). Glass beads were separated by 
filtration prior to centrifugation (20 min, 8000 g, 4°C; Herolab A6.9) to remove the cell debris 
and residual glass beads. The final whole cell extract (WCE) was obtained after centrifugation 
at 100,000 g for 90 min (Kontron TFT55.38 or Beckman Ti45) by separating the clear middle 
phase from the turbid insoluble matter in the lower phase and the top layer of lipids. Protein 
concentrations were determined using the method by Bradford (1976) (see 4.2.4.1). If 
required, the WCE was frozen in liquid nitrogen and stored at -80 °C. 
 
 
4.2.3 Pol I purification 
 
A scheme of the purification strategy is given in Figure 15. All steps were performed at 4 °C. 
50 ml of the GPY2-WCE (see 4.2.2.2) were dialyzed against buffer B (50 mM KAc, 20 mM 
HEPES pH 7.8, 1 mM MgCl2, 10 % glycerol, 1 mM PMSF, 2 mM benzamidine, 5 mM β-
mercaptoethanol) over night, using Spectra/Por 2 dialysis tubing (MWCO 12-14 kDa) 
(Spectrum Laboratories). After centrifugation at 30,000 g for 1 h (Beckman Ti45), the pellet 
was resuspended in buffer C (1.5 M KAc, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10 % 
glycerol, 0.1 % NP40, 5 mM β-mercaptoethanol, 1 mM PMSF, 2 mM benzamidine) and 
applied to 2 ml equilibrated Ni-NTA Agarose (Qiagen). Binding was performed in batch for 4 
hours on a turning wheel, before pouring the suspension into disposable 20 ml Econo-Pac 
columns (Bio-Rad) for subsequent wash-steps with buffer C and buffer D (300 mM KAc, 
20 mM HEPES pH 7.8, 1 mM MgCl2, 10 % glycerol, 0.1 % NP40, 5 mM β-mercaptoethanol, 
1 mM PMSF, 2 mM benzamidine) and elution with buffer E (buffer D + 50 mM imidazole). 
The eluting proteins were loaded onto a Mono Q anion exchange column (Mono Q HR5/5, 
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Pharmacia) and fractionated by applying a salt gradient from 300 mM to 2 M KAc with 
buffers F (20 mM HEPES pH 7.8, 1 mM MgCl2, 10 % glycerol) and G (buffer F + 2 M KAc).  
0.5 ml aliquots of the pooled Pol I containing fractions (eluting at 1.1 M KAc) were applied to 
gelfiltration chromatography on a Superose 6 column (Superose 6 HR10/30, Pharmacia) with 
buffer H (1.5 M KAc, 20 mM HEPES pH 7.8, 1 mM MgCl2, 10 % glycerol). 
 
 
4.2.4 Protein analysis 
 
4.2.4.1 Determination of protein concentrations 
 
Protein concentrations were determined using the Bio-Rad Protein Assay which is based on 
the method by Bradford (1976). Briefly, 1-10 µl of each protein solution to be tested were 
mixed with 1 ml of the protein assay dye (Bio-Rad) after diluting the reagent to the working 
concentration according to the manufacturer’s instructions. The approximate protein 
concentrations in µg/µl were calculated by dividing the absorbance at 595 nm (= OD595, 
corrected for the absorbance of the dye) by the sample volume and multiplying with the factor 
23 which was determined using a BSA standard curve. 
 
 
4.2.4.2 Protein precipitation for analysis 
 
4.2.4.2.1 TCA precipitation 
 
The volume of the protein sample to be analyzed was adjusted to 100µl with cold H2O prior 
to mixing with 10 µl ice-cold 100 % (w/v) TCA (final concentration approximately 10 % 
TCA) and 2 µl 2 % (w/v) DOC (Desoxycholate) (Bensadoun and Weinstein, 1976). 
Precipitation was conducted for about 30 min on ice. The proteins were pelleted by 
centrifugation in a refrigerated table top centrifuge (13000 rpm, 20 min, 4 °C) and the 
supernatant carefully removed with a suction pump. The pH of the pellet was neutralized 
under a stream of NH3, taken from the gaseous phase of a NH4OH-bottle with a Pasteur-
pipette. Finally the proteins were resolubilized in an adequate volume of SDS-sample buffer 
for separation by SDS-PAGE. 
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4.2.4.2.2 Chloroform/methanol precipitation 
 
Protein precipitation for subsequent mass spectrometric analyses was performed using the 
chloroform/methanol precipitation method by Wessel and Flügge (1984). The volume of the 
sample was adjusted to 150 µl with H2O, followed by the addition of four volumes (450 µl) 
methanol, one volume (150 µl) chloroform and 3 volumes (450 µl) H2O. After each of these 
addition steps the sample was mixed well by vortexing. The resulting phases were separated 
by centrifugation in a table top centrifuge for 5 min, 13000 rpm. The upper phase was 
discarded while carefully avoiding loss of the interphase which contains the precipitated 
proteins. Upon addition of another three volumes of methanol (450 µl) and vortexing, the 
proteins were pelleted by centrifugation (5 min, 13000 rpm). The supernatant was completely 
removed and the protein pellet dried for 10 min in a vacuum centrifuge (Speed-Vac 
Concentrator). After resolubilization with NuPAGE sample buffer (Invitrogen) the proteins 
were either directly loaded on a polyacrylamide gel or stored at -20°C. 
 
 
4.2.4.3 Separation of proteins by SDS-PAGE 
 
The proteins contained in the samples were separated according their molecular weight using 
the discontinuous SDS-polyacrylamide gel electrophoresis (SDS-PAGE) method by Laemmli 
(1970). Vertical electrophoresis was performed on 10-12.5 % polyacrylamide gels using 
either the Mini-PROTEAN 3 system (Bio-Rad) or a Peqlab electrophoresis system (Peqlab 
Biotechnologie GmBH, model 45-2010-i). Broad range protein marker (NEB) or pre-stained 
broad range protein marker (NEB) was used for size-determination. 
 
Samples for mass spectrometric analyses were separated on 4-12 % gradient NuPAGE Bis-
Tris gels (Invitrogen) using the NuPAGE MOPS SDS running buffer (Invitrogen) 
complemented with NuPAGE antioxidant (Invitrogen). Gel electrophoresis was performed 
according to the manufacturer’s instructions except for the voltage applied. Instead of running 
the gels at constant 200 V, a constant current of 50 mA was applied while limiting the voltage 
to maximum 180 V. 
 
 
4.2.4.4 Western Blot 
 
In order to detect specific proteins via immunodetection in the samples separated by SDS-
PAGE, the proteins were transferred to PVDF-membrane (Polyvinyldifluoride) 
(Immobilion-P 0.45µm, Millipore) using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad).  
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The gel and the PVDF membrane (pretreated with methanol) were placed into the semi-dry 
blot apparatus between two piles of three 3MM filter-papers (Millipore) soaked with transfer-
buffer (20 % (v/v) methanol, 47.8 mM Tris, 38.6 mM glycine, 0.037 % (w/v) SDS) and a 
constant voltage of 24 V applied for 60-75 min. All filter-papers and the membrane had the 
same size as the SDS-gel and air bubbles between the layers were rolled out, because these 
would interfere with the transfer. 
To control the blotting of the proteins before immunodetection, the total protein content was 
reversibly stained with Ponceau S. The membrane was incubated for 5 min at RT in the 
Ponceau S-staining solution (0.5 % (w/v) Ponceau S, 1 % (v/v) acetic acid) and slightly 
destained with H2O until the protein bands were visible. 
 
Prior to specific immunodetection of defined proteins, the free space on the membrane was 
blocked with non-related proteins from bovine milk to avoid unspecific binding of the 
antibodies by incubating the blot-membrane with 5 % (w/v) milk powder in PBS (137 mM 
NaCl, 2.7 mM KCl, 1.4 mM KH2PO4, 4.3 mM Na2HPO4, pH 7.4) for 1 h at RT or over night 
at 4 °C on a shaker. The antibodies were diluted to an adequate working dilution (see 4.1.8) in 
PBST (PBS plus 0.05 % (v/v) Tween 20) supplemented with 5 % (w/v) milk powder. The 
incubations were performed in small bags made of sealed plastic foils on a turning wheel at 
RT for 1 h (primary antibodies) or 40 min (secondary antibodies). Following each antibody 
incubation step, the membrane was washed three times for 5 min in about 50 ml PBST on a 
shaker. 
To detect the specifically bound antibodies on the blot, the membrane was incubated for 
1 min at RT with 2-4 ml BM Chemiluminescence Blotting Substrate (POD) (Roche) which 
was prepared according to the manufacturer’s instructions. This reagent contains hydrogen 
peroxide (H2O2) and luminol which is a substrate for the horseradish peroxidase conjugated to 
the secondary antibodies used in this study. The light which is emitted during this reaction at 
the corresponding specific positions of the blot-membrane was detected with a LAS-3000 
chemiluminescence imager (Fujifilm) using the software Image Reader (Raytest).  
 
 
4.2.4.5 Polyacrylamid gel staining 
 
4.2.4.5.1 Coomassie staining 
 
To visualize the total protein content of a polyacrylamide gel, it was stained with SimplyBlue 
SafeStain (Invitrogen) according to the manufacturer’s instructions. This stain is a 
commercially available pure (i.e. keratin-free) Coomassie G-250 stain. Briefly, the gel was 
washed 3 times 5 min with H2O to remove SDS and buffer salts which interfere with the 
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binding of the stain to the proteins. Staining was performed for 1 h at RT on a shaker, before 
destaining with H2O. 
 
 
4.2.4.5.2 Silver staining 
 
To stain polyacrylamide gels with low protein content, the more sensitive silver staining was 
preferred over the coomassie staining. The proteins were fixated in the gel by incubation in 
fixation-solution (50 % (v/v) methanol, 12 % (v/v) acetic acid, 0.02 % (v/v) formaldehyde) 
for 1 h or over night (RT). Afterwards the gel was washed in 50 % (v/v) ethanol for 20 min 
and incubated in 0.8 mM Na2S2O3 for 1 min, directly followed by three 20 seconds wash steps 
with H2O. Next, the gel was incubated in staining-solution (12 mM AgNO3, 0.03 % (v/v) 
formaldehyde) for 20 min and washed two times for 20 seconds with H2O. The stained 
protein bands became visible upon incubation with developing solution (566 mM Na2CO3, 
0.02 % (v/v) formaldehyde, 0.016 mM Na2S2O3). The development was stopped with 1 % 
acetic acid. 
 
 
4.2.4.5.3 Phosphoprotein staining 
 
SDS-polyacrylamide gels were stained with Pro Q Diamond Phosphoprotein stain 
(Invitrogen) according to the manufacturer’s instructions and visualized on a 315 nm UV 
transilluminator. The same gel was then stained with SimplyBlue SafeStain (Invitrogen) for 
total protein staining (see 4.2.4.5.1). 
 
 
4.2.5 Unspecific transcription assay 
 
12.5 µl of the RNA polymerase preparation to be tested were incubated with 12.5 µl 
3H-transcription mix for 30 min at RT in 15 ml tubes. The 3H-transcription mix contains 
nicked calf thymus DNA as template as well as all four NTPs including 3H-UTP. RNA 
polymerases are able to initiate transcription in a promoter-independent way at the DNA nicks 
and thus produce 3H-labeled RNA according to their enzymatic activity in this assay. The 
reaction was stopped by mixing with 200 µl of a saturated pyrophosphate solution containing 
0.1 mg/ml salmon sperm DNA (Invitrogen), followed by precipitation of the proteins with 
10 ml 5 % TCA for 30 min on ice. To remove the surplus of radiolabeled nucleotides, the 
solution was filtered through GFC-filters (Millipore) which were pretreated with a saturated 
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pyrophosphate solution. The filters were washed three times with 5 % TCA and once with 
ethanol before drying at RT. The amount of 3H-labeled RNA bound to the filters was 
measured after adding 1 ml Ultima Gold scintillation mix (Packard) by measuring the counts 
per minute for 1 min in a liquid scintillation analyzer 1600 TR (Packard). 
 
3H-transcription mix  
1.5 ml nicked calf thymus DNA 1 mg/ml in TE-buffer, including 5 mM MgCl2 and 20µg/ml 
BSA; nicked by limited digested with DNase I 
1 ml 3H-NTP-mix 3.3 mM ATP, CTP and GTP, each; 0.01 mM UTP; 100 µCi 
5-3H-UTP (Amersham); 125 mM KCl; 25 mM MgCl2
 
 
4.2.6 Protein identification using MALDI-TOF/TOF mass spectrometry 
 
Samples of the purified Pol I preparations were precipitated by methanol/chloroform and 
loaded on a 4-12 % NuPAGE Bis-Tris gel (Invitrogen). After electrophoresis using NuPAGE 
MOPS SDS running buffer (Invitrogen), the gel was stained with SimplyBlue SafeStain 
(Invitrogen) and the bands of interest were excised. The proteins were digested in gel with 
modified sequencing grade trypsin (Roche) (Shevchenko et al., 1996; Shevchenko et al., 
2007). Briefly, the excised gel pieces were cut into small cubes (edge length about 1 mm) and 
subsequently washed with 50 mM NH4CO3, 50 mM NH4CO3 / 25 % (v/v) acetonitrile, 25 % 
(v/v) acetonitrile and 50 % (v/v) acetonitrile, followed by lyophilization. The dried gel pieces 
were rehydrated with an equal volume of trypsin in 50 mM NH4CO3 (endconcentration 4 µg 
trypsin per 100 µl gel) for 30 min at RT. After addition of another volume 50 mM NH4CO3 
and incubation at 37 °C for 16 h, the resulting tryptic peptides were eluted by diffusion upon 
shaking the gel cubes in two volumes of 100 mM NH4CO3 (two times), 100 mM NH4CO3 / 
25 % (v/v) acetonitrile and 50 % (v/v) acetonitrile / 0,1 % (v/v) TFA at RT. The supernatants 
of these elution steps were pooled in a fresh Eppendorf 1.5 ml Tube and the solvents removed 
by lyophilization. 
Prior to analysis, the peptides were desalted using ZipTip C18 pipette tips (Millipore) 
according to the manufacturer’s instructions. The peptides were eluted with 2 µl 50-80 % 
(v/v) acetonitrile / 0,1 % (v/v) TFA, mixed with 1 µl α-cyano-4-hydroxycinnamic acid 
(CHCA; Sigma-Aldrich) (6 mg/ml in 50 % (v/v) acetonitrile / 0,1 % (v/v) TFA; final 
concentration: 2 mg/ml CHCA) and manually spotted on the MALDI target plate using the 
dried-droplet method (Cañas et al., 2007). 
Peptide mass fingerprints and MS/MS analyses were performed on an Applied Biosystems 
4700 Proteomics Analyzer MALDI-TOF/TOF mass spectrometer operated in positive ion 
reflector mode and evaluated by searching the NCBInr protein sequence database with the 
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Mascot search engine (Matrix Science) implemented in the GPS Explorer software (Applied 
Biosystems). 
 
 
4.2.7 Identification of phosphorylation sites 
 
Following in-gel digestion (see 4.2.6), approximately 37.5 pmol of the tryptic peptides of any 
phosphorylated Pol I subunit were used for the chemical derivatization at a time. The 
sulfhydryl groups of the cysteine residues were protected by reduction with 10 mM DTT at 
37 °C and carboxymethylation with 35 mM Iodoacetic acid at 24 °C for 1 h each. The 
β-elimination and Michael-addition reactions were performed in a single step by incubation of 
the alkylated peptides in the presence of 64.5 mM Ba(OH)2 (taken from a freshly prepared 
saturated Ba(OH)2 solution) with either 450 mM ethanethiol or 400 mM pentanethiol in 30 % 
acetonitrile at 50 °C for 90 minutes. The reactions were stopped by precipitation of BaCO3 
after the addition of NH4HCO3 to a final concentration of 100 mM. Residual alkanethiols, 
NH4HCO3 and acetonitrile were removed by lyophilization. The modified peptides were 
either analyzed after desalting with ZipTip C18 pipette tips (Millipore) as described for protein 
identification (4.2.6) or fractionated via C18 reverse phase liquid chromatography. The latter 
was performed using a Dionex UltiMate NanoHPLC applying a gradient from 15 to 60 % 
acetonitrile / 0,05 % TFA at a flow rate of 300 nl/min within 90 min. Fractions were mixed 
with CHCA matrix and collected directly on the MALDI-target using a Dionex Probot  
system. All samples were analyzed on an Applied Biosystems 4700 Proteomics Analyzer 
MALDI-TOF/TOF mass spectrometer. Identification of the originally phosphorylated 
residues is based on the unique mass shift of + 44.0085 Da (for ethanethiol) or + 86.0554 Da 
(for pentanethiol) compared to the expected mass of an unmodified serine or threonine. A 
customized Pol I sequence database (including trypsin and all co-purifying proteins) was used 
to allow more variables in the search parameters and the results were confirmed by searching 
against the NCBInr protein sequence database. 
 
 
4.2.8 Creation of mutant yeast strains 
 
4.2.8.1 Cloning of genes coding for Pol I subunits (RPA-genes) 
 
For the mutational analyses, the genes coding for the in vivo phosphorylated Pol I subunits 
were cloned into vector pRS314 (TRP1) (Sikorski and Hieter, 1989) (see 4.1.3) including 
their endogenous promoter and terminator regions.  
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Molecular biological techniques (including restriction digestion, ligation, PCR and DNA 
analyses by agarose gel electrophoresis) were performed according to standard protocols 
(Sambrook and Russell, 2001). E. coli strains XL1-Blue or DH5α (see 4.1.2) were used for 
plasmid amplification. Transformation of competent E. coli cells was conducted by 
electroporation using a MicroPulser Electroporation apparatus (Bio-Rad) with 2 mm cuvettes. 
Plasmid mini-preps, PCR product purifications and agarose gel-extractions were performed 
using commercially available kits by Invitrogen or Qiagen according to the manufacturers’ 
instructions. 
 
RPA190 was subcloned from plasmid pNOY16 (Wittekind et al., 1988) which contains an 
11 kb fragment of chromosome XV including RPA190 and RPA43. First, a short 870 bp 
fragment spanning the region from position -801 to +69 of RPA190 was amplified by PCR 
and cloned into pRS314 via a new Xho I site from the forward primer and a Bam HI site at 
position +49 of RPA190. This construct was cut with Bam HI and Spe I and ligated with a 
5.8 kb Bam HI - Avr II fragment of pNOY16 which contains the remaining part of RPA190 
including the 3’UTR. Spe I and Avr II can be efficiently ligated due to the compatible 
overhangs, but the resulting sequence can not be recognized by either one of the two 
restriction enzymes. 
RPA34, RPO26 and RPC19 were amplified from yeast genomic DNA (strain S288C, 
Invitrogen) via PCR. The primers contained additional Xho I sites (forward primers) or 
Bam HI sites (reverse primers) which were used for cloning into vector pRS314. 
Plasmid pGP5 (RPA43 cloned into pRS314) (Peyroche et al., 2000) was used for the analyses 
of the A43 subunit. 
 
For the cloning of RPA12 into vectors pRS314 (TRP1) and YCplac33 (URA3), the ORF plus 
promoter and terminator regions was amplified from yeast genomic DNA (strain S288C, 
Invitrogen) using PCR primers with additional Eco RI (forward primer) or Bam HI (reverse 
primer) restriction sites. Cloning into vector YCplac111Gal (LEU2) was performed using 
primers Bam HI (forward primer) or Sph I (reverse primer) sites. In this case the gene was 
cloned starting from +1 (ATG); the RPA12 promoter was replaced by the Gal1-10 promoter 
included in the vector (Ferreira-Cerca et al., 2005). 
 
 
4.2.8.2 Site-directed mutagenesis 
 
A scheme of the mutagenesis strategy is given Figure 25. PCR reactions were performed with 
primers carrying the desired mutations (see 4.1.4) on plasmids containing the gene for the 
respective Pol I subunit. The length of the PCR product was chosen to span a unique 
restriction site, which in turn was used to cut another aliquot of the same plasmid. 45-75 ng of 
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the PCR product were transformed together with 15 ng of the linearized plasmid into a 
BSY420 (1n) wildtype yeast strain (see 4.2.8.3). Transformants were selected for the TRP1 
marker contained on the vector. As a consequence only cells carrying a plasmid repaired by 
homologous recombination could form colonies. After plasmid isolation, vectors containing 
the mutation were selected by restriction analysis screening for a new restriction site, which 
was also introduced in the PCR primer, but results in a silent mutation. All constructs were 
verified by sequencing.  
 
 
4.2.8.3 Yeast transformation 
 
Yeast cells were transformed with plasmids (carrying mutant or WT alleles of RPA-genes) or 
linear DNA fragments (for homologous recombination in gap repair or chromosomal 
integration) using the DMSO-enhanced lithium acetate (LiAc) method by Hill et al. (1991) 
with some slight modifications.  
50 ml liquid YPD cultures were grown to OD600 = 0.5-1.5 in shake flasks. The cells were 
gently pelleted by centrifugation (about 2000 g, 3 min, RT) and resuspended in 15.3 µl LiT-
buffer (100 mM LiAc, 10 mM Tris/Cl pH 7.4) per OD600 and ml. 100 µl of this cell 
suspension were used per transformation batch.  
Each 100 µl cell suspension-batch was supplemented with 40-200 ng plasmid DNA or up to 
1 µg linear DNA to be transformed, 10 µl salmon sperm DNA (10 mg/ml, Invitrogen) and 
500 µl LiT-PEG-buffer (50 % (w/v) PEG 4000 in LiT-buffer), followed by incubation for 
45 min at RT on a turning wheel. Afterwards the transformation-batches were gently mixed 
with 50 µl DMSO, heat-shocked at 42 °C for 15 min and pelleted by centrifugation in a table 
top centrifuge (3000 rpm, 30 sec).  
For selection of auxotrophic markers (e.g. the TRP1 marker contained on the mutant vectors) 
the cells were directly resuspended in 100 µl H2O and plated on SDC-plates lacking the 
corresponding amino acids. If selection of the dominant marker G418R was required, the cells 
were first resuspended in 1 ml YPD medium and incubated for about 2 h at 30 °C while 
shaking to allow the expression of the marker before plating on the selection media as 
described for auxotrophic markers (Mount et al., 1996). Because the selection on G418-
containing YPD-plates often results in a high number of transient transformants, these plates 
were replica-plated on fresh G418 plates before cultivating single clones. 
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4.2.8.4 Yeast plasmid shuffle 
 
Plasmid shuffle yeast-strains were used to replace the essential RPA-genes for the mutant 
alleles. In these strains the chromosomal locus of the gene of interest is knocked-out with a 
marker gene and the deletion complemented by a wild-type copy of the gene of interest on a 
plasmid containing a counterselectable marker. The mutant copy is introduced on another 
plasmid and the strain grown on the corresponding selection-medium. If the mutant allele is 
able complement the chromosomal deletion, the plasmid containing the wild-type copy can be 
lost during cultivation. Finally growth on the respective counterselection medium is lethal for 
all cells still containing the wild-type plasmid. 
 
Single clones derived from LiAc-transformations of the mutant vectors (see 4.1.3) into the 
corresponding shuffle-yeast strains (see 4.2.8.3) were streaked on the counterselection-plates 
with sterile disposable inoculation loops (Sarstedt). A portion of the same clones was streaked 
on control-plates containing the same medium except for the counterselection drug. 
Transformants of the RPA190-shuffle strain NOY222 (Wittekind et al., 1988) (see 4.1.1) 
were cultivated on plates containing L-canavanine to select against the CanS-allele of the 
CAN1-gene which codes for a functional arginine permease and thus allows for the uptake 
and incorporation of this lethal arginine-derivate (Grenson et al., 1966; Whelan et al., 1979; 
Broach et al., 1979). The transformants of all other RPA-shuffle strains (see 4.1.1) were 
cultivated on plates with 5-FOA (5-Fluoro-orotic acid) which facilitates counterselection 
against strains carrying a functional URA3-gene. URA3 codes for the enzyme orotidin-5’-
phosphate decarboxylase of the uracil-biosynthesis pathway which also converts 5-FOA into 
the toxic 5-fluorouracil (Boeke et al., 1984; Boeke et al., 1987).  
Single clones were controlled for 1) the presence of the mutant vector, 2) the loss of the wild-
type plasmid and 3) the maintenance of the chromosomal deletion via the respective 
auxotrophic markers. Single clones were further cultivated on YPD plates to obtain the 
mutant strains listed in 4.1.1. 
 
 
4.2.9 In vivo phenotyping of mutant yeast strains 
 
4.2.9.1 Spot tests on agar-plates 
 
Equally sized colonies of yeast strains carrying the phosphorylation site mutations or the 
corresponding wild type genes were resuspended in 1 ml sterile H2O and diluted to 
OD600 = 0.1. 7-10 µl of this cell suspension and of serial 1:10, 1:100 and 1:1000 dilutions 
were spotted on the test plates and on the corresponding control plates in parallel.  
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6-Azauracil (6AU)-phenotyping was performed with SDC-Ura plates supplemented with 
25-200 µg 6AU (up to 300 µg 6AU in single experiments). SDC-Ura and YPD plates were 
used as controls. Phenotypes were monitored after incubation at either 30 °C or 37 °C for 2 
days (plates without 6AU) or 4-6 days (plates with 6AU). 
Rapamycin was used at concentrations of 0.1-0.2 mM in YPD plates.  
 
 
4.2.9.2 Growth in liquid cultures, inoculated from stationary phase cells 
 
Mutant yeast strains and the corresponding wild-type strains were grown in 20 ml YPAD 
(YPD + 100 µg/ml adenine) to stationary phase. From these cultures fresh 50 ml YPAD liquid 
cultures in shake flasks were inoculated to OD600 = 0.1. Growth at 30 °C was monitored by 
measuring the OD600 in 1 h intervals. 
 
 
4.2.10 Figure preparation 
 
Figures were prepared with Illustrator CS (Adobe) and Photoshop CS (Adobe). Mass spectra 
were reproduced using Data Explorer (Applied Biosystems) and figures of Pol I structures 
were prepared with PyMOL (DeLano Scientific). 
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 6 Abbreviations 
 
 
6AU 6-azauracil 
Å Ångstrøm 
ACN acetonitrile 
ARS autonomous replication sequence 
bRNAP bacterial RNA polymerase 
CF core factor 
CHCA α-cyano-4-hydroxycinnamic acid 
ChIP chromatin immunoprecipitation 
CID collision induced dissociation 
cs cold sensitive 
CSM complete supplement mixture 
CTD carboxy-terminal domain 
Da Dalton 
DFC dense fibrillar component 
EM electron microscopy 
ESI electrospray ionization 
ETS external transcribed spacer 
EtSH ethanethiol 
FC fibrillar center 
GC granular component 
IMAC immobilized metal affinity chromatography 
IP immunoprecipitation 
ITS internal transcribed spacer 
KAc potassium acetate 
kDa kilo Dalton 
LB Luria Broth 
LC liquid chromatography 
m/z mass to charge ratio 
MALDI matrix assisted laser desorption/ionization 
MH+ molecular mass in Da (= M) plus one dalton from the proton added 
during the ionization process (= MH+) 
mRNA messenger RNA 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
nanoHPLC nano high pressure liquid chromatography 
NTS non-transcribed spacer 
OD600 optical density at 600 nm 
PAGE polyacrylamide gel electrophoresis 
PeSH pentanethiol 
 
 Abbreviations 
PKA protein kinase A 
PMF peptide mass fingerprint 
Pol I RNA polymerase I 
Pol II RNA polymerase II 
Pol III RNA polymerase III 
Pol IV RNA polymerase IV 
rDNA ribosomal DNA 
RP ribosomal protein 
rRNA ribosomal RNA 
SCX strong cation-exchanger 
SDC synthetic dextrose complete 
snoRNP small nucleolar ribonucleoprotein 
TBP TATA-binding protein 
TOF time of flight 
TOR target of rapamycin 
TORC target of rapamycin complex 
tRNA transfer RNA 
ts temperature sensitive 
UAF upstream activation factor 
WCE whole cell extract 
YNB yeast nitrogen base 
YPD yeast extract, peptone, dextrose 
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 7 Summary 
 
A tight control of ribosome biogenesis in dependence of the growth conditions is crucial for 
the economics of a cell. Signal transduction cascades forward the status of environmental 
factors to several key regulatory steps via reversible phosphorylation. As one of the first steps 
of ribosome biogenesis, the transcription of the 35S rRNA precursor by RNA polymerase I 
(Pol I) is also one of the main targets for regulation. In logarithmically growing 
Saccharomyces cerevisiae cells, five of the fourteen Pol I subunits were found to be 
phosphorylated in vivo (A190, A43, A34.5, ABC23 and AC19) to a total content of about 15 
± 3 phosphate groups per enzyme. Further in vivo and in vitro studies showed that the activity 
of Pol I is linked to its phosphorylation status. However, little is known about the positions 
and functions of the single Pol I phosphorylation sites. 
 
In this study the site-specific phosphorylation of yeast Pol I was analyzed using a combination 
of chemical derivatization and LC-MALDI-TOF/TOF mass spectrometry. Prerequisite was 
the development of a rapid method to purify Pol I while maintaining its phosphorylation 
status. The resulting enzyme preparations were active in promoter-independent transcription 
assays and the purity was suitable for structural analyses by the cooperating research group of 
Patrick Cramer. A total of 13 phosphoserines and –threonines were identified on the in vivo 
modified subunits. Five of these were confirmed by independent proteome-wide 
phosphorylation analyses which employed alternative methods and additionally provided four 
other sites. A Pol I homology model facilitated the three-dimensional localization of seven 
phosphorylation sites in the new cryo-EM structure.  
The single phosphoresidues were systematically mutated to alanine or aspartate to mimic 
constitutively dephosphorylated or phosphorylated states, respectively, and the resulting yeast 
strains were analyzed using in vivo assays. Surprisingly all Pol I phosphorylations analyzed 
were found to be non-essential posttranslational modifications. None of the mutants showed a 
detectable growth phenotype with one exception: mutation of A190 S685 to aspartate resulted 
in a lowered sensitivity to the NTP-depleting drug 6-azauracil (6AU) compared to the 
isogenic wild-type or the analogous mutation to alanine. This drug is commonly used to 
investigate defects associated to the elongation phase of RNA transcription. Strikingly, in a 
related study by Alarich Reiter the same mutation of phosphorylation site A190 S685 to 
aspartate but not to alanine was found to be synthetic lethal with the non-essential TFIIS-like 
Pol I subunit A12.2 which was described to function in transcription elongation, 3’ RNA 
cleavage and transcription termination. The data suggest a role of the reversible 
phosphorylation at A190 S685 in modulating one these functions.  
 
 
 Summary 
Furthermore a mutation of the TFIIS-like domain of A12.2 was created to analyze its role in 
the intrinsic Pol I RNA cleavage activity. Unexpectedly this mutation of the non-essential 
A12.2 was found to result in a lethal phenotype, possibly due to a dead end situation. Under 
the control of an inducible promoter, this mutant should provide a useful tool for the 
elucidation of the RNA cleavage process. 
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 8 Zusammenfassung 
 
 
Eine strikte Kontrolle der Ribosomen Biogenese in Abhängigkeit der Wachstumsbedingungen 
ist entscheidend für den Energiehaushalt einer Zelle. Signal-Transduktions-Kaskaden 
übermitteln die Umweltbedingungen an mehrere Schlüsselstellen mittels reversibler 
Phosphorylierung. Die Transkription der 35S Vorläufer rRNA durch die RNA Polymerase I 
(Pol I) ist, als einer der ersten Schritte der Ribosomen Biogenese, auch einer der 
Hauptangriffspunkte zur Regulation. In logarithmisch wachsenden Zellen der Hefe 
Saccharomyces cerevisiae werden fünf der vierzehn Pol I-Untereinheiten in vivo 
phosphoryliert (A190, A43, A34.5, ACB23 und A34.5). Insgesamt gibt es etwa 15 ± 3 
Phosphatgruppen pro Enzym. In vivo und in vitro Studien zeigten, dass die Aktivität der Pol I 
mit ihrem Phosphorylierungsstatus verknüpft ist, jedoch gibt es nur wenige Informationen 
über die Positionen und die Funktionen der einzelnen Phosphorylierungsstellen. 
 
In der vorliegenden Arbeit wurde die orts-spezifische Phosphorylierung der Pol I durch eine 
Kombination von chemischer Derivatisierung und LC-MALDI-TOF/TOF Massen-
spektrometrie untersucht. Vorraussetzung hierfür war die Entwicklung einer Methode zur 
schnellen Reinigung der Pol I, welche den Phosphorylierungsstatus erhält. Die 
Enzympräparationen waren aktiv in Promoter-unabhängigen Transkriptions-Tests und der 
Reinheitsgrad war geeignet für Strukturanalysen, die in Zusammenarbeit mit der 
Forschungsgruppe von Patrick Cramer durchgeführt wurden. Insgesamt wurden 13 
Phosphoserine und –threonine in den fünf in vivo modifizierten Untereinheiten identifiziert. 
Fünf davon wurden durch unabhängige proteomweite Phosphorylierungsanalysen bestätigt, 
welche alternative Methoden verwendeten und zusätzlich vier weitere Stellen identifizierten. 
Ein Pol I Homologie-Modell  ermöglichte die dreidimensionale Lokalisierung von sieben 
Phosphorylierungsstellen innerhalb der neuen Cryo-EM Struktur. 
Die einzelnen Phosphoaminosäuren wurden systematisch zu Alanin oder Aspartat mutiert um 
konstitutiv dephosphorylierte bzw. phosphorylierte Stadien zu imitieren, und die daraus 
hervorgehenden Hefestämme wurden mittels in vivo Analysen untersucht. 
Überraschenderweise sind alle untersuchten Pol I Phosphorylierungen nicht-essentielle post-
translationale Modifikationen. Keine der Mutanten zeigte einen erkennbaren Wachstums-
Phänotyp, mit einer Ausnahme: Verglichen mit einem isogenen Wildtyp Stamm oder einer 
analogen Mutation zu Alanin, resultierte die Mutation von A190 S685 zu Aspartat in einer 
geringeren Sensitivität gegenüber 6-Azaurazil (6AU), welches den zellulären NTP-Vorrat 
abreichert. Diese Chemikalie wird häufig verwendet um Defekte in der Elongationsphase der 
Transkription zu untersuchen. Auffallenderweise wurde in einer begleitenden Studie von 
Alarich Reiter die synthetische Letalität zwischen der gleiche Mutation der 
 
 Zusammenfassung 
Phosphorylierungsstelle A190 S685 zu Aspartat und der nicht-essentiellen Pol I Untereinheit 
A12.2 festgestellt, welche Funktionen in Transkriptions Elongation, 3’ RNA Spaltung und 
Transkriptions Termination hat. Die Daten lassen eine Beteiligung der reversiblen 
Phosphorylierung von A190 S685 an einer dieser Funktionen vermuten. 
 
Des Weiteren wurde eine Mutation in der TFIIS-ähnlichen  Domäne von A12.2 generiert um 
deren Rolle in der intrinsischen 3’ RNA-Spaltaktivität der Pol I zu untersuchen. 
Unerwarteterweise resultiert diese Mutation der nicht-essentiellen Untereinheit A12.2 in 
einem letalen Phänotyp. Unter der Kontrolle eines induzierbaren Promoters könnte diese 
Mutante ein wertvolles Werkzeug für weitere Untersuchungen des Mechanismus der Pol I 
RNA-Spaltaktivität darstellen. 
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